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Abstract
Obesity is a costly and growing health concern for the modern world and puts individuals at increased risk for
chronic illnesses. Although obesity is associated with many detrimental peripheral effects, food over
consumption is centrally mediated. The hypothalamus and brainstem regions control homeostatic food
intake, while hedonic food intake is mainly controlled by the central reward system. Palatable foods are
rewarding and over ride the homeostatic system and cause over consumption. Foods high in sugar and fat
acutely activate dopamine neurons in the classical reward pathway consisting of the ventral tegmental area
projecting to the nucleus accumbens and prefrontal cortex. Chronic intake of palatable foods is associated
with neuroadaptations that can lead to behavioral changes and further over consumption. This dissertation
characterizes the behavioral, transcriptional, and circuitry changes in the central dopamine system after
chronic high fat diet and high fat withdrawal in male and female mice. Four models of diet-induced obesity
were examined. Chapters 2 and 3 examined diet induced obesity models and standard chow intervention in
different age groups in order to reveal a developmental period sensitive to programming effects. We
discovered that both age and sex were critical factors in the development and the reversal of neuroadaptations
seen in obesity. Early life nutrition is particularly important to the developing brain and overnutrition during
this time period leads to epigenetic changes that may contribute to the neuroadaptations that persist after
intervention. In chapter 4, we examined exercise as an intervention to prevent the neuroadaptations and
neuroinflammation associated with high fat diet intake. We discovered that although exercise had a beneficial
effect of weight gain, it was not able to reverse reward dysfunction or neuroinflammation in all cases of high fat
intake. It is possible that the neuroadaptations that occur after high fat consumption contribute to the
difficulty individuals have with weight loss. Understanding how age and sex impact brain and behavior in the
high fat withdrawal stage will have implication for obesity management and interventions. We know now that
the brain of an individual is markedly different than the brain of a lean individual and these differences can
predispose one to overconsumption during dietary intervention. Since both pharmacological and behavioral
therapies are often combined with diet replacement, understanding the brain during this switch and factors
that can raise adherence rates will help the success of therapies in the future.
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ABSTRACT	  
 
HIGH FAT DIET AFFECTS THE DOPAMINE REWARD SYSTEM: IMPORTANCE OF 
SEX AND CRITICAL DEVELOPMENTAL PERIODS 
Jesse Lea Carlin 
Teresa M Reyes, Ph.D. 
 
Obesity is a costly and growing health concern for the modern world and puts 
individuals at increased risk for chronic illnesses.  Although obesity is associated with 
many detrimental peripheral effects, food over consumption is centrally mediated. The 
hypothalamus and brainstem regions control homeostatic food intake, while hedonic 
food intake is mainly controlled by the central reward system. Palatable foods are 
rewarding and over ride the homeostatic system and cause over consumption. Foods 
high in sugar and fat acutely activate dopamine neurons in the classical reward pathway 
consisting of the ventral tegmental area projecting to the nucleus accumbens and 
prefrontal cortex. Chronic intake of palatable foods is associated with neuroadaptations 
that can lead to behavioral changes and further over consumption. This dissertation 
characterizes the behavioral, transcriptional, and circuitry changes in the central 
dopamine system after chronic high fat diet and high fat withdrawal in male and female 
mice.  Four models of diet-induced obesity were examined. Chapters 2 and 3 examined 
diet induced obesity models and standard chow intervention in different age groups in 
order to reveal a developmental period sensitive to programming effects.  We discovered 
that both age and sex were critical factors in the development and the reversal of 
neuroadaptations seen in obesity. Early life nutrition is particularly important to the 
developing brain and overnutrition during this time period leads to epigenetic changes 
that may contribute to the neuroadaptations that persist after intervention. In chapter 4, 
	   v	  
we examined exercise as an intervention to prevent the neuroadaptations and 
neuroinflammation associated with high fat diet intake. We discovered that although 
exercise had a beneficial effect of weight gain, it was not able to reverse reward 
dysfunction or neuroinflammation in all cases of high fat intake.  It is possible that the 
neuroadaptations that occur after high fat consumption contribute to the difficulty 
individuals have with weight loss. Understanding how age and sex impact brain and 
behavior in the high fat withdrawal stage will have implication for obesity management 
and interventions. We know now that the brain of an individual is markedly different than 
the brain of a lean individual and these differences can predispose one to 
overconsumption during dietary intervention. Since both pharmacological and behavioral 
therapies are often combined with diet replacement, understanding the brain during this 
switch and factors that can raise adherence rates will help the success of therapies in 
the future.	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CHAPTER	  1:	  General	  Introduction	  
	  
The current statistics on obesity in the U.S are staggering with 34.4% of adult 
males and 36.1% of adult females considered obese in 2010 (Ogen et al., 2012). The 
obesity trend in adolescents is just as dire; 23.9 million children ages 5-19 are 
overweight or obese and the epidemic continues to grow (Go et al., 2013). Both genetic 
and environmental factors contribute to the development of obesity. Population studies 
have revealed specific gene mutations to cause monogenic forms of human obesity 
(Farooqi et al., 2005), and monozygotic twin studies reveal adiposity levels to be strongly 
heritable (Stunkard et al., 1986; Maes et al., 1997). However, those single gene 
mutations are very rare and human genetics are very stable. Therefore, it is unlikely that 
the current obesity epidemic is explained by mutations or gene x environment 
interactions alone.  The most drastic change for humans has occurred in the 
environment. The broad availability of energy dense foods and the decrease in daily 
activity has most Americans living in an environment that drives obesity and makes 
weight loss extremely difficult. The obesogenic environment affects the individual as 
early as the fetal stage. Over nutrition or poor nutrition during early life development can 
put one on a trajectory toward obesity in adulthood. Body weight and eating patterns 
early in life are extremely important in setting the risk for development of obesity and the 
ability to lose weight. In fact, it has recently been shown that establishment of obesity at 
age 5 predicts obesity at age 18 (Cunningham et al., 2014).  Sex is another factor that 
plays a role in an individual’s obesity risk. Women tend to have higher rates of obesity 
compared to males (Go et al., 2013). Women have higher overall body fat content as 
well as additional distribution to the breast, buttocks, and lower body (Martin et al., 
2013). Not only do women have a different physical presentation of obesity, women also 
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have different behaviors toward palatable foods that could put them at increased risk for 
overconsumption. Women rate food images as more pleasant, they have more negative 
feelings in the hunger state, and have a higher fMRI response to food cues compared to 
males (Geliebter et al., 2013).  In an effort to better treat and/or prevent obesity, an 
understanding of how sex and early life experiences interact to affect obesity risk is 
required. 
Central	  Acting	  Interventions	  for	  Obesity	  
	  
Approaches to the treatment of obesity include dietary intervention, exercising, 
pharmacological treatments, and gastric bypass surgery. Success rates at weight loss 
vary enormously between individuals and, in most cases, lost weight is gained back. 
Although obesity is associated with peripheral effects, such as increased adiposity, high 
blood pressure, and inflammation, food consumption is controlled centrally. In fact, many 
of the single gene mutations known to cause obesity do so by failing to produce satiety.  
The most studied Mendelian inherited obesity genes (leptin, leptin receptor, pro-
opiomelanocortin, melanocortin 3 receptor, melanocortin 4 receptor) lie within the central 
leptin-melanocortin signaling pathway of the hypothalamus and result in human obesity 
when loss of function occurs from mutation (Montague et al., 1997; Clement et al., 1998; 
Farooqi et al., 2007; Krude et al., 1998; Yeo et al., 1998).  Looking at obesity as a 
central food intake issue is an important direction for the field and has led to the 
development of centrally acting drugs to combat adiposity. Clinical drug trials for weight 
loss have targeted the brain in order to attempt to decrease food intake. Most 
medications prescribed for obesity regulate satiety through an effect on serotonergic, 
noradrenergic or dopaminergic receptor systems (Bray et al., 2000, Clapham et al., 
2001). Action on these neurotransmitter systems has led to reduced appetite or hunger 
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and, thus decreased food-seeking behavior.  Four centrally acting noradrenergic agents 
(phentermine, diethylpropion, phendimetrazine, benzphetamine) are currently FDA-
approved for management of obesity (Yanovski et al., 2014). These agents reduce 
appetite by activation of adrenergic and dopaminergic receptors. However, even in the 
most successful trials, high rates of drop out and weight gain occur at follow-up time 
points (Ioannides-Demos et al., 2012). There are still many obstacles, including non-
CNS effects that make it so difficult to lose weight and need to be overcome during 
obesity intervention. Age of onset of obesity is one factor not taken into consideration 
when analyzing clinical weight loss trial data. It is true that weight loss becomes more 
challenging as one ages, and adults who were obese as children find it even more 
difficult to lose weight (Cockrell & Skinner, 2008). Identifying the factors that make 
childhood obesity more resistant to weight loss may lead to changes in 
pharmacotherapy for this population in the future. 
The	  Obese	  Brain	  	  
	  
Obesity is associated with excessive overeating and preference for palatable, high-fat 
foods even when body energy stores are high (Sclafani, 2001; Gaillard et al., 
2008). There seems to be a mismatch between the caloric needs of the body and what 
the brain tells the body to consume. Since the brain controls food intake, much research 
has been done to see how the obese brain has changed in comparison to its lean 
counterpart. Imaging studies in obese patients have given us insight into the regions 
possibly involved in the loss of homeostatic food consumption.  Combined evidence 
points to regions involved mainly in reward processing, taste, and attention that are 
altered in obese patients. Imaging studies in obese patients have detected increased 
blood flow to the striatum, the orbitalfrontal cortex, and the insula when viewing pictures 
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of highly palatable foods (Rothemond et al., 2007; Scheinle et al., 2009, Sharmueller et 
al., 2012). Imaging studies have also revealed diminished functional connectivity 
between these regions important for reward evaluation (Stoeckel et al., 2009; Kulleman 
et al., 2011). These changes are thought to lead to deficiencies in evaluating food 
reward value and contribute to the drive to overeat. In fact, behavioral studies have 
shown obese individuals to direct their attention to food related stimuli more so than lean 
individuals (Nijs et al., 2010). This shift in attention and preference may also increase the 
vulnerability to further over consume food. The shift in attention toward a learned reward 
is not specific to obesity in general, but has also been seen to occur in addicted 
individuals and drug cues. Obese patients seem to have an increased central response 
to food cues, but how does the brain react during actual food consumption? 
 Interestingly, studies have revealed a decrease in the hedonic response to food intake. 
Over weight individuals have reduced activation of the striatum in response to ingesting 
a palatable solution (Stice et al., 2010). Although obese individuals seem to react 
strongly to food cues, the hedonic response to intake is diminished. Hedonic drive is 
mediated by the dopamine reward system and is acutely activated by rewards like 
palatable foods, sex, and drugs of abuse. A decrease in dopamine receptors have been 
reported in the striatum of obese patients and this has implications for appetite control as 
well as other reward behaviors (Wang et al., 2001, Steele et al., 2010).  Some, but not 
all, differences in the obese brain reverse after individuals lose weight. Imaging studies 
have also looked at the post-obese population and have shown insula activation remains 
elevated after weight loss (DelParigi et al., 2004). On the other hand, experiments have 
also shown normalization of dopamine receptors after bariatric surgery (Steele et al., 
2010). The neurobiological changes that persist after intervention may contribute to the 
high failure rates and relapse to unhealthy eating habits. It is important to understand if 
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some kinds obesity interventions can reverse or prevent the brain changes seen in 
obesity better than other types on intervention. 
The previous studies support the theory of reward dysfunction in obesity. Obese 
individuals seem to be more sensitive to food cues; however, reward activation is 
diminished during food intake. This would suggest that there is an increased drive to 
obtain food. However, because patients are less sensitive to the rewarding effects of 
food, they would therefore consume more in an effort to obtain sufficient reward levels. 
This has been demonstrated in progressive ratio studies where obese individuals give a 
higher reinforcing value to food (Epstein et al., 2007; Temple et al., 2008). Future studies 
are warranted to see if a higher reinforcing value plus diminished reward activation are 
behind the overconsumption of palatable foods in obese individuals and if there are sub 
populations of obese patients that may benefit from targeting overconsumption 
behaviors. 
Obesity	  Interventions	  
	  
Successful weight loss is extremely difficult for the obese population and is 
influenced by many factors, such as age of onset and sex. Caloric restriction or “dieting” 
is very effective for weight loss, but has proven to be very difficult to adhere to in the 
general population. One reason is caloric restriction induces biological changes that 
make adherence difficult. The over abundance of highly rewarding, highly palatable 
foods makes relapse even easier. Dieting produces changes in appetite, notably an 
increase in hunger (Pasman et al., 1997) and persistent thoughts about eating (Green et 
al., 2005). Other approaches to the treatment of obesity include, exercise, 
pharmacological treatments, and gastric bypass surgery. Pharmacological interventions 
cause a moderate loss in body weight and have many negative side effects. 
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Pharmaceutical trials focus exclusively on reduction of body mass and normalization of 
markers of obesity and do not usually assess the state of mind or drive to eat. Gastric 
bypass surgery is a last line of defense treatment for extreme obesity and is very 
successful in long-term body weight reduction. Adaptive responses that increase 
appetite after weight loss do not seem to occur after weight loss induced by bariatric 
surgeries as they do with typical dieting interventions (Berthoud et al., 2012). Bariatric 
surgery patients have a diminished desire to eat (Shultes et al., 2010) and exhibit 
normalization of dopamine receptor D2 (DR2) levels after surgery (Steele et al., 2010; 
Dunn et al., 2010). However, dieting is still the most common way to attempt weight loss 
in the obese population.  How the dopamine reward system changes after high fat 
replacement needs to be studied in order to better understand the behavioral changes 
that either promote or hinder adherence to a diet. Characterizing how dopamine circuitry 
changes when high fat diet is switched to a low fat diet may help us discover why dieting 
is so difficult for obese individuals. Additionally, characterizing important factors, such as 
age and sex that impact the response to high fat withdrawal will be important for 
analyzing clinical weight loss trial results in the future. 
Many factors, such as stress, can make caloric restriction difficult and cause 
return to high fat food consumption. High-fat diet removal elicits palatable food cravings 
and exposure to foods cues and/or stressful experiences can cause relapse (Nair et al., 
2009). Many kinds of stress, such as physical, psychosocial, and pharmacological 
stressors can stimulate palatable food seeking and return to unhealthy eating habits 
(Grilo et al., 1989; Ghitza et al., 2006; Nair et al., 2011). This is comparable to what is 
seen in drug addiction. After extinction of the drug reward, different types of stressors 
can reinstate drug seeking (Hyman et al., 2006). Many researchers have noted 
similarities between drug withdrawal and palatable food removal. It has even been 
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documented that removal of a high fat/high sugar diet causes withdrawal symptoms 
similar to opiate withdrawal (Avena et al., 2008a). The mechanisms behind stress-
induced reinstatement of palatable food seeking are still being examined. Nair et al., 
(2011) have discovered that blocking dopamine receptors in the prefrontal cortex can 
inhibit stress-induced reinstatement of food seeking. Ghitza et al. (2006) discovered a 
similar role for CFR1 receptors in the amygdala. By blocking activation of CRF1, food 
seeking is not reinstated by a pharmacological stressor. Food cues also have the ability, 
like stress, to trigger relapse to palatable food seeking. The reinstatement by food cues 
is likely to be mediated by additional mechanisms and brain regions than reinstatement 
by stressors. Priming with drugs that increase dopamine, such as cocaine or 
amphetamine works to reinstate palatable food seeking as well as priming with food or a 
cue that predicts palatable food (Ghitza et al., 2007; Keiflin et al., 2008; Odum & 
Shahan, 2004). One factor to consider when interpreting these results is many of these 
studies were performed in lean rodent models. There are many neurobiological changes 
that occur after diet induced obesity and research on palatable food reinstatement after 
acute high fat withdrawal or long term high fat withdrawal need to be examined. 
We have seen that stressors can be a trigger to cause increased intake of 
palatable foods. However, can removal of the palatable food be a stressor in itself?  
Little is known about the consumption of palatable foods following withdrawal from 
chronic HFD and the reward-relevant neurobehavioral changes that may occur. We 
know that food restriction in lean animals causes stress and increases administration of 
drugs of abuse like cocaine and amphetamine (Carroll and Meisch, 1980; Stuber et al., 
2002). Other studies have confirmed a strong relationship with food restriction and the 
increase in the rewarding properties of drugs such as amphetamine (Takahashi et al., 
1978), heroin (Oei et al., 1980) and cocaine (Carroll et al., 1981). It is unlikely however, 
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that food restriction in lean animals is similar to withdrawal of a high fat diet in obese 
animals, given what is known about the differences in reward relevant circuitry in the 
brains of lean and obese animals. High fat diet withdrawal has also been shown to 
increase responding for sucrose in obesity prone rats (Pickering et al., 2009). This 
suggests that the propensity to relapse may be stronger in some individuals than others. 
Further, we know from Zorilla lab and colleagues (Cottone et al., 2008a; 2008b; 2009) 
that intermittent access to a high fat diet causes anxiety behavior and increases 
responding to palatable food reward in rodents. Others have found that an acute 
withdrawal (only 24 hours) causes anxiety behavior in an open field test (Teegarden et 
al., 2007). Withdrawal from a high fat diet can increase basal corticosterone levels 
(Sharma et al., 2013) but has no effect on stress induced cort levels (Pickering et al., 
2009) and changes in CRF levels in the amygdala (Teegarden et al., 2007). Removal of 
other rewarding substances, such as sucrose, can also be a stressor and cause an 
increase in anxiety-like behaviors (Avena et al., 2008b). Body weight loss goes hand in 
hand with high fat diet removal.  It is possible that body weight loss can cause an 
activation of the body’s stress system as well (Bailey et al., 2004). Looking at a time 
point where high adiposity is still present but the diet has been withdrawn can be a 
helpful way to control for the stress of high body weight loss. Although changes in CRF1 
levels were not seen in the amygdala after high fat withdrawal in a diet induced obese 
model (Sharma et al., 2013), it is still possible that activation of stress circuitry after high 
fat diet removal can contribute to reward behavior observed after high fat diet removal.  
 
Homeostatic	  Regulation	  of	  Food	  Intake	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The hypothalamic and mesolimbic dopamine systems participate in the 
integration and control of food intake. Dopamine acting in the hypothalamus is important 
for basal food intake and influences feeding frequency and volume (Meguid, et al., 
2000). For example, dopamine is released in the lateral hypothalamic area in response 
to feeding and normalizes after meal termination (Yang et al., 1996). Dopamine release 
in the hypothalamus leads to activation of neuropeptides involved in both food intake 
stimulation (e.g. melanin concentrating hormone (MCH), neuropeptide Y (NPY), Agouti 
related peptide (AgRP), galanin, and orexin) and food intake inhibition (e.g., a-
melanocyte-stimulating hormone (MSH), cocaine and amphetamine-regulated transcript 
(CART), and corticotrophin-releasing factor (CRF)) depending on the complex metabolic 
conditions occurring in the body. The basic circuitry of the hypothalamus and brain stem 
is under multiple points of regulation and has the ability to sense macronutrients, 
hormones, gut signals, and energy stores to control energy metabolism and food intake 
behavior in order to maintain homeostasis.  There are two main sources of circulating 
nutrients: food intake, and production of glucose and lipids by the liver. Increased 
availability of macronutrients such as glucose and lipids activates sensing pathways in 
the brain, either directly through metabolic signals (e.g., fatty acids), or indirectly, 
through stimulation of insulin and leptin biosynthesis and secretion.  Leptin is 
synthesized by white adipose tissue, and its level increases in proportion to fat mass. 
Among its many actions, high levels of leptin potently suppress food intake and stimulate 
metabolic processes to dissipate excessive energy stores. The activation of brain 
efferent pathways in turn suppresses food intake and hepatic output of glucose and 
lipids. (Schwartz et al., 1996; Obici et al., 2002; Loftus et al. 2000; and reviewed in Lam 
et al., 2005).  In obesity, however, this feeding circuit is altered and palatable foods are 
consumed after energy requirements are met. It has been confirmed that 
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overconsumption of palatable foods and obesity can eliminate the ability of 
intracerebroventricular (icv) administration of insulin to reduce food intake (Posey et al., 
2009). The hypothalamus also becomes insensitive to leptin signals and there is a 
decrease in AGRP signaling to the mesolimbic pathway (Varela & Horvath, 2012). How 
the high fat diet impairs the negative feedback system is unclear. One hypothesis is that 
high fat diet causes neuroinflammation in the hypothalamus that impairs insulin 
sensitivity and the signal to stop eating (DeSouza et al., 2005). Palatable foods that drive 
obesity are often consumed after energy needs are met. It is thought that other brain 
regions, such as the mesolimbic dopamine area, control the intake of energy dense 
foods and this is one area pharmacotherapy can target in obese patients in the future. 
The	  Dopamine	  Reward	  Pathway	  
	  
The modern environment is characterized by the availability of highly palatable, 
energy dense foods as well as powerful food cues. High fat and high sugar foods 
activate the mesolimbic dopamine system to drive food intake even after energy 
requirements have already been met (Berthoud et al., 2007; Stratford & Kelly, 1999). 
Dopamine neurons in the mesolimbic pathway originate in the ventral tegmental area 
and have been implicated in the reinforcing and motivational aspects of food intake 
(Ikemoto & Panksep, 1996; Brennan et al., 2001; Ishiwari et al., 2004). Dopamine 
neurons are found in the VTA and project to the NAC to form the classic reward pathway 
studied in drug addiction. The dopamine neurons in the VTA also innervate several 
regions of the prefrontal cortex (PFC), central amygdala, basolateral amygdala (BLA) 
and hippocampus. All the reward related regions are inter-connected and synapse back 
on each other in complex ways.  The VTA–NAc circuit is crucial for the recognition and 
consumption of rewards (Koob et al., 2008).  DA in these regions is synthesized from 
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tyrosine, through the conversion of l-tyrosine to l-dihydroxyphenylalanine (l-DOPA) by 
the rate-limiting enzyme tyrosine hydroxylase (TH). DOPA is subsequently converted to 
DA by the enzyme l-aromatic amino acid decarboxylase. DA is then transported from the 
cytoplasm to storage vesicles via the synaptic vesicular monoamine transporter (VMAT). 
After DA is released into the synapse, the plasma membrane DA transporter (DAT) can 
transports DA in and out of the terminal depending the concentration gradient and other 
factors (Amara and Kuhar, 1993). The conversion of DA to HVA occurs extra-neuronally 
by the enzyme catechol-O-methyltransferase (COMT) (Feldman et al., 1997). 
Receptors that translate dopamine release into a signal are found in projecting 
regions NAc, PFC, amygdala, and other regions. DA receptors are classified into two 
subfamilies, D1- and D2-like receptors (Brown and Makman, 1972; Kebabian and Calne, 
1979), based on their pharmacological and functional properties. The D1-like receptors 
are dopamine receptor D1 (DR1) and D5 (DR5) (Sunahara et al., 1990 and Sunahara et 
al., 1991), whereas the D2-like receptors are dopamine receptor D2 (DR2), D3 (DR3), 
and D4 (DR4) (Sokoloff et al., 1990) based on their respective gene sequences. 
Dopamine receptors D1 and D5 are coupled to adenylyl cyclase through G protein Gs, 
while dopamine D2, D3, and D4 receptors inhibit adenylyl cyclase by coupling to Gi/o. 
The D1-like and D2-like receptors are both present in all dopamine-containing regions of 
the rodent brain (Meador-Woodruff, 1994). Higher levels of DR2 mRNA are detected in 
the substantia nigra and VTA. DR3 display a much more restricted pattern of distribution 
and are mainly found in limbic regions (Levesque et al., 1992).  D1R knock out (KO) 
mice show normal appearance and no obvious neurological defects, but exhibit growth 
retardation and low survival after weaning (Drago et al., 1994). Midbrain levels of 
dopamine are elevated in D1R KO mice, suggesting a compensatory increase in 
dopamine synthesis and/or release following inactivation of the receptor (El-Ghundi et 
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al., 1998). D2R KO mice exhibit significantly lower levels of locomotor activity than 
controls (Palmer et al., 2003) but total dopamine levels are not altered in D2R KO mice, 
suggesting D2R does not exert strong tonic control of dopamine activity (Benoit-Marand 
et al., 2001). On the post-synaptic side, the dopamine signal is transduced after 
activation of DR1 by the actions of Protein phosphatase 1 regulatory subunit 1B 
(DARPP-32). DARPP-32 is phosphorylated by cAMP-dependent protein kinase (PKA) 
and cyclin-dependent kinase 5  (Cdk5) on threonine residues, thr34 and thr75, resulting 
in inhibition of protein phosphatase-1. Additionally, DARPP32 dephosphorylation at 
serine residue 97 has also been observed and this modification appears to be important 
in both addiction and food intake behaviors (Stipanovich et al., 2008). Dopamine 
signaling elicited by drugs of abuse or palatable foods also increases the activity of 
ΔFOSB, cyclic AMP-responsive element binding protein (CREB), and cyclin-dependent 
kinase 5 (CDK5) pathways in medium spiny neurons (Joressen et al., 2007; Carlezon et 
al., 1998; Bibb et al., 2001). These proteins play a prominent role in the synaptic 
plasticity seen after chronic drug intake and could possibly regulate plasticity after other 
rewarding substances, such as palatable food. 
Hedonic	  Eating	  
	  
Energy dense foods are widely available and there are many aspects of modern 
society tempting us to eat. Wanting’ and ‘liking’ reactions are generated by neural 
systems after the intake of sweet, palatable foods. Drive to eat palatable foods is still 
present even when the individual is sated. For example, in humans, pleasure ratings for 
chocolate never hit zero even after consumption of two whole bars (Lemmons et al., 
2009; Small et al, 2001). The “always room for dessert” phenomenon is also seen in 
mice who can consume 10% of their body weight in milk and have their drive for 
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“sweetness” never completely diminish (Berridge et al., 1991). This suggests the ability 
of certain foods to override homeostatic stop signals and drive over consumption. The 
“wanting” and “liking” of palatable foods is regulated by dopamine and opioid 
neurotransmitters in the reward regions. Palatable food activates “hedonic hot spots” in 
the reward system, specifically the nucleus accumbens, ventral pallidum, amygdala, 
obitofrontal cortex, anterior cingulate cortex and the anterior insula cortex (de Araujo et 
al., 2003; Aldridge & Berridge, 2010; Kringelbach et al., 2004; Small et al., 2003). 
Consumption of palatable foods increases dopamine concentrations in the NAc 
(Bassarero & DiChiara, 1999). Dopamine in this region is thought to coordinate the 
action of food intake, increase arousal, and conditioned learning in order to obtain the 
food reward. Increases in dopamine, as seen in dopamine transporter (DAT) knockout 
mice, produce elevated “wanting” for sweet foods (Pencina et al., 2003). Palatable food 
is a powerful motivating force. Rats prefer palatable solutions to cocaine infusions 
(Lenior et al., 2007), and will voluntarily expose themselves to a noxious environment or 
pain to obtain high fat food over standard chow (Cabanac and Johnson, 1983; Foo and 
Mason, 2005). In fact, DA is necessary for the motivation to consume food (Ungerstedt , 
1971; Zhou & Palmiter, 1995) and DA-deficient mice from tyrosine hydroxylase gene 
knockout are hypophagic and eventually die of starvation unless DA is restored to the 
striatum (Szczypka et al., 2001). Dopamine also controls food choice. Dopamine 
agonists have been shown to enhance preference for and the motivation to obtain fatty 
foods in rodents (Thanos et al., 2011, Cooper et al., 2006). These taken together show 
that palatable foods activate the dopamine reward system acutely and cause 
overconsumption of calories. How exactly palatable food elicits the release of dopamine 
is currently unclear. It has been demonstrated, however, that the reward effect is 
independent of taste receptor activation (Ferriera et al., 2012; De Araujo et al., 2008). 
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Further investigation is needed to see what role post-ingestive factors, such as fat 
sensing in the gut, have in reward signaling in the brain.   
Interestingly, mutant mice lacking dopamine are still able register the hedonic 
impact and show preferences, and learning to work for a palatable sweet reward.  This 
suggests other neurotransmitters have a role in maintaining hedonic intake of food. In 
fact, a number of investigators found opioid or cannabinoid receptor activation in the 
nucleus accumbens to stimulate appetite by enhancing the ‘liking’ for the perceived 
palatability of food (Bodnar et al., 2005; Cooper, 2004; Kelly et al., 2002; Zhang & 
Kelley, 2000). Opioids in the nucleus accumbens shell are involved with the “wanting” 
aspect of palatable food intake through the modulating effect they have on dopamine 
release. Activation of mu opioid receptors indirectly dis-inhibit dopamine neurons and 
thereby increase dopamine release. For example, DAMGO, a mu-opioid receptor 
agonist, more than doubled the amount of food intake when administered centrally to 
rats (Pencina & Berridge, 2005). Moreover, anandamide, an endocannabinoid that likely 
acts in the brain by stimulating the CB1 type of cannabinoid receptor, has been shown to 
act in the nucleus accumbens to magnify the impact of sucrose taste (Mahler et al., 
2007). There has also been evidence for additional hedonic neurotransmitters acting in 
the nucleus accumbens to enhance “liking” of palatable foods. The ventral 
pallidum/nucleus accumbens region receives orexin inputs from the hypothalamus 
(Nixon & Smale, 2007) and orexin in this region can enhance ‘liking’ for sweet rewards 
(Harris et al., 2005). While more studies are needed, it is possible that dopamine 
dysfunction in the reward system seen in obesity can allow these other 
neurotransmitters to have a larger role and promote over consumption of palatable 
foods. 
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Neuroadaptations	  in	  DA	  system	  after	  Chronic	  HFD	  
	  
Research in both human and animals suggests that long-term intake of palatable 
foods leads to neuroadaptations in the dopamine reward system that could have 
implications for obesity treatments and other reward behaviors. Several lines of evidence 
support the hypothesis of dysregulated dopamine function in obesity. Chronic 
consumption of a high fat diet is associated with a state of reward hypofunction and 
imaging studies reveal blunted activation of brain reward regions during consumption of 
palatable foods in obese individuals (Stice et al., 2008). Other human studies have 
shown a down regulation of dopamine D2 receptor in obese individuals (Wang et al., 
2001). This is consistent with obesity being overrepresented in Taq1AA1 allele carriers 
that affects dopamine D2 receptor (DR2) expression (Blum et al., 1996, Nobel et al., 
1991). Down regulation of DR2 could potentially be involved in the increased craving 
and increased reward seeking that is associated with the obese population (Blum et al., 
2008; Downs et al., 2009). Down regulation of DR2 has previously been associated with 
many other disorders that are involved with dysregulation of motivation such as 
addiction, and attention deficit hyperactivity disorder (Volkow et al., 2011a; Volkow et al., 
2011b).  
Obesity prone rats have shown increases in extracellular dopamine in the 
striatum (Narayanaswami et al., 2005). However, when animals become obese we see a 
decrease in dopaminergic tone.  Animal models of diet-induced obesity (DIO) exhibit 
lower basal extracellular dopamine levels in the nucleus accumbens (NAc) and the 
ventral tegmental area (VTA)  (Geiger et al., 2007; Geiger et al., 2009; Cone et al., 2010; 
Rada et al., 2010). Diet induced obesity models have lower dopamine turnover (Davis et 
al., 2008), decreased dopamine release (York et al. 2010), and reduces DA clearance 
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(Speed et al., 2011) compared to standard chow controls in the nucleus accumbens. 
Genes involved in dopamine uptake and metabolism in addition to dopamine receptors 
DR1 and DR2 have been reported to decrease expression in obese rodent models (Alsio 
et al., 2010, Huang et al., 2005). Protein levels of both DAT and DR2 protein levels are 
also diminished after high fat diet intake (Huang et al., 2006; South & Huang, 2008; 
Johnson & Kenny, 2010). Decreases in sucrose preference (Vucetic et al., 2012, Carlin 
et al., 2013), a decrease in response for a sucrose pellet (Davis et al., 2008) and a 
decrease response to food reward (Corwin et al., 2011; Cottone et al., 2008; Johnson 
and Kenny, 2010) are associated with the dopaminergic protein changes after high fat 
intake. Changes in DR2 expression may impact the animal’s willingness to work for a 
goal (Trifilieff et al., 2013) and an animal’s sensitivity to dopamine agonists. For 
example, rats eating high fat chow are more sensitive to quinpirole-induced yawning (D2 
and D3 receptor-mediated; Baladi and France, 2010). 
Neuroadaptations	  in	  Leptin,	  Insulin,	  Ghrelin	  in	  the	  VTA	  
	  
The previous body of literature supports altered dopamine function in obesity and 
suggests a decreased sensitivity to reward in the obese population. Whether the high fat 
diet is directly affecting dopamine metabolism and release at the molecular level or other 
adjacent neurotransmitter systems are indirectly changing VTA activity is currently 
unclear.  It is possible that hormones involved with energy homeostasis may play a role 
in natural reward intake and changes in signaling may disrupt dopamine and lead to 
hedonic overeating. It is known that insulin, leptin, and ghrelin can decrease food reward 
behaviors and modulate the function of neurotransmitter systems that mediate food 
reward. Insulin receptors are expressed in brain regions that are rich in DA neurons and 
studies have shown co-expression of insulin receptor with tyrosine hydroxylase 
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(Figlewicz et al., 2003). This suggests an interaction between energy sensing and DA 
systems occurring in the reward regions. Manipulations of insulin concentrations 
significantly affect DA synthesis, turnover, and signaling in reward regions (Kwok and 
Juorio, 1986; Lim et al., 1994; Lozovsky et al., 1981; Saller, 1984). For example, acute 
injection of insulin into the brain enhances expression and activity of dopamine 
transporter (DAT) (Carvelli et al., 2002; Figlewicz et al., 1994). High fat diet consumption 
causes both peripheral and central insulin resistance over time. Because insulin 
regulates DA systems, it is likely that decreases in insulin signaling could contribute to 
the changes seen in dopamine circuitry and reward behaviors in obesity (Daws et al., 
2011; Niswender et al., 2011). Leptin levels are associated with total adipose fat stores 
and may directly or indirectly regulate dopamine dysfunction in obesity.  Leptin receptors 
are also found in the VTA and are downregulated in DIO animals (Figlewicz et al., 2003; 
Fulton et al., 2006; Blendy et al., 2005). Leptin has been shown to modulate response 
for rewarding brain stimulation, and modulate conditioning for high fat food (Fulton et al., 
2000 and Fulton et al., 2004). Leptin knockout mice (ob/ob mice) have a significant 
impairment of DA release and tyrosine hydroxylase capacity in the NAc (Fulton et al., 
2006).   
Ghrelin is a gut-derived hormone that is associated with food-deprivation and 
ghrelin receptors are also distributed in the ventral tegmental area and co-express with 
tyrosine hydroxylase (Mitchell et al., 2001). Ghrelin is involved in appetitive actions and 
the food seeking response (Naleid et al., 2005) possibly through the action of increasing 
VTA action potentials and the release of dopamine in the nucleus accumbens (Abizaid et 
al., 2006; Abizaid, 2009). It is thought that ghrelin signaling is altered in obese 
individuals and affects dopamine dependent behaviors such as novelty seeking (Savage 
et al., 2014) and high fat/high sugar intake (Menzie et al., 2013). One common 
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downstream signaling mechanism in the VTA for these energy related hormones is 
PI3Kinase. Studies have identified that insulin and leptin increase PI3kinase activity in 
the VTA (Figlewicz et al., 2007) and increase JAK-STAT phosphorylation, which is 
necessary for the decrease in feeding response (Morton et al., 2009). One potential 
cellular target for PI3Kinase is the DAT. It has been shown that insulin regulates the 
expression and activity of DAT through PI3Kinase (Garcia et al., 2005; Vaughan et al., 
1997) and diabetic models lacking insulin show DAT deficits (Figlewicz et al., 1994; 
Sevak et al., 2008). This implies that insulin resistance in obesity may alter DAT 
expression and activity and therefore alter DA signaling and reward seeking behavior. 
Energy related hormones are perfectly poised to regulate reward behavior and palatable 
food intake. If overweight individuals are less sensitive to homeostatic signals and 
therefore less sensitive to natural rewards they may consume more in an effort to obtain 
a larger positive effect. This is similar to the phenomenon of “tolerance” in addicted 
individuals. Moreover, altered sensitivity to natural rewards may also mean altered 
sensitivity to drugs of abuse that activate the same reward pathways.  
The	  Neurobiological	  Overlaps	  of	  Addiction	  and	  Obesity	  Pathways	  
	  
Dopamine is the key neurotransmitter involved in drug abuse as well as food 
intake. It is important to understand factors, such as obesity, that might alter sensitivity to 
the behavioral effects of drugs acting directly or indirectly at DA receptors. The repeated 
stimulation of dopamine reward pathways leads to adaptations in neurotransmitters and 
reward circuitry that may lead to increases in compulsive behaviors affecting both food 
and drug intake (Volkow & Li, 2004). Human studies reveal that obese individuals 
display decreased propensity to use recreational drugs and a decreased prevalence of 
substance abuse disorders (Simon et al., 2006; Warren et al., 2006; Bluml et al., 2012). 
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Additionally, obese individuals have been shown to self-administer less nicotine and 
demonstrated diminished hedonic drive toward nicotine cigarettes than their lean 
counterparts (Blendy et al., 2005). In one demographic study being “obese” or extremely 
obese” has been associated with an increase risk of alcohol abuse disorder as well as 
other mood and anxiety disorders (Petry et al., 2008). Research in both fields confirms 
the mechanisms behind addiction and overconsumption of palatable food converge on 
the same molecular targets in the reward system. One neuroadaptation found in both 
obesity and addiction is the decreased expression of DR2. Positron emission 
tomography has revealed decreased DR2 in the striatum of addicted individuals that 
persists well after drug withdrawal (reviewed in Volkow et al., 2009). This finding has 
also been replicated in preclinical rodent studies given chronic exposure to drugs of 
abuse (Thanos et al., 2007; Nader et al., 2006; Volkow et al., 2001). Down regulation of 
both DR2 and DR1 expressing neurons in the striatum that mediate the direct striatal 
pathway enhances the sensitivity to drugs of abuse (Fergusen et al., 2010; Hideka et al., 
2010). Dysregulated dopamine signaling in this region is likely to contribute to the 
compulsive and impulsive drug intake seen in addiction (Goldstein et al., 2002).  
High impulsivity may underlie the inability of obese individuals to resist excessive 
eating. Both addicted and obese individuals show impairment in PFC and OFC regions 
of the brain that control reward and impulsivity (Volkow et al., 2001; Volkow et al., 1993; 
Volkow et al., 2008). Moreover, decreased D2R striatal expression and signaling has 
been detected among obese individuals (Geiger et al. 2009; Wang et al., 2001, de 
Weijer et al. 2012) and in rodents given a high fat diet (Johnson & Kenny, 2010). Other 
studies have shown overeating palatable foods can produce behavioral and 
neurochemical signs that resemble dependence in laboratory animal models such as 
compulsivity, adaptation, and sensitization to food (Avena et al., 2008, Corwin et al., 
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2011 and Volkow et al., 2011c). When rewarding substances target the same 
downstream signaling mechanisms they have the ability to cross sensitize or cause 
tolerance towards one another. For example, eating high fat chow increases sensitivity 
of drugs acting at both D3 and D2 receptors (Baladi et al., 201, Corwin et al., 2011). 
High fat diet intake also leads to increased sensitivity to cocaine (Baladi et al., 2012; 
Shumsky et al., 1997) and methamphetamine (McGuire et al., 2011).  
Addictive drugs act on known receptors to increase dopamine release or 
dopamine levels in the nucleus accumbens. It is not yet fully elucidated how palatable 
foods increase dopamine in nucleus accumbens, but there are some downstream 
molecular targets that are affected in both palatable food consumption and addiction that 
could give us some hints. Dopamine signaling in the accumbens modulates the activity 
of ΔFOSB, cyclic AMP-responsive element binding protein (CREB), DARPP32 and 
CDK5 signaling pathways in medium spiny neurons, and influences the rewarding 
properties of both food and addictive drugs (Kenny, 2011). One example of this is 
ΔFOSB.  ΔFOSB is increased in the striatum of rodents given a high fat or high sucrose 
diet and is associated with the motivation to obtain palatable food (Christiansen et al., 
2008; Teegarden & Bale, 2007). Cocaine and other drugs of abuse increase the 
expression of ΔFOSB throughout the striatum, more specifically in the dopamine 
receptor D1 and dynorphin-expressing medium spiny neurons in the direct pathway 
(Muller et al., 2005). The overlap of addiction and food intake pathways can also be 
seen with peptides involved in homeostatic feeding and is reviewed extensively in 
(Volkow et al., 2013). Orexigenic peptides ghrelin, orexin, melanocortin, and 
neuropeptide Y are found to affect reward regions and modulate reward behavior such 
as alcohol intake (Leggio et al., 2011; Gilpin et al., 2012), conditioned reward learning for 
cocaine (James et al., 2011) and morphine self administration and conditioned place 
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preference (Harris et al., 2007; Proudnikov et al., 2008 ). Anorexigenic peptides also act 
in reward regions of the VTA, NAc, and amygdala to modulate reward behavior. 
Glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), peptide YY (PYY), galanin, 
cocaine-and amphetamine-regulated transcript (CART), corticotropin-releasing hormone 
(CRH), and oxytocin have been shown to affect behaviors towards amphetamines 
(Erreger et al., 2012; Vaccarino et al., 1994; Crawley et al., 1985; Beinfeld et al., 2003), 
alcohol (Barson et al., 2011; Le Strat et al., 2012), and cocaine (Cippitelli et al., 2012; 
Upadhya et al., 2012). The regulation of homeostatic food intake, palatable foods, and 
other natural rewards all converge on the dopamine neurons in the ventral tegmental 
area. The dopamine reward system is hijacked by unnatural rewards (drugs of abuse) 
and neuroadaptations that occur in addiction to drugs of abuse are similar to those seen 
in obesity. The combined results suggest that both obese and drug-addicted individuals 
suffer from overlapping impairments in dopaminergic pathways that lead to 
overconsumption and impulsivity. 
Another neurotransmitter system that is involved in both palatable food intake 
and reward is the central opioid system. Both neurotransmitter systems are activated in 
concert and are dependent on each other. For example, opioids increases intake of 
palatable foods in sated animals and this depends on the expression of dopamine 
receptor D2 (Hayward et al., 2007). Further, opioid receptors are distributed throughout 
regions important for food and drug reward (Olszewski, et al., 2007) and mu opioid 
receptor activation increases dopamine release (Bontempi et al., 1997; Horner et al., 
2012; Steiner et al., 1999). Mu opioid receptor (MOR) expression is altered by high fat 
diet at different time periods. Chronic high fat diet in adulthood decreases MOR 
expression (Vucetic et al., 2011; Ong et al., 2013; Blendy et al., 2005). Conversely, high 
fat diet during pregnancy increases expression of MOR in reward regions of the offspring 
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(Vucetic et al., 2010; Ong et al., 2011; Grissom et al., 2013; Carlin et al., 2013b).  It is 
yet to be discovered how high fat diet regulated the expression of MOR, however, 
studies out of our lab point to possible recruitment of epigenetic markers (Vucetic et al 
2010; Grissom et al., 2013). It seems that changes in opioid signaling could play a role in 
the reward dysfunction of obesity either by amplifying the effects of dopamine 
dysregulation or altering the palatability of food. Endogenous opioids code the 
palatability of food in the brain and neuroadaptations in this system could have 
implications in overconsumption of food in obesity. If MOR is down regulated in obesity, 
it could be a homeostatic mechanism to reduce the drive to eat and the dopamine 
dysfunction just happens to over ride that effect. Conversely, down regulation of MOR 
can add to the hypo reward seen in obesity which could further drive palatable food 
intake in order to normalize reward levels in the brain. Further experiments are needed 
to answer how endogenous opioids are altered alongside dopamine and if these 
neuroadaptations reverse after standard chow replacement. 
Sex	  Differences	  in	  the	  Dopamine	  Reward	  System	  and	  Obesity	  
	  
Sex differences are found in both the central dopamine system and in the 
presentation of obesity. The overlapping dopamine pathways seen in obesity and drug 
addiction are also highly influenced by sex and sex hormones. We see that women are 
more susceptible to developing eating disorders and obesity compared to men (Hoek et 
al., 2003; Berghöfer et al., 2008; Keel et al., 2007). Women also have lower success 
rates at dieting then men. This could be due to their more intense interaction with 
palatable foods. Women tend to show increased brain activity in the prefrontal cortex 
and OFC after ingestion of palatable liquids compared to men and this has been 
associated with decreased inhibitory control when it comes to food intake (Del Parigi et 
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al., 2002). This difference in inhibitory control could underlie the lower success rates 
when losing weight with dieting (Appelhans et al., 2011). Studies have shown sex 
hormones directly influence food intake, body weight, and fat distribution. Preclinical 
studies in rodents have shown an opposite effect of what we see in humans. Male mice 
are more vulnerable to HFD-induced weight gain (Martin et al., 2007) and this sex 
difference can be attributed to the positive metabolic effects of estrogen in females 
(Heine et al., 2000). Further studies are needed to see why this protective effect is 
absent in the human population, which is clearly a more complicated issue than what is 
observed in rodent. Sex hormones also have an effect in the brain and can modulate 
central leptin signaling. Female rats are more sensitive to the anorexic effects of leptin 
than male rats (Clegg et al., 2003). Given the gender differences in obesity and the high 
rate of failure in weight loss therapeutics, examining overconsumption and dopamine 
circuitry in females would be an extremely important contribution to the field.   
Sex differences are also present in the incidence rates of psychiatric disorders. 
For example, major depression, which involves the disruption in the dopamine reward 
system, is twice as common in females then in males (Marcus et al., 2005).  Women 
also experience addiction to drugs of abuse differently than men. Female drug users 
tend to be more sensitive to cocaine-conditioned stimuli and report more intense 
cravings (Elman et al., 2001; Robbins et al., 1999). Sex differences persist when 
examining the central reward system in rodents.  Female rats develop cocaine CPP after 
fewer conditioning sessions and with lower doses compared to males (Parylak et al., 
2008). This suggests that females are more sensitive to the rewarding effects of drugs 
acting the dopamine system and this could be behind the sex differences seen in 
addiction incidence rates (Zakharova et al., 2009). Estradiol has the ability to modulate 
dopamine at the molecular level. In fact, estradiol rapidly increases dopamine efflux in 
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the nucleus accumbens (Becker, 1999) and in cell culture (Alyea  et al., 2008). Female 
gonadal steroids inhibit DA neurotransmitter turnover in prefrontal regions and ventral 
tegmental area (Handa et al., 1997) and regulate the reuptake of DA in regions involved 
in satiety and motivation depending on estrus cycle (Thompson et al., 1997). 
 Experiments looking at sex differences have added richness to the addiction field. 
Studies in the field of neuroscience of obesity often do not include females in the 
analysis. This is potentially excluding 50% of the population that will receive the 
pharmacotherapies that come out of these studies. Examining how neuroadaptations to 
chronic high fat diet and their reversibility are influenced by sex is an important step in 
developing proper drug targets to combat obesity. 
 
Consequences	  of	  Early	  Life	  Nutrition	  on	  Obesity	  and	  Brain	  Development	  
	  
Age is another critical factor to consider when studying obesity and the brain. 
There are important times during development in which the brain seems to be 
particularly sensitive to the environment. Changes in the environment during critical time 
periods can alter the trajectory of development and affect the health of the adult in the 
future. We see this sensitive time period come into play when setting adulthood body 
weight. Obese children are more likely to become obese adults (Serdula et al., 1993) 
and obese children will find it more difficult to lose weight when they become adults 
(Cockrell-Skinner et al., 2010). It seems this critical time period is set before age five in 
humans. A recent study showed that obesity by age 5 could predict future obesity at age 
18 (Cunningham et al., 2014).  At first glance, childhood obesity is similar to adult 
obesity in that it is caused by increase food intake, sedentary lifestyle, complex 
interaction between over 250 obesity-associated genes and early life factors (Rankinen 
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et al., 2002). However, childhood obesity can be more detrimental to future health and 
weight loss goals in the future.  
Both genetic makeup and early-life environmental factors play a significant role 
determining body weight and adiposity. The early life environment begins in utero and is 
affected by maternal nutrition and health during pregnancy. It seems that the risk for 
obesity can begin at conception and depend on the in utero nutritional and hormonal 
environment. Both maternal overnutrition and maternal under nutrition has been 
associated with obesity later in life (Whitiker & Dietz, 1998; Boney et al., 2005; Ravelli et 
al., 1976). The in utero environment has the ability to program adulthood appetite, 
neuroendocrine functioning, and metabolism. Modeling maternal obesity in animals has 
yielded a wealth of data on altered genes and behaviors that can contribute to behaviors 
in offspring.  The brain is developing throughout gestation; the dopamine reward system 
circuitry and its control on food intake are not spared from maternal programming.  
Maternal high fat diet alters hypothalamic neurons that express appetite-regulating 
neuropeptides, leading to hyperphagia (Plagemann et al., 1999; Muhlhausler et al., 
2006) and exacerbated preference for fatty foods in offspring (Vucetic et al., 2010; Bayol 
et al., 2007). Naef and colleagues (2013a) have shown offspring exposed to high fat diet 
in utero demonstrate reduced anticipatory response to a food reward. Additionally, these 
offspring had increased responding for high fat food (Naef et al., 2011).  It seems 
maternal high-fat diet not only increases offspring’s risk for obesity, but it also leads to 
alterations in dopaminergic circuitry. Our lab documented changes in DAT, dopamine 
receptors DR1 and DR2, DARPP-32, and TH, and mu opioid receptor (MOR) mRNA in 
reward regions in offspring from a high fat fed dam. These mRNA changes were 
associated with alterations in DNA methylation at the promoter region of these genes 
(Vucetic et al., 2010). This is evidence for possible epigenetic mechanisms linking 
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maternal diet during pregnancy with offspring behavior.  These studies show that 
gestation is a particularly sensitive time period in programming feeding behavior and 
dopamine circuitry. The brain continues to develop after gestation in humans and even 
more so in rodents.  Another study done by Naef, et al (2010) targeted the last week of 
gestation as well as the 3 week weaning period. Maternal high fat diet during the later 
gestation period and weaning led to offspring with weaker amphetamine-induced 
extracellular NAc DA levels, higher NAc DAT activity, and reduced D2 receptor mRNA in 
the VTA. This study demonstrates that post-natal time periods are also sensitive to 
nutritional insults. The early post-natal period is very important for brain development 
and sensitive to many types of environmental insults, not just nutrition, which can be 
associated with dysfunction in adulthood. Disruption of early life environment in humans 
can lead to increased risk of depression risk (reviewed in Hein et al., 2010, Chapman et 
al., 2008), inflammation (Danese et al., 2008), glucocorticoid resistance (Carpenter et 
al., 2004), reduced cortical volume (van Harmelen et al., 2010) and reduced 
hippocampal volume (Vythilingam et al., 2002) in the adult population. These studies 
point to the existence of important sensitive time windows in development that can set 
an individual on a trajectory to dysfunction in adulthood. How early life nutrition interacts 
with the brain during these critical development periods and leads to adult reward 
dysfunction and obesity needs to be further explored. 
The brain continues to develop from postnatal day one through adolescence. If 
the environment is particularly damaging during that period, programming of adulthood 
diseases can occur.  “Metabolic imprinting” is a term used to describe how alterations in 
developing young can predispose individuals to obesity and its associated illnesses. We 
already examined how gestation was critical for the development of feeding and reward 
circuits.  The weaning period up until adolescence also represents a critical 
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developmental window with regard to the establishment of metabolic-regulating neural 
pathways (King et al., 2006). In fact, dietary preferences and feeding behaviors are 
programmed during childhood (Sato et al.,1991). The projections from the arcuate 
nucleus to other hypothalamic nuclei regulating energy balance mature by the 8th to 
10th day of postnatal life (Grove and Smith, 2003; Grove et al., 2003; Bouret et al., 
2004a). These projections are sensitive to both gestational and postnatal overnutrition 
(Plagemann, 2006; Chang et al., 2008). Additionally, levels of the metabolic hormones 
leptin and insulin play a role in the development of the hypothalamus and projecting 
areas during these developmental periods (Bouret et al., 2004b; Frank et al., 2005). 
Projections from the VTA to the NAc and PFC mature post-natally as well (Antonopoulos 
et al., 2002; Kalsbeek et al., 1988).  These studies demonstrate that early life nutritional 
insults could have consequences for DA circuitry and DA-mediated behaviors. Early 
postnatal overnutrition in mice, simulated by a small litter number throughout lactation, 
predisposes the offspring to adult obesity (Bouret, 2010). Early exposure to a high fat 
diet for as little as one week was able to alter adult caloric intake and dopamine 
signaling protein levels (Teegarden et al., 2009). Additionally, high fat during the 
peripubertal period sensitized the response of dopamine in the NAc to a tail pinch test 
(Naef et al., 2013b). Finally, high fat feeding was sufficient to disrupt PPI when given 
during peripubertal period, whilst high fat feeding failed to affect PPI when limited to 
adulthood (Labouesse et al., 2013). Other brain regions are also affected by high fat diet 
given early in development, such as the HPA axis, and can also impact feeding and 
metabolism through different mechanisms (McCormick & Mathews, 2007). 
The previous studies demonstrate that the time from weaning until adolescence 
is particularly sensitive to nutrition and can determine the risk of obesity in adulthood.  
However, this time period is also sensitive to other environmental insults that can affect 
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mental health throughout the lifetime (Michel et al., 2004; Boukouvalas et al., 2008). The 
developmental period from PD 20 to 40 in rodents is analogous to preadolescence and 
adolescence in humans (Spear, 2000).  A surge of synaptogenesis occurs in the brain 
during these adolescent years. Therefore, adolescence is one of the most dynamic 
events of human growth and nutrition is just one example of the early life environment 
that has consequences on circuitry development and adult mental health. Disruption in 
maternal care is another example of an environmental insult that has long-lasting effects 
on adulthood health and behaviors. Unsatisfactory maternal care leads to dysregulation 
of the neuroendocrine response to stress (Plotsky & Meaney, 1993; Liu et al., 2000) and 
can lead to an increased risk of addiction in adulthood (Piazza & Le Moal, 1997). 
Because the early post natal time period is so sensitive, it may be possible to positively 
impact development through intervention at this time. For example, early post weaning 
exercise can reverse the damage done to metabolic feeding circuits caused by maternal 
high fat diet (Sun et al., 2013). Understanding what molecules are specifically sensitive 
to over nutrition during the early postnatal period will allow us to develop targets for 
possible positive intervention to prevent dysfunction is adulthood.  Many diet induced 
obesity rodent studies begin the diet months after weaning (Kanoski et al., 2010; Baladi 
et al., 2009; Lassiter et al., 2010) and therefore results from these studies cannot be 
applied to childhood obesity treatments. Research is still needed to identify the periods 
of sensitivity in the programming of dopamine reward system in obesity and determine 
how permanent metabolic programming is after intervention. 
 
The	  Basics	  of	  Epigenetics	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The body and brain respond to a changing environment by altering gene 
expression patterns both acutely and on a long term basis.  One reason for variations in 
response to a changing environment could be a gene-environment interaction. For 
instance, a polymorphism in an important gene could lead to increased risk of a 
psychiatric disorder in a stressful environment. This has been seen in epidemiological 
studies of serotonin receptor polymorphisms and the risk for depression (Caspi et al., 
2003). However, it is also possible to have increased risk for psychiatric disorder without 
a corresponding change in genetic code. For example, early life stress in humans 
(Chapman et al., 2004) and animal models (Kaffman & Meaney, 2007) can increase the 
risk of depression and depressive-like behaviors.  The mechanism by which early life 
stress is able to program the brain involves epigenetic modulation of the expression of 
individual genes or large clusters of related genes. Epigenetics refers to the potentially 
heritable, but environmentally modifiable, regulation of genetic function mediated 
through a mechanism that doesn’t involve altering the genetic code (Russo et al, 1996; 
Wu and Morris, 2001). Epigenetics is viewed as the vehicle through which the 
environment interacts with the genome to determine function, in health and disease. 
Aberrations in epigenetic markers have been associated with many diseases such as 
cancer, diabetes and addiction (Dawson & Kouzarides, 2012; Gilbert & Liu, 2012; Feng 
& Nestler, 2013). DNA is wrapped around a cluster of histone proteins and covalent 
histone modifications, such as acetylation, phosphorylation, methylation, sumoylation 
and ubiquitylation, modulate gene expression via alterations in chromatin structure in 
conjunction with DNA methylation. These epigenetic mechanisms in total can play a role 
during times of development to program behavioral phenotypes in adulthood, or increase 
vulnerability for a psychiatric disorder caused by other phenomena.  
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DNA methylation has been widely studied in the context of early life 
environmental insults. DNA methylation occurs with the addition of a methyl group to the 
C5 position of cytosine (5-mC) predominantly at CpG sites (Klose and Bird, 2006). CpG 
islands are stretches of DNA around 1000 base pairs long that have a high CpG density 
(Bird et al, 1985). CpG islands are important for transcriptional regulation and 70% of 
gene promoters reside within CpG islands (Saxonov et al, 2006). The importance of 
CpG islands in transcription are maintained between species and conserved between 
mice and humans and transcription factor binding sites often found to be within and 
around these regions (Illingworth et al, 2010). Classically, DNA methylation reduces 
access of transcription factors to regulatory elements and causes transcriptional 
repression by decreasing the binding of specific transcriptional enhancers (Murgatroyd 
et al., 2010). DNA methylation plays a pivotal role in cell differentiation, imprinting, and X 
chromosome inactivation and is viewed as a more stable epigenetic mark compared to 
others (Martinowich et al., 2003). A family of methyl CpG-binding domain proteins, 
including MeCP2, and MBD1-4, bind to methylated cytosines and interact with histone 
deacetylases and DNA-methyltransferases to repress genes and maintain methylation 
(Chen et al., 2003). Methyl binding proteins, such as MeCP2, are highly expressed in the 
brain and necessary for proper circuitry and behavioral development (Amir et al., 1999, 
Skene et al., 2010).  
DNA methylation is catalyzed by DNA methyltransferases (DNMTs) DNMT1, 
DNMT3a and DNMT3b. The expression of DNMTs normally declines in terminally 
differentiated cells in all tissues except for the brain. The brain is specialized for sensing 
the environment and responding and adapting to change. One of the mechanisms 
behind the ability to adapt to a changing environment is epigenetic plasticity. Both 
DNMT1 and DNMT3a are expressed by post mitotic neurons and serve unique functions 
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in the central nervous system (Goto et al., 1994). The best-studied DNMT in the nervous 
system is DNMT1. Unlike the other DNMTs, DNMT1 preferentially methylates 
hemimethylated DNA (Pradhan et al, 1999) and is involved in methylation repair and 
maintenance (Mortusewicz et al, 2005). Chromatin structure can be altered because of 
steric hindrance or charge introduced by the DNA methylation in combination with other 
epigenetic markers, such as histone modifications. Epigenetic mechanisms controlling 
transcriptional activity may be cell-type, and even gene-specific. There have been 
several instances discovered where DNA methylation increased transcription at some 
gene promoter sites (Mellen et al., 2012; Labonte et al., 2012). Changes in epigenetic 
markers may explain how the environment regulates the genome in specific concepts. 
These changes are well poised to mediate the effects of early environmental factors on 
adult disease and behavior. 
 
Epigenetics	  and	  the	  Early	  Life	  Environment	  
	  
The crucial role of the epigenetic processes in mediating maladaptive 
neurobiological and behavioral consequences of the early-life environment and 
environmental adversity has been demonstrated in animal models. Brain specific brain 
DNA methyltranferase knockouts have been generated and characterized and 
demonstrated behavioral dysfunction (Feng, et. al 2010). This was the first proof of 
concept that it was possible to alter behavior through epigenetic mechanisms. Further 
advances in the field revealed in animal models of early life stress that epigenetic 
mechanisms are recruited and could be the mechanism behind the observed behavioral 
dysfunction (McGowan et al., 2009; McGowan et al., 2010; Weaver et al., 2004). Early-
life adversity triggers DNA methylation changes in several brain regions and controls 
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genes that mediate a depressive phenotype (Lutz et al., 2013). For example, the 
glucocorticoid receptor gene promoter methylation is increased by early life stress and 
leads to adult stress dysregulation in both human (McGowan et al., 2009) and rodent 
samples (Weaver et al., 2004; McGowan et al., 2010). Other studies have revealed that 
DNA methylation is central to various types of aversive learning (Miller et al., 2010) and 
synaptic plasticity (Roth et al., 2009) after early life insults. For instance DNMT1 has a 
role in regulating the induction of synaptic plasticity in the hippocampus (Levenson et al., 
2006; Miller & Sweatt, 2007). The early life time period may provide a window where 
epigenetic machinery is vulnerable to insult and could change developmental trajectories 
and cause psychiatric dysfunction in adulthood.  
Epigenetic Recruitment after Rewarding Substances 
Activity-dependent methylation and demethylation of DNA is essential for the 
behavioral and neuronal plasticity driven not only by early life stress, but in reward-
related experiences as well. Epigenetic marks have been seen to change in reward 
related brain regions in response to drugs of abuse (Hiroi et al., 2005). Reward learning 
induces changes in DNA methylation patterns that are gene specific and correlate with 
changes in mRNA levels (Day et al., 2013). Cocaine is one example of a drug of abuse 
that alters DNMT levels and DNA methylation in the NAc. The epigenetic changes are 
thought to program reward memory by regulating structural changes and influencing 
addictive behaviors such as conditioned place preference (LaPlant et al., 2010). Drug-
induced neuronal plasticity is viewed as a major molecular mechanism for the 
development of drug addiction and relapse (Kalivas et al., 2008; Nestler, 2001; Shaham 
& Hope, 2005; Wong et al., 2011). Significant changes in DNA methylation have been 
seen after alcohol (Bonsch et al., 2004; Marutha Ravindran et al., 2004; Philibert et al., 
2008), amphetamine (Deng et al., 2010), cocaine (He et al., 2006; Novikova et al., 
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2008), nicotine (Philibert et al., 2009; Sata et al., 2008) and opiate (Neilsen et al., 2008) 
exposure in human and mouse models. These studies show that rewarding substances 
have the ability to recruit epigenetic machinery and cause epigenetic changes in brain 
circuitry that regulates behavior. Our lab identified DNA methylation as an epigenetic 
mechanism linking the chronic intake of HF diet with altered dopaminergic gene 
expression and mu opioid receptor expression (Vucetic et al., 2010; Vucetic et al., 2011). 
Little is known about the mechanisms that drive gene expression changes in response to 
diet and/or obesity. Epigenetic gene regulation, including DNA methylation, and histone 
modifications, represent a pathway through which organisms can rapidly adapt to 
nutritional challenges. There is also a strong possibility that these mechanisms are more 
vulnerable to alteration when the brain is still developing, such as in utero or the pre-
adolescent time period. Identification of such windows will be of major public health 
importance, given the vast number of psychiatric and metabolic disorders linked to early 
life adversity and early life nutrition. 
 
Reward	  System	  and	  Epigenetic	  Effects	  of	  Exercise	  on	  the	  Brain	  
 
Exercise is an example of a non-nutritional environmental exposure that recruits 
epigenetic machinery and causes neuroadaptations in the brain. Because it affects 
similar brain regions as high fat diet, it is a potential option for the prevention of 
neuradaptations of the reward system that occurs in obesity. Voluntary physical activity 
is important to human health for the prevention of obesity and it has positive effects on 
learning, memory, and cognition. The obesogenic environment of Western culture 
includes overconsumption of palatable foods and increases in sedentary lifestyle. This 
increase in inactivity has been associated with obesity, cardiovascular disease, Type II 
	   34	  
Diabetes, and certain types of cancer (Powell et al., 1994). Inactivity and obesity are 
also associated with neurological disorders such as Alzheimer’s disease and 
depression. There is a growing field of research that illustrates that high fat diet has a 
direct damaging effect on the brain. Diets high in saturated fat are known for reducing 
molecular substrates that support cognition and therefore increase the risk for 
neurological dysfunction in both humans (Greenwood et al., 2005) and animals (Molteni 
et al., 2002). Holloway et al. (2011) reported that healthy adults who ate a high fat diet 
for 5 days performed worse on tasks measuring attention and speed of retrieval than 
they had prior to the diet. Studies with rodents confirm chronic high fat diet produces 
cognitive deficits and neuroinflammation in the hippocampus (Heyward et al., 2012, 
McNay et al., 2010; Molteni et al., 2004 and Pistell et al., 2010). Rodents on high fat diet 
also have reduced levels of BDNF and CREB, which are important for neuronal plasticity 
(Molteni et al., 2002). Fortunately, exercise has positive actions on the brain and is a 
low-cost, and common way to combat obesity. Studies looking at the beneficial effects of 
exercise have mainly focused on learning and memory in the hippocampus. In humans, 
exercise counteracts the mental decline associated with aging (Kramer et al., 1999), 
enhances the mental capacity of young adults (Winter et al., 2007), and facilitates 
functional recovery after brain injury or disease (Vayman & Gomez-Pinilla, 2006).  
Rodent models of voluntary wheel running have given us insight to the 
mechanism behind these cognitive benefits.  Exercising rats show exercise promotes 
neurogenesis in the brain (van Praag et al., 1999) and increases expression of BDNF 
mRNA (Gomez-Pinilla et al., 2011). When exercise and high fat diet are paired together, 
exercise has the ability to reverse the damaging effects of high fat diet on synaptic 
plasticity in the hippocampus by normalizing BDNF levels and reducing oxidative 
damage (Molteni et al., 2004). Exercise can protect the hippocampus from nutritional 
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insults, but what about other brain regions?  We now know that consumption of high fat 
diet also causes neuroadaptations in the mesolimbic reward system. Damage to 
hippocampal function by high fat diet seems to be through reduced BDNF signaling and 
oxidative damage. Dysfunction in the reward system after high fat diet, however, is 
through a different mechanism. Chronic intake of a rewarding substance leads to 
changes in dopamine signaling and subsequent obesity causes central resistance of 
metabolic hormones found in reward regions of the brain. It is possible that exercise is a 
way to combat the dopamine dysfunction in the mesolimbic reward system seen in 
obesity. 
  For years now, exercise has been used as a treatment for depression and other 
psychological disorders (Lawlor & Hopker, 2001; Blumenthal et al., 1999; Petruzzello et 
al., 1991). Recently, exercise has been suggested to be beneficial for treating drug 
addiction (Smith & Lynch, 2011). Since the mechanisms of depression, addiction, and 
palatable food overconsumption pathways overlap, exercise may also be beneficial for 
treating dopamine dysfunction in obesity. There are many theories as to why exercise is 
beneficial in these disorders. Exercise increases body temperature (Petruzzello et al., 
1991), causes an increase in serum calcium levels (Sutoo & Akiyama, 1996) and causes 
an increase in monoamine synthesis (Dishman, 1997). The central belief among these 
researchers is that exercise acts on the same pathway of antidepressant medications in 
the treatment of depression. Mechanistically, physical activity and exercise activate the 
same reward pathway as drugs of abuse. Exercise increases dopamine concentrations 
and dopamine receptor binding (Greenwood et al., 2011 and MacRae et al., 1987) and 
may act as an alternative reward so to prevent drug administration. It is unknown how 
exercise in conjunction with a rewarding substance like high fat diet may interact within 
the reward system. Because the consumption of palatable food and administration of 
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addictive drugs are controlled by the dopamine reward pathway, I hypothesize that 
exercise can also counter the dopamine dysfunction caused by chronic high fat diet.  
 Exercise functions as an alternative non-drug reinforcer and can compete with 
the drug and reduce vulnerability to addiction. Rodents given concurrent access to a 
running wheel and methamphetamine self-administer less drug as compared sedentary 
rats (Miller et al., 2012). Similar findings have been reported for cocaine self-
administration (Smith and Pitts, 2011) and was protective both when the running wheel 
was given concurrently or when given before drug exposure. This has possible 
implications for exercise as a preventive measure against dopamine dysfunction before 
it even begins. At the molecular level, exercise reduces drug induced dopamine release 
(Chen et al., 2008, Marques et al., 2008). Additionally, running increases levels of 
tyrosine hydroxylase, and total dopamine levels the reward pathway (Droste et al., 2006 
and Greenwood et al., 2011). These neuroadaptations caused by exercise may 
influence an individual's vulnerability to initiate drug use and/or develop addiction. One 
way exercise prevents consumption of rewarding substances is that exercise has reward 
value of its own. In fact, rats are willing to “work,” for and show conditioned place 
preference to the running wheel (Belke et al., 2005; Brene et al., 2007). The reward 
value of exercise comes from increases in dopamine in reward regions. Microdialysis 
studies revealed increased in extracellular DA in the mesolimbic region after a 20-60min 
treadmill run that remained elevated for 2hrs (Hattori et al., 1994; Meeusen et al., 1997; 
Wightman et al., 2002). These findings are important because they suggest that exercise 
may normalize the hypofunctioning in the mesolimbic system that occurs following 
chronic high fat diet exposure and high fat withdrawal.  
Molecules that could explain the beneficial effects of exercise in the reward 
system may be the same as those discovered to be beneficial in the hippocampus. For 
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instance, important factors in synaptic plasticity and cognitive function, such as BDNF, 
synapsin I, calcium/calmodulin-dependent protein kinase II (CaMKII) and cyclic AMP-
responsive element (CRE)-binding protein (CREB) are enhanced in both addiction and 
after exercise in reward regions of the brain (Wu & Gomez-Pinilla,2007). Chronic 
exposure to high fat diet alters epigenetic markers that may underlie the propensity to 
develop neuroadaptations in reward regions. The beneficial effects of exercise may work 
through a similar epigenetic pathway and remodel chromatin structure in a way that 
prevents dopamine dysfunction (Gomez-Pinilla, 2011). Further research will be needed 
to see if an epigenetic pathway is activated in reward regions by exercise to prevent the 
dopamine dysfunction of obesity. Exercise seems to produce efficacious effects in other 
brain regions, therefore, researching the effects of exercise in the reward system of the 
obese brain will be important for future weight loss studies and the control of palatable 
food consumption. 
Conclusion	  
	  
We now see that obesity can be thought of as a disease of the central regulation 
of food intake and many behavioral dysfunctions and neuroadaptations are associated 
with the obese state. The brain is a highly adaptive organ and changes in response to 
multiple internal and external environmental signals. However, these changes could lead 
to maladaptive behavior or disease in the future. Studies described here support the 
finding of dopamine dysfunction in obesity patients and animals given access to high fat 
diet. The neuroadaptations seen after chronic high fat diet are similar to those seen after 
chronic intake of drugs of abuse.  The following experiments will characterize how 
dopamine circuitry has adapted to chronic high fat diet intake at the molecular and 
behavioral level. Understanding whether these reward system neuroadaptations are 
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persistent after chronic high fat is critical for the field of obesity interventions; therefore, 
the following experiments also characterize the dopamine system after high fat 
withdrawal. We now see how critical the early nutritional environment is for optimal brain 
development. Early postnatal life is a dynamic period where dopamine projections are 
still being laid down.  It is possible that the pre-adolescent period is more vulnerable to 
the damaging effects of high fat diet than other points in time. Overnutrition during this 
time period may lead to epigenetic programming and lasting neuroadaptations after 
intervention. The following experiments characterize chronic high fat diet in pre-
adolescent male and female mice and compared them to adult animals on high fat diet. 
This experimental design allows us look at the effect of high fat diet on a critical time 
period in brain develop and assess if any permanent damage is seen in adulthood.  The 
experimental design includes females as well as males. There are crucial sex 
differences in the presentation of obesity and in dopamine system activation. Bringing 
sex differences into the analysis of high fat intake and high fat withdrawal effects on the 
brain will be important contribution to the obesity intervention field. Finally, there is 
sufficient evidence that exercise activates the dopamine reward system and studies 
show exercise to be beneficial in other brain areas important for learning and memory. 
Exercise has the ability to be a rewarding replacement for palatable foods and may be 
protective against dopamine dysfunction in obesity. Access to the running wheel recruits 
epigenetic machinery similar to other rewarding substances and this may be the 
mechanism underlying its protective benefits. Obesity is a complex state and 
understanding the mechanisms behind obesity interventions like diet and exercise as 
well as how the brain changes along with increasing BMI and decreasing BMI will help 
us come up with viable drug targets and therapies to combat this widespread epidemic. 
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Introduction	  
	  
Overconsumption of widely available, calorie-dense palatable food is considered a major 
factor contributing to the high rates of obesity in the U.S (Swinburn et al., 2009). 
Because palatable foods are often consumed after energy requirements have been met, 
the rewarding properties of palatable foods may override homeostatic satiety signals. 
Many neurotransmitters play a role in feeding behavior (e.g. opioids, dopamine, GABA, 
serotonin) as well as the integration of peripheral nutrient signals (e.g., leptin, insulin, 
ghrelin). Dopamine signaling is a key mediator in both food reward and reward-seeking 
behavior, as dopamine in the mesolimbic/ mesocortical region is associated with the 
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rewarding properties of food, sex, and drugs of addiction (Fibiger & Phillips, 1988). 
Acutely, palatable food causes a burst of dopamine in the central reward system 
(Hernandez et al., 1988; Sahr et al., 2008). With chronic consumption of rewarding food, 
the increased dopamine release over time may lead to adaptations that are associated 
with reward hypo-function. 
Several lines of evidence support the hypothesis of altered dopamine function in 
obesity. Human imaging studies revealed blunted activation in reward regions of obese 
patients while drinking a highly palatable solution (milkshake) (Stice et al., 2008). The 
blunted reward response was associated with less brain dopamine receptor D2 
availability. In fact, mutations in the human dopamine D2 receptor have been linked with 
both obesity and addiction (Noble et al., 1991). Dopamine content in the synapse is 
largely controlled by dopamine transporter (DAT) uptake. Dopamine transporter levels 
are negatively correlated with body mass index and genetic variants of DAT are also 
associated with obesity (Chen et al., 2008; Need et al., 2006). Animal models of obesity 
have demonstrated decreases in basal extracellular dopamine and reduced dopamine 
neurotransmission in the nucleus accumbens and ventral tegmental area (Geiger et al., 
2007; Geiger et al., 2009; Cone et al., 2010). Decreases in dopamine-related genes after 
chronic high fat (HF) diet suggest decreased signaling in reward regions (Vucetic et al., 
2012; Alsio et al., 2010; Johnson & Kenny, 2010, Huang et al., 2005). This decrease in 
dopamine activity after chronic high-fat diet may reduce the sensitivity to natural rewards 
and facilitate continued overconsumption and further weight gain. 
Early life is a critical period in brain development, and the early nutritional 
environment can influence brain pathways controlling food intake and energy 
metabolism. Early exposure of mice to a high fat diet for as little as one week altered 
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adult caloric intake and expression of dopamine-related signaling molecules (Teegarden 
et al., 2009). Further, early postnatal over nutrition in mice, driven by a small litter 
number throughout lactation, predisposes the offspring to adulthood obesity by altering 
hypothalamic development (Bouret, 2010). While it is clear that early life nutrition can 
affect brain development and obesity risk, little is known about the relative permanence 
of these changes across the lifespan. Additionally, previous studies have been done in 
male animals but females have been rarely studied in this context. To these ends, both 
male and female mice were studied for changes in gene expression and dopamine 
metabolism after they were made obese in early life through chronic consumption of a 
HF diet from birth through 12 weeks of age. The dopamine system was also evaluated 4 
weeks after removal of the HF diet, to examine whether the changes persisted or 
reversed. 
 
Methods	  and	  Procedures	  
	  
Animals and experimental model. C57BL/6J females were bred with DBA/2J males 
(The Jackson Laboratory, Bar Harbor, ME). All dams were fed standard control diet 
(#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) up until parturition when half the 
dams/litters were placed on high fat diet (Test Diet, Richmond, IN #58G9; 18% protein, 
60% fat, and 20.5% carbohydrate). Offspring were weaned at 3 weeks of age and 
remained on either the control diet or the high fat diet until 12 weeks of age. Body 
weights were recorded weekly, and both male (n=5-10) and female (n=5-10) mice were 
used. The Institutional Animal Care and Use Committee (IACUC) of the University of 
Pennsylvania approved all procedures. 
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      Sucrose and Saccharin Preference. In separate experiments, mice were 
individually housed (n=8-10/group) in standard cages for 3 days with one bottle of 
200 ml of the test solution (4% sucrose or 1% saccharin solution (w/v)) and another 
bottle with 200 ml of tap water. House chow was available ad libitum. Sucrose (ml), 
water (ml), and food consumption (g), were measured and the placement of the bottles 
was reversed daily.  Preference was calculated using the average of the measurements 
from the last 2 days as follows: preference % = [(sucrose consumption/sucrose + water 
consumption) × 100].  
     Genomic DNA and Total RNA isolation from the brain. Animals (n=5/group) were 
euthanized with an overdose of carbon dioxide, followed by cervical dislocation; a 
method recommended by the Panel on Euthanasia of the American Veterinary Medical 
Association. Brains were then rapidly removed and placed in RNAlater (Ambion, Austin, 
TX) for 4-6 hours before dissection. Brain dissections to isolate the prefrontal cortex, the 
nucleus accumbens and the ventral tegmental area were preformed as previously 
described (Vucetic et al., 2010; Reyes et al., 2003; Cleck et al., 2008). Genomic DNA 
and total RNA were isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen). 
     Gene expression analysis by quantitative Real-Time PCR. For each individual 
sample, 500ng of total RNA was used in reverse transcription using High Capacity 
Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes was 
determined by quantitative RT-PCR using gene specific Taqman Probes with Taqman 
gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler. Gene 
probes are listed in supplemental material. Relative amount of each transcript was 
determined using delta CT values as previously described in (Pfaffl, 2001). Changes in 
gene expression were calculated against an unchanged GAPDH standard. 
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Western blot. Ventral tegmental area tissue was dissected out and flash-frozen 
on dry ice and stored at -80 °C. Frozen tissue was homogenized in 350 ul of 1X 
Extraction Buffer with 1:1000 DDT Solution and (1:1000) PIC added (Epigentek, 
Farmingdale, NY). Homogenates were incubated on ice for 15 minutes with vortexing 
every 5 minutes. Homogenates were then centrifuges at 14,000rpm for 10 minutes at 
4°C. Supernatants were collected and processed for total protein concentration 
according to the Micro BCA procedure (Pierce, Rockford, IL, USA). Protein levels of 
tyrosine hydroxylase were measures by western blot analysis. Protein samples were 
separated by electrophoresis on a 10% polyacrylamide gel and electrotransferred to a 
PVDF (polyvinylidene fluoride) membrane. Non-specific binding sites were blocked in 
Odyssey Blocking Buffer (Licor, Lincoln, Nebraska) for 1 hr at 4°C. Membranes were 
incubated at 4 °C overnight, with the primary rabbit antibody anti-TH (1:200, Pel-Freez 
Biologics, Roger, Arkansas  #p40101-0) and rinsed with 0.01% Tween20 in Tris-buffered 
saline. Membranes were then incubated for 1hr at room temperature with IRDye 800CW 
Goat anti-Rabbit IgG (H + L,), 25 µL (Licor, Lincoln, Nebraska, 1:2000 in 0.01% 
Tween20 Tris-buffered saline, 0.1% SDS) and washed with 0.01% Tween20 in Tris-
buffered saline. Membranes were imaged with the LI-COR Odyssey Infrared Imaging 
System and TH fluorescence was normalized to GAPDH florescence. 
     Ex vivo Dopamine and Dopamine Metabolites. High performance liquid 
chromatography (HPLC) was used to measure the content of dopamine and its 
metabolites in the mesolimbic reward areas of the brain (n=8-12), as described 
previously (Mayorga et al., 2001, Vucetic et al., 2010). Brains were collected from 
animals and bisected into right and left hemispheres. The NAc and PFC were dissected 
out and quickly frozen by dry ice and stored at -80°C. The tissue was prepared for 
analysis by homogenization in 0.1 N perchloric acid, centrifuged at 15,000 rpm for 15 
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min at 2-8˚C, and the supernatant filtered.  Samples were analyzed by a Bioanalytical 
Systems HPLC (West Lafayette, IN, USA) using a LC-4C electrochemical detector.  
Samples (12 ul) were injected onto a reverse phase microbore column at a flow rate of 
0.6 ml/min and electrodetection set at +0.6 V. Separation for dopamine and dopamine 
metabolites was accomplished by a mobile phase consisting of 90-mM sodium acetate, 
35-mM citric acid, 0.34-mM ethylenediamine tetraacetic acid, 1.2-mM sodium octyl 
sulfate, and 15% methanol v/v at a pH of 4.2.  Peak heights of samples were measured 
and compared with standards for dopamine and its metabolite 3,4-dihydroxyphenylacetic 
acid (DOPAC).   
      Methylated DNA Immunoprecipitation (MeDIP) Assay. MeDIP assay was 
preformed using MagMeDIP kit (Diagenode, Denville, NJ). Methylated DNA was 
immunoprecipitated using 15ul of magnetic beads coated with anti-5methylcytidine 
antibody (Diagenode) or mouse pre-immune serum. Enrichment in MeDIP fraction was 
determined by quantitative RT-PCR using ChIP-qPCR Assay Master Mix (SuperArray) 
on the ABI7900HT Real-Time Cycler. For all genes examined, primers were obtained 
from SuperArray (ChIP-qPCR Assays (-01) kb tile, SuperArray) for the amplification of 
genomic regions spanning the CpG sites located approximately 300-500 bp upstream of 
the transcription start sites. MeDIP results were expressed as fold enrichment of 
immunoprecipitated DNA for each site. To calculate differential occupancy fold change 
(% enrichment), the MeDIP DNA fraction CT values were normalized to Input DNA 
fraction CT values.  
 Statistics.  Gene expression analysis was performed using Student T-test 
comparing aged matched controls to HF and HF + recovery groups. The alpha level was 
adjusted for the multiple brain regions surveyed. Significance of a gene used in one 
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brain region was p=.05; for two regions, p=0.025, for 3 brain regions p=.016. Sucrose 
preference, saccharin preference, HPLC and MEDIP, body weights and corticosterone 
assay analyzed using one-way ANOVA to compare control, HF, and HF + recovery 
groups. Post-hoc Bonferonni Multiple Comparison Tests were used to compare pair-wise 
differences between groups. Significance for these tests was set at an alpha level of 
p=.05. 
 
 
Results	  
	  
Mice had continuous access to control diet (control) or 60% high fat diet (HFD) 
until 12 weeks of age. At 12 weeks of age, half of the HF-fed animals were placed on the 
house chow for 4 weeks (HF +recovery). In both males and females, HFD animals 
(circles) were heavier than controls beginning at 9 weeks of age (p<.05) and remained 
heavier than controls throughout the recovery period (Supplemental Figure 1). 
       Sucrose and saccharin preference tests were administered to assess animals’ 
response to natural and nonnutritive rewarding stimuli. Sucrose preference but not 
saccharin preference was altered after HF diet exposure and returned to normal levels 
after HFD recovery in males and females. One-way ANOVA revealed sucrose 
preference was significantly decreased in males (Fig. 1A) and trended toward a 
decrease in females (Fig. 1B) after HFD exposure (F(2,16)=4.82, p<.05; F(2,16)=5.41, 
p<.06, respectively). After removal of the HFD, this behavior normalized and sucrose 
preference no longer differed from controls. Saccharin preference was not altered in 
either males (Fig. 1C) or females (Fig. 1D) as a result of HFD exposure. 
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         Because dopamine is a key regulator of reward behavior, dopamine-related gene 
expression was examined within the reward circuitry of a separate cohort of males and 
females after 12 weeks on the HFD, and in an additional group, after 4 weeks recovery 
from the HFD. Table 1 summarizes the gene expression patterns and statistical analysis 
in the VTA, PFC and NAc. In the VTA, three genes important in regulating dopamine 
levels at synaptic terminals were measured: catecholamine methyl transferase (COMT) 
involved in inactivation of catecholamine neurotransmitters; dopamine transporter (DAT), 
membrane spanning pump that clears dopamine from the synapse, and tyrosine 
hydroxylase (TH), the rate-limiting enzyme for dopamine synthesis. Fold change values 
for each group were determined using aged matched controls (e.g. both control time 
points are set to 1, and for clarity only the control for HFD is depicted on the graph). 
Student’s t-test (n=5/group) revealed in the male VTA that COMT, DAT, and TH mRNA 
were significantly decreased by HFD exposure (Fig 2A) and returned to or exceeded the 
control levels after a recovery period off the diet (HF +recovery).  
In the PFC and NAC, genes important for dopamine signaling and dopamine 
turnover were examined (n=5/group): COMT; protein phosphatase 1 regulatory subunit 
1B (DARPP-32), a down stream signaling protein regulated by receptor stimulation; 
dopamine receptor D1 (DRD1), a postsynaptic G-protein coupled receptor that 
stimulates adenylyl cyclase; and dopamine receptor D2 (DRD2), a postsynaptic G-
protein coupled receptor that inhibits adenylyl cyclase. In the male PFC (Fig. 2B), 
DARPP-32 was increased, while DRD1, and DRD2 were decreased after HFD 
exposure, and these changes persisted after the removal of the HFD (although the 
increase in DARPP-32 mRNA was not statistically reliable). In the male NAC (Fig. 2C), 
COMT, DRD1, and DRD2 were decreased by HFD exposure, and remained below 
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control levels after removal of the HFD. DARPP-32 levels were increased by HFD, but 
significantly decreased from controls after 4 weeks off the HFD. 
      The same brain regions and genes were examined in female mice (n=5/group). As 
shown in Table 2, there were significant differences observed in the pattern of gene 
expression in response to the HFD, as well as to the recovery off the diet. Similar to 
males, in the VTA, mRNA levels of COMT, and TH were significantly decreased after 
HFD exposure (Fig 2D). However, unlike the males, these changes persisted after the 
removal of the HFD. Further, in direct opposition to the pattern observed in males, HFD 
exposure increased DAT mRNA expression in the VTA in females, and after removal of 
the HFD levels were even lower than age matched controls. In the PFC, only DARPP-32 
was affected by chronic HFD, with a significant increase in mRNA levels after 12 week 
HFD, and a return to control levels after removal of the HFD. Both COMT and D1R 
mRNA were significantly decreased after 4 weeks off the HFD. In the female NAC, 
COMT, DRD1, and DRD2 were all decreased after HFD exposure (Fig. 2F). DRD1 and 
DRD2 recovered to control levels after diet removal, while COMT remained levels 
remained significantly decreased after 4wk recovery. Protein levels of TH were 
quantified in the ventral tegmental area to confirm gene expression results. Chronic high 
fat diet was decreased in males (Figure 3A F(2,18)=3.502, p=.0519) and remained 
decreased after 4 week recovery period, however post hoc analysis showed this 
decrease was only a trend not statistically reliable. Protein levels of TH in the VTA of 
females (Figure 3B F(2,19)=3.544, p=0.0492) were also decreased after high fat diet 
and levels trended toward normalization after a 4 week recovery period. 
Given the consistent decrease in gene expression for dopamine regulating genes 
in the VTA, dopamine and dopamine metabolites were quantified in regions that receive 
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projections from the VTA, the PFC and NAC. Figure 3 shows dopamine (DA) and the 
dopamine metabolite (DOPAC) from the PFC and NAC in males (Fig. 4A, 3C) and 
females (Fig. 4B, 3D). In males, exposure to the HFD produced a decrease in dopamine 
levels in PFC (Fig. 4A) and NAC (Fig 4C) (F(2,13)=3.95;F(2,18)=3.536, p<.05), which 
recovered after HFD removal only in the NAC. Dopamine turnover (DOPAC:DA ratio) 
increased in male PFC (F(2,12)=3.85, p<.05) and NAC (F(2,17)=4.69, p<.05). In 
contrast, the effect of HFD on DA and DOPAC in females was qualitatively different than 
in males. In the PFC, HFD did not affect DA or DOPAC levels. In the NAc, DA levels 
were decreased in HFD-fed animals and remained decreased even after removal of the 
HFD  (Fig. 4D, F(2,23)=4.79, p<.05). DOPAC levels were unchanged in the NAc of 
females, which resulted in an increase in DA turnover (DOPAC:DA ratio) (F(2,23)=7.00, 
p<.01). 
      Given that DAT transcription can be regulated by differential DNA methylation and 
the observation of a notable sex difference in the expression of DAT in the VTA, DNA 
methylation in the promoter region of DAT was examined. In Figure 5A, 5C DAT gene 
expression in the VTA is presented again for clarity (taken from Fig 2A and 2D). DAT 
promoter methylation was significantly increased in males (Fig. 5B) after HFD and 
returned to control levels in HFD + recovery males (F(2,11)=23.64, p<.01). In females, 
DAT promoter methylation trended toward decrease in HFD animals (D) and was 
significantly decreased in HFD + recovery females (Fig 5D, F(2,12)=5.70, p<.05). 
      To assess if removal of the HFD in the recovery period was a stressor, baseline 
plasma corticosterone levels (ug/dl) were taken in control, HFD exposed (12 weeks), 
HFD +1wk recovery and HFD + 4wk recovery groups (n=5/group, Supplemental Fig. 2). 
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One-way ANOVA revealed no significant differences between groups in male animals 
(F(3,16)=3.21, n.s.). 
 
	  
Discussion	  
 
Chronic consumption of a high fat diet (HFD) beginning in early life was used to 
establish diet-induced obesity in mice. Mice displayed decreased sucrose preference 
and evidence of reduced dopaminergic tone in reward regions of the brain. After 4 
weeks off the HFD, sucrose preference normalized in both males and females, however, 
some dopamine gene expression changes persisted. These experiments provide 
important new data describing the effect of chronic HFD on the brain reward system, 
highlighting the capacity for recovery and key sex differences between male and female 
mice.  
         In the HFD fed animals, a decreased sucrose preference was observed, which 
reversed after a recovery period. These findings extend our previous report of HFD 
intake driving a reduced sucrose preference (Vucetic et al., 2003) by demonstrating that 
this can occur with a shorter duration of HFD exposure (12 weeks versus 22 weeks), 
and importantly, that the response recovers in the absence of HFD. Female mice 
demonstrated the same response patterns as males. These findings are consistent with 
others in the literature which have shown through the inclusion of a pair fed group that 
chronic HFD, and not obesity per se, attenuates the response for sucrose in an operant 
task (Davis et al., 2008). Similarly, in the current study, sucrose preference recovered 
after 4 weeks off the HFD, while body weight remained significantly elevated, supporting 
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the conclusion that decreased sucrose preference was driven by the HFD exposure and 
not the accompanying body weight gain. It was particularly interesting that there was no 
change in saccharin preference. This may indicate that chronic HFD differentially affects 
the response to caloric and non-caloric sweet rewards. Post ingestive effects have been 
shown to influence preference independent of palatability, as sucrose intake has been 
shown to induce dopamine release in “sweet-blind” taste receptor knockout mice (de 
Araujo et al., 2008), nutritional value is required for reward and reinforcement (Beeler et 
al., 2012) and taste-independent metabolic sensing pathways have been defined in 
drosophila (Dus et al., 2011). Saccharin is significantly sweeter than sucrose, so an 
effort was made to establish equivalency in sweetness (typically 4-10x higher 
concentration of sucrose (Beeler et al., 2012)) however the overall preference for 
saccharin was lower than that for sucrose in these animals. Therefore, an alternative 
explanation may be that HFD differentially affected the sucrose preference because it 
was relatively more rewarding than saccharin (high vs. low value reward), although 
animals still evinced a strong preference for saccharin (~75-80% preference for 
saccharin compared to ~85-90% preference for sucrose). 
      Overall, dopaminergic gene expression within the VTA, NAc and PFC was 
decreased in male mice following chronic HFD. These findings are consistent with other 
studies that observed decreases in dopamine related genes in response to HFD (Vucetic 
et al., 2012; Alsio et al., 2010; Huang et al., 2005). Decreases in dopamine D2 receptor 
expression and function have been observed in human imaging studies  (Stice et al., 
2008; Wang et al., 2001) and rodent obesity models (Johnson & Kenny, 2010; Huang et 
al., 2006). Decreased dopamine signaling reduces the sensitivity to natural rewards and 
may therefore facilitate continued overconsumption of palatable foods and further weight 
gain (Fortuna et al., 2012; Koob et al., 2008). Further, disrupted dopamine homeostasis 
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driven through decreased DAT surface expression is known to drive increased intake of 
high fat diet (Speed et al., 2008). An exception to this pattern was seen with DARPP-32, 
a dopamine- and cyclic AMP-regulated phosphoprotein, which increased after HFD in 
NAc and PFC. DARPP-32 plays a key role in integrating a variety of biochemical and 
behavioral responses controlled by dopamine. It may be that DARPP-32 upregulation 
was compensatory in response to the chronic down regulation of D1R. In a similar model 
(12 wk HFD in mice), it has been shown that D1R down regulation was matched by an 
increase in phosphorylation of DARPP-32 in NAc (Sharma et al., 2012).  
       Few studies have examined the capacity for recovery of these changes after 
removal of the HFD. However, in two recent reports, gene expression changes and 
reward system defects persisted after a short withdrawal period (14-18d) (Alsio et al., 
2010; Johnson & Kenny, 2010). In contrast, studies in obese patients before and after 
gastric bypass surgery have shown a reversal of dopaminergic changes after a longer 
period of weight loss (Steele et al., 2009). In males, the pattern of recovery varied by 
brain region. In the VTA, the observed decreases in COMT, DAT, and TH were all 
normalized with the removal of the HFD. In contrast, all gene expression changes 
observed in the NAc and PFC did not normalize. In the current study, chronic HFD led to 
significant weight gain and after 4 weeks off the diet, animals were still significantly 
heavier than controls. Therefore, the subsequent metabolic and hormonal changes that 
accompany obesity (e.g., increased leptin, elevated adipokines) were likely still present 
at 4 weeks off the diet. Therefore, gene expression changes that normalized (e.g., in the 
VTA) may have been primarily driven by the HFD, while those that were maintained (in 
NAc and PFC) may be more tightly coupled to obesity. Maintenance of weight loss by 
dieting is characteristically low (with 67% (Phelan et al., 2010) to 80% (Field et al., 2001) 
of patients regaining the lost weight). This persistence of gene expression changes in 
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reward regions could be important in partly explaining this common occurrence. It is also 
important to note that the observed behavioral and gene expression changes are not 
likely to be due to stress associated with changing diets, as there were no significant 
changes in basal plasma corticosterone levels on the HFD or after 1wk or 4wk recovery. 
        Interesting sex differences were revealed, in both the response to chronic HFD, as 
well as in response to diet removal. Females were similar to males in showing an overall 
decrease in dopamine related genes that would predict a decrease in DA activity, 
particularly in the VTA and the NAc. One noteworthy sex difference was the increase in 
DAT mRNA expression in the female VTA after HFD. This difference in gene expression, 
coupled with similar decreases in TH gene expression in both sexes, would suggest 
significant differences in dopamine neurotransmission within the NAc, both at the end of 
the HFD exposure as well as after the recovery period. A greater appreciation for the 
functional significance of these differences is an important focus of future research. 
      Additionally, while COMT and TH decreases recovered in the male VTA, these 
decreases persisted in the females after 4-week off the HFD. It is yet to be determined 
whether these differences would reverse with a longer time off the diet, however, it 
supports the conclusion that females are, at the very least slower to recover, if they 
recover at all. Protein levels of TH matched gene expression levels on the high fat diet 
but were not significantly decreased after a 4 week recovery period in both males and 
females. Further, gene expression changes of D1R and D2R in NAc and PFC were quite 
different between males and females. In males, there was a general decrease in gene 
expression in both regions that largely persisted after diet removal. In females, D1R and 
D2R were decreased in the NAc and then recovered, but there was no effect of HFD on 
dopamine receptors in PFC. In the current studies, female animals were sacrificed 
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without accounting for estrus stage. While some of the observed endpoints are known to 
vary across the estrus cycle, female animals in this study did not demonstrate increased 
variance across the endpoints, particularly when compared to the effect of the diet 
manipulations. 
         To complement the gene expression and protein findings, dopamine was 
measured in the primary projection regions of the VTA, namely the PFC and the NAc. 
Dopamine levels tended to parallel changes seen in TH mRNA in the VTA. In the NAc of 
both males and females, levels of DA decreased in response to the HFD diet; a 
response which recovered in males, but not females. In the PFC, dopamine levels were 
also decreased by HFD, however, there was no recovery off the diet in the PFC. 
Additionally, females had lower levels of dopamine in the prefrontal cortex than males. 
Sex differences in DAT expression and function are well known in the literature, with 
females demonstrating increased DAT expression (Morissette et al., 1993) and function 
(Bhatt et al., 2005), and these differences may contribute to the different baseline levels 
of dopamine between males and females.  Examination of the DOPAC:DA ratio is 
informative as well. An increase in this ratio may have reflected a compensatory 
response driven by decreases in DA. The long-term functional significance of these 
changes in dopamine metabolism would be illuminated by measuring changes in 
dopamine release using in vivo microdialysis.   
 Moreover, these data identify dynamic regulation of DNA methylation within the 
promoter of the DAT gene, particularly in the males. Recently, we have demonstrated 
that DAT expression can be dynamically regulated by differential DNA methylation in 
response to HFD (Vucetic et al., 2012), and that increased DAT promoter methylation 
correlates with a decrease in gene expression. Here we identify the plasticity of this 
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response, as the increased DNA methylation (and decreased expression of the mRNA) 
seen in males reverses upon removal of the HFD. Epigenetic gene regulation, for 
example through changes in DNA methylation, presents a pathway whereby organisms 
can readily adapt to environmental challenges. Epigenetic marks can be maintained 
across the lifespan (Ollikainen et al., 2010), and in cultured embryonic stem cells, both 
reversible and persistent patterns of differential DNA methylation were observed in 
response to changing environmental conditions (Tompkins  et al., 2012). These data are 
the first to demonstrate in vivo a dynamic methylation pattern that changes with the 
presence or absence of an environmental challenge. It was notable that this same 
pattern was not observed in females. While the initial response to the HFD was as 
predicted (decreased DNA methylation driving increased gene expression), this pattern 
was not maintained throughout the recovery period. This suggests that DNA methylation 
and gene expression may become uncoupled during the four weeks off the HFD or it 
may suggest that DAT mRNA is regulated by other means in females. 
  In males, sucrose preference, DA-related gene expression in the VTA, and 
dopamine in the NAc follow a consistent pattern, of suppression in response to the 
chronic HFD that recovers after removal of the diet. Interestingly, while the behavioral 
responses to sucrose are similar in the females, both the gene expression pattern and 
NAc dopamine levels show a lack of recovery upon removal of the HFD. Reward-related 
behaviors are clearly influenced by additional neurotransmitter systems such as the 
opioids, and perhaps in females, the behavioral response to sucrose is more strongly 
associated with changes in opioids. Overall, the present data suggest that sex 
differences in the both the initial response to HFD, as well as to recovery after removal 
of the HFD, with regard to dopamine-related gene expression represent an important 
direction for future research directed at how chronic consumption of a HFD impacts the 
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brain reward system. Most notably, these data identify significant plasticity in the 
dopaminergic response to HFD, suggesting that while the adverse effects of chronic 
HFD consumption and/or obesity are significant, the potential for recovery exists. 
 
Table	  and	  Figure	  Legends	  
	  
Table 1.  Gene Expression Summary and Statistics in Males. Gene expression 
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus 
accumbens. Summary of fold change, significance and p values are presented for HF 
and HF +recovery groups as compared to their age matched control.  
Table 2.  Gene Expression Summary and Statistics in Females. Gene expression 
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus 
accumbens. Summary of fold change, significance and p values are presented for HF 
and HF +recovery groups as compared to their age matched control.  
Figure 1. Sucrose preference but not saccharin preference is altered after high-fat 
diet (HFD) exposure and returns to control levels after HFD recovery in males and 
females. Sucrose preference (A,B) and saccharin preference (C,D) were evaluated in 
counter balanced order of control (white bars) HFD (black bars) and HFD + recovery 
(patterned bars) males and females. (n=8/group) *p<.05 significantly different from 
control group.  
Figure 2.  Chronic high-fat diet (HFD) and recovery after HFD alters dopamine 
related gene expression in males and females.  Gene expression was measured in 
the ventral tegmental area (VTA; A,D.), prefrontal cortex (PFC; B,E), and nucleus 
accumbens (NAc; C,F) of control (white bars), HFD (black bars) and HFD + recovery 
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(patterned bars) males and female mice (n=5/group). HFD and HF + recovery groups 
are fold change from their own aged matched controls. Only one control group (12wk) is 
shown and set to 1. *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly different from 
own control group.  
Figure 3. Chronic high fat diet (HFD) reduced TH protein levels in the ventral 
tegmental area in both males and females. Protein levels of TH were visualized in the 
VTA of both males (A) and females (B) and representative western blots are shown. C) 
Quantification of TH protein florescence normalized to GAPDH from all male samples 
(n=8). D) Quantification of TH protein florescence normalized to GAPDH from all female 
samples (n=9). Statistically significant results are shown at an alpha level of p=0.05  
Figure 4. Decrease in Dopamine levels in PFC and NAC after HFD from birth and 
mixed recovery after HFD removal.  Dopamine and dopamine metabolites were 
measured in the PFC (A,B) and NAC (C,D) of control (white bars), HF from birth (black 
bars) and HF + recovery (patterned bars). (n=8-10/group) *p<.05, **p<.01 significantly 
different from control group.  
Figure 5. Changes in DNA methylation status of DAT promoter parallel changes in 
gene expression in the VTA. Genomic DNA was isolated from the dissected VTA of 
control (white bars), HF from birth (black bars) and HF + recovery (patterned bars). DNA 
was digested by restriction enzyme MSE1 and immunoprecipitated by a 5-
methylcytosine antibody. The enrichment of DNA methylation relative to input DNA in the 
promoter region of DAT was quantified by qPCR (B, D). DAT mRNA levels, (A, C; 
previously presented in Fig 1) are shown for comparison (n=5/group). *p<.05, **p<.01, 
***p<.001 significantly different from control group.  
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Supplementary	  Information	  Description	  
 
Supplemental Figure 1. Body weights increase after 12 weeks HF diet and do not 
normalize after 4wk recovery period. HF from birth animals (black circles) were placed 
on 60% HF diet at postnatal day 1. After 12 weeks HF diet exposure, half the animals 
were placed on control diet for a recovery period. Red line depicts time on HFD. Control 
animals (black squares) remained on standard chow ad libitum throughout the 
experiment. (n=5/time point/group) *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly 
different from control group. 
Supplemental Figure 2. Corticosterone levels in males were not different after 12 
weeks HF diet or after HF + recovery.  Plasma corticosterone levels (ug/dl) were taken 
from trunk blood in control (white bar), HF from birth (black bar), HF +1wk recovery (gray 
bar), and HF +4wk recovery (striped bar). Blood was taken at same time of day during 
the light phase. 
Taqman Gene Expression Primers: 
COMT Mm00514377_m1 
DAT  Mm00438388_m1 
TH  Mm00447557_m1* 
DARPP-32  Mm00454892_m1 
DRD1 Mm01353211_m1 
DRD2 Mm00438545_m1 
Epitect ChIP qPCR Assay for MedIP assay: 
DAT Slc6a3, nM_010020.3(-)01Kb  
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Tables	  and	  Figures	  
	  
Table	  1.	  Gene	  Expression	  Summary	  and	  Statistics	  in	  Males.	  	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   	   	   MALES	   	   	  
Gene	   12wk	  HFD	  
Fold	  change	  
P	  value	   	   4wk	  Recovery	  	  
Fold	  Change	  
P	  value	  
VTA	   	   	   	   	   	  
COMT	   0.360	   <0.001	   	   1.93	   <0.01	  
DAT	   0.423	   <0.001	   	   1.46	   <0.05	  
TH	   0.380	   <0.01	   	   1.15	   0.145	  
PFC	   	   	   	   	   	  
COMT	   0.748	   0.0662	   	   .586	   <0.01	  
DARPP-­‐32	   1.62	   <0.01	   	   1.55	   0.0386	  
DRD1	   0.373	   <0.001	   	   0.553	   <0.01	  
DRD2	   0.522	   <0.01	   	   0.450	   <0.01	  
	   	   	   	   	   	  
NAC	   	   	   	   	   	  
COMT	   0.402	   <0.01	   	   0.133	   <0.0001	  
DARPP-­‐32	   2.03	   <0.025	   	   0.235	   <0.001	  
DRD1	   0.521	   <0.01	   	   0.189	   <0.01	  
DRD2	   0.512	   <0.001	   	   0.190	   <0.01	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Table 2. Gene	  Expression	  Summary	  and	  Statistics	  in	  Females 
 
 
	   	   	   FEMALES	   	   	  
Gene	   12wk	  HFD	  
Fold	  
change	  
P	  value	   	   4wk	  Recovery	  	  
Fold	  Change	  
P	  value	  
VTA	   	   	   	   	   	  
COMT	   0.502	   <0.0001	   	   0.074	   <0.0001	  
DAT	   1.93	   <0.0001	   	   0.171	   <0.0001	  
TH	   0.648	   <.05	   	   0.270	   <0.0001	  
PFC	   	   	   	   	   	  
COMT	   0.776	   <0.025	   	   0.376	   <0.0001	  
DARPP-­‐
32	  
1.98	   <0.001	   	   0.853	   0.213	  
DRD1	   1.21	   0.397	   	   0.567	   <0.025	  
DRD2	   1.14	   0.662	   	   0.670	   0.1566	  
	   	   	   	   	   	  
NAC	   	   	   	   	   	  
COMT	   0.678	   <0.01	   	   0.171	   <0.0001	  
DARPP-­‐
32	  
0.830	   0.292	   	   2.05	   0.0521	  
DRD1	   0.476	   <0.0001	   	   0.767	   0.186	  
DRD2	   0.489	   <0.0001	   	   0.749	   0.0631	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CHAPTER	  3:	  Response	  of	  the	  Dopamine	  Reward	  System	  to	  High	  Fat	  
Diet	  and	  Diet	  Withdrawal	  Depends	  on	  Age	  of	  Onset	  and	  Sex	  
	  
Jesse L. Carlin, Sarah Mckee, Tiffany-Hill Smith, Nicola Grissom, Robert George, Irwin 
Lucki, Teresa M Reyes 
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Introduction	  
	  
Obesity rates have risen at an alarming rate in both children and adults over the 
last decade (WHO, 2012).  Obese children are more likely become obese adults with all 
associated health issues (Reilly & Kelly, 2011; Wija et al., 2010; Wake M., et al., 2010) 
and find it more difficult to lose weight in the future (Cockrell Skinner et al., 2013).  
Overconsumption of readily available palatable food is one factor driving the increased 
incidence of obesity in the U.S. Palatable foods are rewarding and acute consumption 
releases the neurotransmitter dopamine, in a manner similar to the response to drugs of 
abuse (Gieger et al., 2009). Repeated stimulation of dopamine (DA) reward pathways is 
thought to cause adaptations in neurotransmitter levels and brain circuitry. These 
adaptations can lead to an increase in compulsive behaviors and over consumption of 
food/drugs of abuse (Volkow & Li, 2004; Verbeken et al., 2012). There is evidence of 
dopamine dysregulation in obese patients. Obese individuals have decreased dopamine 
receptor D2 binding (Wang et al., 2001) and decreased caudate activity (Stice et al., 
2008). Human dopamine D2 receptor mutations have previously been linked with 
compulsive disorders and drug addiction (Blum et al., 1991; Vereczkei et al., 2013, 
Wang et al, 2013). Palatable foods are often consumed when energy requirement have 
already been met, indicating dysfunction in food intake behaviors. In fact, imaging 
studies have revealed obese individuals have decreased activation in reward regions in 
response to palatable food consumption (Stice et al., 201114,15; DelParigi et al., 2004).  
The neuroadaptations that occur after chronic high fat intake alter the response 
to drugs that act on the dopamine reward system; however, the reported effects have 
been mixed.  Some studies have shown the high fat diet to have a dampening effect on 
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the rewarding aspects of drugs. Rodents on a high fat diet (HFD) have exhibited reduced 
cocaine self administration (Wellman et al., 2007) and reduced conditioned place 
preference for amphetamines (Davis et al., 2008). Rodents prone to develop obesity 
show a reduced conditioned place preference for cocaine (Thanos et al., 2010). Johnson 
& Kenny (2010) have reported reward dysfunction in obesity after rodents given high fat 
diet had increased brain stimulation reward thresholds. One possible mechanism behind 
the decrease reward value could be a decrease in basal extracellular DA (Gieger et al., 
2009) and reduced DA reuptake in the nucleus accumbens (NAc) (Cone et al., 2012) in 
obese animals. Reward dysfunction has also been associated with decreases in 
dopamine-related gene expression (Carlin et al., 2013; Alsio et al., 2010, Huang et al., 
2005). On the other hand, other studies have shown high fat diet to have a stimulating 
effect on drugs acting in the dopamine reward system. Baladi et al. (2011) reported an 
increase in cocaine-induced locomotion after high fat diet intake in adolescent and adult 
rats. Additionally, a separate study reported obesity-prone rodents to have increased 
extracellular dopamine (Narayanaswami, et al., 2013). These results demonstrate that 
high fat diet alters the dopamine reward system, but direction and scale of effect may 
depend on factors such as diet composition, length of exposure and age of the animals. 
In fact, there are significant developmental and sex-related differences found in 
dopamine neurochemistry (Rivest et al. 1999; Walker et al. 2000). Understanding the 
critical factors that regulate the neuroadaptations seen in obesity may help the treatment 
of the disease and the associated overconsumption of palatable foods. 
  Dopamine transporter (DAT) is a membrane-spanning pump that regulates 
synaptic dopamine concentration by reuptake of the neurotransmitter into the synaptic 
terminals and could be the target regulating the age and sex differences seen after high 
fat diet. In obese individuals, DAT levels are reduced and negatively correlate with body 
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mass index (Chen et al., 2008).  Disruption of DAT expression increases synaptic 
dopamine, elevates food intake, and increases preference for palatable foods (Pecina, et 
al., 2003). Changes in dopamine levels in the synapse could alter the sensitivity to 
natural rewards and facilitate even more overconsumption and further weight gain 
(Johnson & Kenny, 2010; Pecina et al, 2003; McCutcheon et al., 2012). 
 Few studies have looked at the dopamine system after removal of the high fat 
diet (Johnson & Kenny, 2010; Alsio et al., 2010, Steele et al., 2009) and none of these 
studies have taken into account the age of onset of high-fat exposure. Research models 
have also shown the importance of the early life environments in affecting behavioral 
outcomes in adulthood (Zhu et al., 2010; Carlin et al., 2013b; Weaver et al., 2004; 
Murgatroyd et al., 2009; Schwarz et al., 2011;). The first postnatal day through 
adolescence is a particularly sensitive time period for brain development. Like early life 
exposure to drugs of abuse, early exposure to HFD may induce stable changes in 
circuitry that remain stable even after insult is removed. It has been increasingly 
understood that timing of HFD modulates the development of adulthood reward seeking 
behaviors (Teegarden et al., 2009; Labouesse et al., 2013; Naef et al., 2013; Naef et al., 
2012). The following experiments were designed to test the hypothesis that beginning a 
high fat diet earlier in life would result in greater and more lasting changes in the 
dopamine reward system. Further, they look to determine if age and sex are factors in 
the development and persistence of dopamine changes and overconsumption of 
palatable foods seen in obesity. Behavioral tests were preformed by the Gomez-Pinilla 
lab at UCLA and the neurochemistry and gene expression experiments were performed 
by the Reyes Lab at UPenn. 
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Materials	  and	  Methods	  
	  
 Animals and experimental model. C57BL/6J females were bred with DBA/2J 
males (The Jackson Laboratory, Bar Harbor, ME) and were fed standard control chow 
(#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) throughout pregnancy and 
lactation. Offspring were weaned at 3wks of and a third of animals were then placed on 
high fat diet (Test Diet, Richmond, IN #58G9; 18% protein, 60% fat, and 20.5% 
carbohydrate). Another third of animals were placed on high fat diet at 6wks of age. The 
final third were kept on standard hour chow.  Animals remained on high fat diet for 12 
weeks. A separate cohort after 12 weeks ad lib access to high fat diet was then switched 
to control chow. Body weights were recorded weekly, and both male (n=5-
10/experiment) and female (n=5-10/experiment) mice were used. The Institutional 
Animal Care and Use Committee (IACUC) of the University of Pennsylvania approved all 
procedures. 
 Fat pad Weights. Animals (n=5-10/group) were euthanized with an overdose of 
carbon dioxide, followed by cervical dislocation; a method recommended by the Panel 
on Euthanasia of the American Veterinary Medical Association. Body weights were 
taken and white adipose tissue was removed. Specifically, the abdominal fat pads, the 
gonadal fat pads, and the inguinal fat pads were weighed separately. Normalization of 
fat pads to body weight was calculated.  
Sucrose Preference. Mice were individually housed in standard cages for 3 
days with access to ad lib food and two bottle choice. One bottle was filled with 200 ml of 
4% sucrose solution (w/v), another with 200 ml of tap water. Sucrose (ml), water (ml), 
and food consumption (g), were measured. Preference was calculated using the 
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measurements from the last 2 days only as follows: preference % = [(sucrose 
consumption/sucrose + water consumption) × 100]. (n=8-10/group) 
One-Hour Palatable Food Intake. Mice were individually housed (n=11-
12/group) in standard cages for a total of 8 days. Each day, home cage food and body 
weight were measured. Animals were given access to a bowl with palatable high fat/high 
sugar food (Peanut Butter Chips) or control diet for one hour and measured. Daily caloric 
intake of ad libitum chow, palatable food, and percent calories/day were calculated. 
Because presence of high fat diet could have an effect on intake of palatable food, a 
separate cohort of Pre-Adolescent HF and Adult HF were acutely placed on ad libitum 
control chow during the experiment. This group is labeled HF+1wk recovery and 
compared to HF and HF + 4wk recovery groups.  
 Genomic DNA and Total RNA isolation from the brain. Animals (n=5/group) 
were euthanized with an overdose of carbon dioxide, followed by cervical dislocation; a 
method recommended by the Panel on Euthanasia of the American Veterinary Medical 
Association. Brains were then rapidly removed and placed in RNAlater (Ambion, Austin, 
TX) for 4-6 hours before dissection. Brain dissections to isolate the prefrontal cortex, the 
nucleus accumbens and the ventral tegmental area were preformed as previously 
described (Vucetic et al. 2010, Reyes et al. 2003). Genomic DNA and total RNA were 
isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen). 
 Gene expression analysis by quantitative Real-Time PCR. For each 
individual sample, 500ng of total RNA was used in reverse transcription using High 
Capacity Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes 
was determined by quantitative RT-PCR using gene specific Taqman Probes with 
Taqman gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler. 
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Gene probes are listed in supplemental material. Relative amount of each transcript was 
determined using delta CT values as previously described in (Pfaffl 2001). Changes in 
gene expression were calculated against an unchanged GAPDH standard. 
Ex vivo Dopamine and Dopamine Metabolite Measurement by HPLC. High 
performance liquid chromatography will be used to measure dopamine content of the 
mesolimbic reward areas of the brain (n=8-12). Brains will be collected from animals and 
cut into right and left hemispheres. NAc and PFC will be dissected out and quickly frozen 
by dry ice and stored at -80°C. Samples will be analyzed by the Bioanalytical Systems 
HPLC (West Lafayette, IN, USA) with a PM-80 pump, a Sample Sentinel autosampler, 
and an LC-4C electrochemical detector.  Samples (12 ul) will be run through a reverse 
phase micropore column at a flow rate of 0.6 ml/min and electrodetection at +0.6 V. 
Separation for dopamine and dopamine metabolites will be accomplished by a mobile 
phase consisting of 90-mM sodium acetate, 35-mM citric acid, 0.34-mM ethylenediamine 
tetraacetic acid, 1.2-mM sodium octyl sulfate, and 15% methanol v/v at a pH of 4.2 
(Mayorga et al., 2001; Vucetic et al., 2010). 
 
Statistical Analysis. Gene expression analysis was performed using 
Student T-test comparing aged matched controls to HF and HF + recovery groups. 
The alpha level was adjusted for the multiple brain regions surveyed using a 
Bonferronni correction (e.g. significance of a gene used in one brain region was 
p=.05; for two regions, p=0.025, for 3 brain regions p=.016). Sucrose preference, 
HPLC measurements, food intake, body weights, and fat pad weights were 
analyzed using one-way ANOVA to compare control, HF, and HF + recovery 
groups. Post-hoc Bonferonni Multiple Comparison Tests were used to compare 
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pair-wise differences between groups. Significance for these tests was set at an 
alpha level of p=.05.  
 
Results	  
 
Nomenclature. 
Animals that started the high fat diet at weaning are labeled “Pre-Adolescent HF”, while 
animals that started the high fat diet at 6 weeks of age are labeled “Adult HF.”  
Body and Fat pad weights. 
Body weights were taken weekly and fat pad weights were taken at the sacrifice at end 
of study.  Within 6 weeks on HF diet, animals reached significantly higher body weight 
than control and remained significantly heavier than controls after a 4-week chow 
recovery period in both Pre-Adolescent (Figure 1A, F(18,100)= 110.4, p<0.0001) and 
Adult HF males (F(20,108)=97.60, p<0.0001). Pre-Adolescent HF females (Figure 1B, 
F(17,95)=56.57, p<0.0001) took less time to reach significantly higher body weight than 
Adult HF females (F(20,115)=34.89, p<0.0001). A 4-week standard chow recovery was 
not sufficient to normalize body weights in females.  Figure 1C shows male body weights 
heavier in HF and HF+ recovery at experimental time points compared to their own aged 
matched controls in Pre-adolescent (F(3,30)=39.59, p=0.0051) and Adult HF 
(F(3,28)=26.67, p<0.0001). The same weight pattern is seen in females. HF and HF+ 
recovery Pre-adolescent (Figure 1E, F(3,40)=40.89, p<0.0001) and Adult 
(F(3,54)=24.86, p<0.0001) females are heavier than their aged matched control at 
experimental time points. Abdominal fat pad weights were taken and shown as a 
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percentage of body weight and compared to own aged matched controls. Pre-
Adolescent males have increased fat pad mass as a percentage of body weight after 
high fat diet and after a 4 week standard chow replacement (Figure 1D, F(3,34)=103.9, 
p<0.0001). Planned comparisons shown significant increase in fat pad mass in Pre-
Adolescent HF males and in Pre-Adolescent HF+recovery compared to their own aged 
matched controls (Figure 1D, p<0.0001, p<0.05). Adult males show a similar increase in 
fat pad mass after high fat diet and after a standard chow recovery (Figure 1D, 
F(3,29)=79.57, p<0.0001). Planned comparisons reveal Adult HF males to have 
significantly heavier fat pad mass versus their aged match controls (Figure 1D, 
p<0.0001) and Adult HF + recovery males were similarly increased versus their own 
aged matched controls (Figure 1D, p<0.0001). In females we see a similar increase in 
fat pad mass after high fat diet intake and failure of a 4 week standard chow 
replacement to normalize body fat pad percentage. 
Pre-Adolescent females have increased fat pad mass as a percentage of body 
weight after high fat diet and after a 4 week standard chow replacement (Figure 1F, 
F(3,30)=59.86, p<0.0001). Planned comparisons shown significant increase in fat pad 
mass in Pre-Adolescent HF females and in Pre-Adolescent HF+ recovery compared to 
their own aged matched controls (Figure 1D, p<0.0001, p<0.05). Adult HF females show 
a similar increase in fat pad mass after high fat diet and after a standard chow recovery 
(Figure 1F, F(3,32)=43.79, p<0.0001). Planned comparisons reveal Adult HF females to 
have significantly heavier fat pad mass versus their aged match controls (Figure 1F, 
p<0.0001) and Adult HF + recovery females to have increased fat pad mass increased 
versus their own aged matched controls (Figure 1F, p<0.01). 
Sucrose Preference 
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Sucrose preference test was administered to assess the animals’ response to a natural 
and nutritive rewarding stimulus. All animals preferred the 4% sucrose solution over 
water (preference > 50%). In males, sucrose preference was significantly reduced after 
12 weeks HF diet in the Pre-Adolescent animals (Figure 2A, F(2,17)=17.58, p<0.0001), 
yet unchanged in adult HF animals. Sucrose preference was decreased in both female 
Pre-Adolescent HF (Figure 2C, F(2,16)=12.07, p<0.0006) and Adult HF mice 
(F(2,15)=7.497, p<0.0055) after 12 wks high fat diet. Preference in all groups where 
sucrose preference was decreased returned to control levels after standard chow 
recovery period.  
One-Hour Palatable Food Intake 
Animals were given one-hour access to high fat/high sugar food to assess their 
response to intermittent palatable food. In Pre-Adolescent males, chronic HF reduced 
the amount of palatable food intake (Figure 3A, F(7,39)=13.58, p<0.0001). 1 hr access 
to control food was not changed. Post-hoc analysis shows that standard chow 
replacement during the experimental period or for 4 weeks prior increased palatable 
food intake compared to pre-adolescent animals on chronic HF (Figure 3A, p<.001, 
p<.0001). Female Pre-Adolescent HF animals did not significantly reduce their 1hr 
palatable food but they increased their intake after the 4wk standard chow replacement 
(Figure 3B, F(7,41)=9.281, p<0.0001). Post hoc analysis revealed an increase in 1hr 
palatable food intake after 4wk standard chow replacement to be statistically greater 
than controls (Figure 3C, p<.01). Both a 1wk and 4wk standard chow recovery groups 
were statistically higher than Pre-Adolescent HF female group (Figure 3B, p<.001, 
p<0.0001).  
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Similarly, adult HF males had significantly reduced 1hr palatable food intake 
compared to controls. (Figure A F(7,38)=11.89, p<0.0001). A standard chow 
replacement normalized 1hr intake levels after 1wk recovery and after 4wk recovery. 
Post hoc analysis in males revealed Adult 1wk recovery group to be statistically higher 
than Adult HF (Figure 3A, p<0.0001). Adult HF females also reduced their 1hr intake 
while on HF diet and normalized intake after both a 1wk standard chow recovery and a 
4wk standard chow recovery (Figure 3B, F(7,39)=16.47, p<0.0001). Post hoc analysis 
revealed both HF+ 1wk recovery and HF+ 4wk recovery to be significantly higher than 
Adult HF intake in females (Figure 3B, p<0.01, p<0.0001). 
Percent of daily calories eaten during the 1 hr food access was also calculated in 
Pre-Adolescent males (Figure 3C, F(7,37)=7.698, p<0.0001). There was a decrease in 
percent of daily calorie intake in Pre-Adolescent HF males that normalized after standard 
chow removal. Post hoc analysis revealed a statistical increase after 4 wk standard 
chow replacement compared to animals on a HF diet (Figure 3C, p<0.0001). Pre-
Adolescent HF females did not significantly decrease their 1 hr palatable food’s percent 
of daily calories, however it was significantly increased after 1wk and 4wk  standard 
chow replacement (Figure 3D, F(7,41)=9.907, p<0.0001). Post hoc analysis revealed 
standard chow replacement for 1wk or 4wks was significantly higher than controls 
(Figure 3D, p<0.0001,p<0.05). 1wk recovery and 4wk recovery females also significantly 
increased their daily calorie percentage compared to Pre-Adolescent females on HF diet 
(Figure 3G, p<0.0001, p<0.001). Pre-adolescent HF females reached binge level intake 
of palatable food after 1wk and 4 wk recovery (<25% daily intake).  Adult HF males had 
decreased percent daily intake of palatable food compared to controls and this was 
normalized after 1wk or 4wk standard chow recovery (Figure 3C F(7,37)=11.62, 
p<0.0001). Post hoc analysis revealed that a 4wk standard chow recovery leads to a 
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significant increase in daily percentage compared to Adult males on HF (Figure 3C, 
p<0.0001). Similarly, adult HF females had a decreased percentage of daily calories 
from 1hr intake compared to controls and this was normalized by 1wk or 4wk standard 
chow recovery (Figure 3D, F(7,39)=16.25, p<0.0001). Post hoc analysis revealed that 
1wk recovery or 4wk recovery lead to significantly higher percentage of daily intake than 
Adult females on HF (Figure 3D, p<0.001, p<0.0001).  
Gene Expression 
Dopamine-related gene expression was examined within the reward circuitry [Table 1 
summarizes the statistical analysis and gene expression patterns in the VTA, NAc, and 
PFC regions in both male diet groups compared to their aged matched controls]. All 
gene expression data is presented in the table as fold change values from separate 
aged-matched controls for HF and HF+ recovery cohorts. Only one control group for HF 
group is shown on graph and set to 1 for clarity. Key findings will be highlighted here.  
Significance was determined at a corrected alpha level of p=(0.05/# brain regions 
assayed). Dopamine related genes in the VTA of Pre-Adolescent males were down 
regulated after high fat intake and changes were more persistent than Adult HF males. 
Student’s t-test (n=5/group) revealed in the VTA of Pre-Adolescent HF males DAT and 
TH mRNA were significantly decreased after HF exposure (Figure 4A, p<0.001, p< 
0.001). COMT followed a different pattern; mRNA levels were elevated after 12wks HFD 
(Figure 4A, p<0.01). After a 4 week standard chow replacement, DAT and TH mRNA 
levels remained significantly decreased (Figure 4A; p<0.0001, p<0.0001) and COMT 
remained significantly elevated (Figure 4A, p<0.01). In the VTA of Adult HF males, DAT 
and TH were similarly decreased after 12 week HF exposure (Figure 4B; p<0.05, 
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p<0.01), however in these animals DAT and TH mRNA levels in Adult HF males to 
control levels normalized after the 4wk standard chow replacement.  
 In the NAc and PFC, genes important for DA signaling and DA turnover were 
examined (n=5/group). Pre-Adolescent HF males had a different pattern of gene 
expression than Adult HF males in the NAc. Figure 4C shows Pre-Adolescent HF males 
had increased mRNA levels of COMT and DARPP-32 after 12 wks HFD. DR1 and DR2 
showed a different pattern of expression and were decreased in the NAc  of Pre-
Adolescent HF males (Figure 4C, p<.01, p<.01). A 4 week standard chow replacement 
was able to normalize COMT and DARPP-32 back to control levels in Pre-Adolescent 
HF male NAc. Pre-Adolescent HF male DR1 and DR2 mRNA levels remained 
significantly decreased after a 4 week recovery period (Figure 4C, p<.025, p<.0001). In 
Adult HF males a different pattern emerged. In the NAc of Adult HF, exposed mice had 
decreased mRNA levels of COMT and DARPP-32 (Figure 4D, p<.01, p<.01) and 
decreased DR1 and DR2 mRNA (Figure 4D, p<.01, p<.025) after 12wk HFD exposure. 
All genes examined in Adult HF males normalized to control levels after a 4 week 
standard chow replacement. 
Gene expression of DA related genes decreased in the PFC of both Pre-
Adolescent HF and Adult HF males and both were able to normalize to control levels 
after a 4wk recovery in most genes analyzed. Figure 4E shows decreased expression of 
COMT, DR1 and DR2 mRNA in Pre-adolescent HF (Figure 4E, p<.001, p<.001, p<.025) 
after 12wks HFD. After a 4-week standard chow replacement, mRNA levels of COMT 
and DARPP-32 normalized in the PFC of Pre-Adolescent HF males (Figure 4E). The 
Adult HF male PFC had decreased COMT, DARPP-32 and DR1 mRNA levels (Figure 
4F, p<.01,p<.01, p<.0001) after 12wk HFD. COMT remained significantly decreased in 
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Adult HF+ recovery males (Figure 4F; p<0001); however, DR1 levels returned to control 
levels normalized after the standard chow recovery period. DR2 mRNA levels in the PFC 
remained unaffected. 
 The same regions and genes were examined in female mice (n=5/group). [Table 
2 summarizes the statistical analysis and gene expression patterns in the VTA, NAc, and 
PFC regions in both female diet groups compared to their aged matched controls]. There 
were significant differences observed in the gene expression pattern in response to 
12wks HFD and HFD followed by recovery at different developmental periods. Most 
notably, we observed an important sex difference in the regulation of DAT in the female 
VTA. DAT mRNA levels increased after 12 week HF diet (Figure 5 p<.05). Additionally in 
the VTA, female Pre-Adolescent HF TH mRNA levels were decreased (Figure 5A; 
p<.05) and COMT remained unchanged. DAT mRNA levels remained elevated (Figure 
5A, p<.05) and TH mRNA remained decreased (p<.01) in Pre-Adolescent HF female 
VTA after a 4 week standard chow replacement. In Adult HF female VTA, we observed a 
similar increase in DAT expression (Figure 5B; p=.054) that recovered. COMT and TH 
expression were unchanged in Adult HF female VTA.  
 In the NAc, both Pre-Adolescent and Adult HF females had a similar pattern of 
disruption of dopaminergic gene expression after HF diet and diet removal. Pre-
Adolescent females had decreased DR1 and DR2 receptor mRNA in the NAc (Figure 
5C, p<.01, p<.01) as well as decreased COMT mRNA (Figure 5C,  p<.01). A 4-week 
standard chow replacement was unable to normalize the expression of COMT and DR2 
and they remained significantly decreased in Pre-Adolescent HF females (Figure 5C; 
p<.001, p<.001). Adult HF females showed a similar decrease in DR1 and DR2 (Figure 
5D, p<.01; P<.001) as well as decreased DARPP-32 mRNA (Figure5D, p<.01) in the 
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NAc. After a 4 week standard chow replacement, DARPP-32 and DR1 expression 
normalized to control levels. However, DR2 mRNA remained decreased (Figure 5D, 
p<.001) in Adult HF +recovery female NAc.  
Gene expression analysis in the PFC revealed further differences between Pre-
Adolescent HF and Adult HF exposed females. In Figure 5E, Pre-Adolescent females 
showed decreased COMT, DARPP-32, DR1 and DR2 mRNA expression after 12wks 
HFD (p<.001, p<.01, p<.0001, p<.025, respectively) and all but COMT recovered. A 4-
week standard chow replacement failed to normalize DARPP-32 (Figure 5E, p<.025) 
and left DR1 significantly increased compared to controls (p<.025). 12 weeks HF diet in 
Adult females did not alter dopaminergic genes in the PFC (Figure 5F). However, the 
standard chow replacement did lead to significant increases in DARPP-32 and DR1 
mRNA (Figure 5F; p<.025, p<.0001) in Adult female PFC. 
 
Dopamine and DOPAC Levels 
Given the changes in gene expression for dopamine (DA) regulating genes in the VTA, 
DA and DA metabolites were quantified in regions that receive projections from the VTA: 
NAc and PFC (n=7-10/group). Figure 6 shows DA and the DA metabolite, DOPAC, 
measured in the NAc and PFC of males and females exposed to the HF diet at different 
developmental periods. In general, the NAc had higher levels of DA and DOPAC than 
the PFC. High fat diet altered DA levels only in Pre-Adolescent males while Adult HF 
males were unaffected. Dopamine in the NAc was increased after chronic HFD in Pre-
Adolescent males and remained significantly increased after standard chow replacement 
(Figure 6A, F(2,26)=8.267, p< .0.01). DOPAC in the NAc was decreased by chronic HF 
in these animals and remained decreased after standard chow replacement (Figure 6A, 
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F(2,26)=6.127, p< 0.01). On the other hand, DA and DOPAC levels in Adult HF males 
NAc were unaffected by HF and HF+recovery (Figure 6A, F(2,22)=1.832, p=0.1838; 
F(2,22)=1.503, P=0.2444, respectively). A measure of dopamine turnover was 
calculated as the ratio of DOPAC:DA for all groups and brain regions. Dopamine 
turnover was decreased in Pre-Adolescent HF and remained decreased after recovery 
period (Figure 6B, F(2,26)=10.25, p< 0.001). Dopamine turnover was unaltered in Adult 
HF animals. In the PFC, only Pre-Adolescent male DA levels were affected by chronic 
HFD. Figure 6E shows the DA and DOPAC levels in the PFC of Pre-Adolescent males. 
One-way ANOVA revealed DA was increased compared to controls (Figure 6E, 
F(2,25)=5.321, p< 0.05) after 12wk HFD. A 4wk standard chow recovery period 
normalized DA back to control levels in this region. Pre-Adolescent HF DOPAC levels in 
the PFC was unaltered (Figure 6E F(2,17)=1.135, P= 0.3447). DA and DOPAC levels 
were not significantly different compared to controls in Adult HF.  
DA, DOPAC and DA turnover were also measured in the NAc and PFC of 
females. In general, females DA levels seemed less affected by HFD and age of 
exposure in these regions. In contrast to males, female Pre-Adolescent group was 
unaltered by HF and HF+recovery in the NAc. DA (Figure 6C, F(2,27)=0.1211, 
P=0.8864) and DOPAC (Figure 6C, F(2,26)=2.840, P=0.0767) were not changed 
compared to controls. DA turn over was decreased in Pre-Adolescent HF+ recovery 
group ( Figure 6D, F(2,27)=5.543, P < 0.01). Adult HF females had higher levels of DA in 
the NAc, but neither dopamine or DOPAC were significantly different than controls after 
HF or HF+recovery ( Figure 6C, F(2,20)=1.132, P=0.342; F(2,20)=2.521, P= 0.1056). 
Dopamine turnover in the female Adult HF NAc was also unaltered compared to controls 
(Figure 6D, F(2,20)=0.9218, P=0.4141). 
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Similar to males, female Pre-Adolescent HF PFC had increased DA after 12 wks 
HFD that normalized after 4wk recovery (Figure 6G). One-way ANOVA revealed 
dopamine was significantly different than control levels and DOPAC levels were 
unaffected (Figure 6G, F(2,26)=3.845, p < 0.05; F(2,21)=0.1879, p=0.8301). In contrast 
to the NAc, PFC dopamine turnover was unaffected by 12wk HF. However it was 
increased in Pre-Adolescent HF+ recovery (Figure 6H, F(2,17)=16.03, P< 0.0001). 
Similar to Pre-Adolescent HF females, dopamine in the Adult HF PFC was significantly 
increased compared to controls (Figure 6G, F(2,23)=6.839, P < 0.01) and normalized 
after 4wk recovery period. In Figure 6H, analysis revealed DOPAC to be unaltered in 
Adult HF (Figure 6G, F(2,15)=1.630, P=0.2288) and dopamine turnover to be increased 
in Adult HF+ recovery female PFC (Figure 6H, F(2,13)=16.67, P < 0.001). 
 
Discussion	  
	  
We have investigated the age of onset and sex as critical variables in the neuro-
adaptations seen after chronic high-fat diet intake and standard chow replacement. 
Chronic high-fat diet caused changes in sucrose preference, intake of palatable food, 
dopaminergic gene expression, and dopamine neurotransmitter levels. We 
demonstrated that it is possible to reverse the neuroadaptations and behavioral changes 
seen after high fat diet by a 4-week standard chow replacement. However, in some 
cases, we observed a pattern of persistence that depended on both age of diet onset 
and sex.  The rodent brain continues to development after parturition and this postnatal 
development is highly influenced by the environment and nutritional state. We 
hypothesized that an earlier exposure to high fat diet would be more damaging to the 
dopamine reward system than if the diet was started later in life. We demonstrated an 
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earlier onset of high fat diet intake decreased sucrose preference and increased 
dopamine neurotransmitter levels while adult onset remained unaffected in our male 
animals. We demonstrated that high fat diet had a similar effect in females starting high 
fat intake early or later in life. However, there were important sex differences observed in 
response to diet onset. We also hypothesized that an earlier exposure to high fat diet 
would lead to more a more persistent phenotype than if diet was started later in life. After 
a 4-week standard chow replacement, behavioral changes returned to control levels, 
however gene expression changes and neurotransmitter level changes persisted in 
males beginning the diet early in life.  Gene expression changes also failed to normalize 
in females who began the high fat diet earlier in life. Failure to normalize gene 
expression changes after standard chow replacement may be due to disruption during a 
sensitive time window from weaning to 6 weeks of age. 
The two critical factors we looked to examined in response to high fat diet and 
high fat withdrawal were sex and age of onset. Some important sex differences were 
observed in body weight gain, one-hour palatable food intake, and dopaminergic gene 
expression. Many of the sex differences were seen in response to the high fat diet and 
not in the response to high fat removal. In both males and females age of diet initiation 
had little impact on final body weight. However, Adult HF males gained weight more 
rapidly than Pre-Adolescent males and obtained a significantly different body weight 
after only 3 weeks on HF diet. The opposite was seen in females; it took longer for Adult 
HF females to become significantly heavier than controls. This could be due to the 
protective effects higher level of estrogen in the post-pubertal period that can increase 
metabolism. Both males and females failed to normalize their body weight after a 4-week 
standard chow replacement. This fact was important to analyzing the effects of removal 
of the high fat diet and the response to significant weight loss. An important sex 
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difference occurred in the sucrose preference test where adult HF exposed males 
remained unaffected and females had decreased preference for sucrose. Sex has 
previously been shown to be important in self administration of other rewarding 
substances such as saccharin, cocaine and morphine (Dess et al., 1998; Dess, 2000; 
Carroll et al., 2002) with females having a more rapid rate of acquisition and an increase 
in administration. The decrease in sucrose preference is consistent with the reward 
deficiency model of obesity. The decrease in value natural rewards could lead to 
overconsumption of rewarding food in order to increase total reward levels. 
To determine the risk of overconsumption in animals given chronic HF diet, we 
gave mice daily 1-hour access to high fat/high sugar food and measured their caloric 
intake. Intermittent access has been previously used to elicit binge eating in lean rodents 
(Corwin et al., 2004). “Bingeing” is typically defined as a bout of food intake greater than 
what normally would be consumed in the same period (>25% daily calories in one hour). 
One important sex difference we see that females given high fat diet earlier in life do not 
suppress their palatable food intake while on high fat diet as seen in males. This could 
mean that pre-adolescent exposed females lose the ability to regulate their intake when 
there is already calorically dense food available. Another important observed sex 
difference was seen in response to high fat diet removal on one-hour palatable food 
intake. Both males and females on the HF diet tend to reduce thier intake during the 1hr 
palatable food access than controls. However, after acute and long term removal of high 
fat diet, males normalized palatable food intake while pre-adolescent exposed females 
greatly increased intake and reached binge levels of eating. Indeed, binge eating is more 
prevalent in females than in males (Kessler et al., 2013) but this seems to be an 
interaction with sex and removal of HF diet. Decreased inhibitory control could be the 
underlying factor behind the difficulty with dieting and weight loss in women (Woods et 
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al., 2003).  Our study has shown that chronic HF intake does not cause 
overconsumption when the HF is present.  It is the acute removal of HF that causes an 
increase in palatable food consumption and females may be prone to bingeing in this 
state.  
 Dopamine is an important neurotransmitter that regulates the intake of rewarding 
substances. Our lab has previously published decreases in DA and opioid related genes 
in reward related regions after chronic HF for varying lengths of time (Vucetic et al., 
2012; Carlin et al., 2013). Changes in dopaminergic genes have been seen in many 
obese rodent models, but few studies have looked at this system after a standard chow 
replacement period.  Interesting age and sex differences were revealed both in the 
response to the HF diet and after a 4 week recovery period. In females, we observed an 
interesting sex difference in the VTA. Females given chronic high fat diet had increased 
DAT expression while males had decreased DAT levels. The difference in DAT 
expression would oppositely affect levels of dopamine in the synapse and may be 
important for some of the behavioral differences observed. Sex differences in basal DAT 
expression have previously been observed in both humans (Lavalaye et al., 2000) and 
animals (Rivest et al., 2005) and revealed DAT levels to be overall higher in females. 
Our lab has previously published that high fat diet beginning at birth regulated DAT 
levels through DNA methylation at the promoter region (Carlin et al., 2013). Further 
studies are needed to understand how sex hormones and epigenetic machinery interact 
to regulate gene expression in response to high fat diet and high fat replacement. 
The second factor we found to be important in regulating the reward system’s 
response to high fat diet and HF replacement was age of onset. We predicted that an 
earlier age of onset for high fat diet would be more damaging to the dopamine reward 
system than adult onset. Sucrose preference test in our study was one example where 
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age of HF diet onset was important. The pre-adolescent time period is an important 
window for programming the taste for palatable foods (Teegarden et al., 2009). We 
found a decrease in sucrose preference for pre-adolescent HF males while adult HF 
males remained unaffected. Sucrose preference is a broad measure of natural reward 
intake. Decrease in sucrose consumption is considered an animal model of anhedonia.  
The decrease in sucrose preference is consistent with the hypo reward hypothesis of 
obesity. Obese patients show decreased activity in reward related regions when 
ingesting a palatable solution (Stice et al., 2010). We also observed normalization of 
sucrose preference after a 4 week standard chow recovery period. Normalization is also 
observed in gastric bypass patients who show increases in sucrose preference after 
surgery (Bueter et al., 2011). The decrease in sucrose preference seems to be caused 
by the presence of the HF diet and not the factor of obesity itself. This factor emerges in 
non-diet induced obese rodent models such as the OLETF CCK-1 knockout rats that 
become obese on control chow. OLETF rats show increased preference for sucrose 
preference compared to controls (Marco et al., 2012). This could be due to high fat diet 
neuroadaptations causing decreases in reward value or increases in satiety levels. 
We predicted that an earlier high fat diet would cause changes in the dopamine 
reward system that would persist throughout a standard chow recovery period because 
of possible programming effects that can occur during a vulnerable developmental 
window. Pre-Adolescent and Adult HF animals had a similar gene expression response 
to the high fat diet. It was in the standard chow replacement period where we observed 
differences in the ability to normalize between age groups. For example, a 4 week 
standard chow recovery period was unable to normalize the gene expression levels 
COMT, DAT, and TH in the VTA in animals who began HF diet earlier in life. In the post 
synaptic region of the NAc, animals that began high fat diet earlier in life had decrease 
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expression of DR1 and DR2. This is consistent with the hypodopaminergic hypothesis of 
obesity. Further, a 4 week standard chow recovery was unable to normalize DR1 and 
DR2 in the NAc of these animals. Adult HF exposure had similar decreases in dopamine 
receptors but normalized expression after the recovery period. Further, pres-adolescent 
exposure to high fat caused increases in DA that persisted in the NAc after 4 week 
standard chow replacement while adult exposure DA levels remained unchanged. Early 
life exposure to high fat also seemed to be more detrimental in females. Early life 
exposure to high fat decreased expression levels of COMT, DARPP-32, DR1, and DR2 
in both the NAc and PFC. A 4 week standard chow replacement was unable to 
normalize genes in the NAc, however DR1 and DR2 both normalized in the PFC. 
Interestingly, the PFC of the Adult HF females exposure group was unaffected by high 
fat diet. Decreases in DR2 were seen in response to high fat diet and remained 
decreased after a recovery period in animals exposed to diet earlier in life. Low 
dopamine receptor D2 levels are implicated in obesity, drug addiction and impulsive 
behaviors (Wang et al., 2001). Decreased DRD2 in reward regions predicts reward 
dysfunction and binge-like behavior (Johnson & Kenny., 2010) and decreases in gene 
expression in diet induced obesity could leave animals more prone to overconsumption.  
We see from these results that age of onset is an important factor when examining gene 
expression changes and persistence after diet manipulation. It suggests the existence of 
a vulnerable period that when manipulated, can alter the response to high fat diet in 
adulthood. 
In summary, we have shown that chronic HF diet leads to changes in dopamine 
circuitry and reward consumption and that it is possible to reverse these changes before 
body weight normalization with a 4 week standard chow replacement. We revealed 
chronic HF diet leads to altered dopaminergic gene expression, neurotransmitter levels, 
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and dopamine turnover in a sex and age dependent manner. Moreover, the reversal of 
these changes is more difficult in animals who received high fat diet earlier in life. 
Women and adults who were obese as children find it more difficult to lose weight then 
the rest of the population. Altered dopamine circuitry that persists during “dieting” could 
be behind high failure rates seen in these populations. Further studies are needed to 
examine how these populations are more vulnerable to high fat diet circuitry changes 
and which specific changes are behind the overconsumption of palatable food in obesity. 
Other neurotransmitters, such as the endogenous opioid system, also regulate intake 
and the “liking” of natural rewards. It has been shown that mu opioid receptors (MOR) 
levels are decreased on high fat diet and this is associated with increase in epigenetic 
marker levels, such as DNA methylation at promoter region (Vucetic et al., 2011). It is 
possible that epigenetic machinery may be altered by high fat diet during the vulnerable 
window from weaning to 6 weeks of age, therefore programming the obesity phenotype 
into adulthood. Differences in the ability of these changes to normalize may be behind 
the difficulty in weight loss and the relapse to over consumption that occurs in many 
obese individuals. Understanding how age of onset and sex interact with gene 
expression changes after removal of HF diet will help us predict who is most vulnerable 
to overconsumption and point us in the right direction for better obesity interventions. 
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Figure	  and	  Table	  Legends	  
 
Table 1.  Gene Expression Summary and Statistics in Males. Gene expression 
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus 
accumbens in both Pre-Adolescent and Adult HF males. Summary of fold change, 
significance and p values are presented for HF and HF +recovery groups as compared 
to their age matched control.  
Table 2.  Gene Expression Summary and Statistics in Females. Gene expression 
results for male ventral tegmental area (VTA), prefrontal cortex (PFC), and nucleus 
accumbens in both Pre-Adolescent and Adult HF females. Summary of fold change, 
significance and p values are presented for HF and HF +recovery groups as compared 
to their age matched control.  
Figure 1. 12 week exposure to high fat diet causes increase in body and fat pad 
weights and these increases are not normalized by a 4 week standard chow 
replacement. Body weights (n=10/group) were measured weekly in Pre-adolescent 
(blue triangles) and Adult HF animals (green squares) males (A) and females (B) and 
shown in grams. Red dashed line depicts time on HF diet, blue dashed line depicts time 
of standard chow recovery. Control animals (black triangles) remained on standard chow 
throughout the experiment. C) Bar graph of end point body weights of control (white bar), 
HF (black bar), and HF+ recovery (horizontal striped bar) males in grams. D) Normalized 
Abdominal Fat Pad weights in males shown as percentage of end point body weight  E) 
Bar graph of end point body weights of control (white bar), HF (grey bar), and HF+ 
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recovery (horizontal striped bar) females in grams. F) Normalized abdominal fat pad 
weights in females shown as percentage of end point body weight.  
Post hoc comparisons shown at alpha levels *p<.05, **p<.01, ***p<.001, ****p<.0001 
significantly different from aged matched control group. 
Figure 2. Sucrose preference is decreased after high-fat diet (HFD) exposure in 
Pre-Adolescent HF males and females and recovers after standard chow 
replacement. Percent preference for 4% sucrose was evaluated in control (white bars) 
HF (solid bars) and HFD + recovery (striped bars) Pre-Adolescent and Adult HF age 
groups (n=8/group). Males are shown in black (A), females are shown in grey(B). Post 
hoc comparisons are shown at alpha levels *p<.05, **p<.01, ***p<.001 significantly 
different from own control group.  
Figure 3. Chronic HFD causes decrease intake of palatable food during one-hour 
challenge. Standard chow replacement during experiment or 4 weeks caused an 
increase in palatable food intake. Intake during one-hour palatable food access was 
measured in control (white bars) HF (solid bars) and HF + 1wk recovery (dotted bars) 
and HF + recovery (horizontal striped bars) for Pre-Adolescent and Adult HF males (A) 
and females (B). Percent of daily calories eaten during the 1 hr palatable food access 
was calculated for both male (C) and female (D) age groups (n=3/group for 1hr control 
chow access and n=9/group for 1hr palatable food access. Post hoc planned 
comparisons shown at alpha levels *p<.05, **p<.01, ***p<.001 significantly different from 
own control group or  ##p<.01, ###p<.001, ####p<.0001 significantly different from HF 
group.  
Figure 4.  Chronic high-fat diet (HFD) alters dopamine related gene expression in 
males. Pre-Adolescent HF males were less able to normalize gene expression in 
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examined reward regions of the brain.  Gene expression was measured in the ventral 
tegmental area (VTA;A,D), nucleus accumbens (NAc; B,E), and prefrontal cortex (PFC; 
C,F) of control (white bars), HFD (solid bars) and HFD + recovery (striped bars) Pre-
Adolescent and Adult HF male age groups (n=5/group). HF and HF + recovery groups 
are shown as fold change from their own aged matched controls. Only one control group 
(15wk) is shown and set to 1 for clarity. Post hoc planned comparisons shown at alpha 
levels *p<.05, **p<.01, ***p<.001, ****p<.0001 significantly different from own control 
group.  
Figure 5.  Chronic high-fat diet (HFD) and HF+ recovery alters dopamine related 
gene expression differently in Pre-Adolescent and Adult HF females. Gene 
expression was measured in the ventral tegmental area (VTA; A,D), nucleus accumbens 
(NAc; B,E), and prefrontal cortex (PFC; C,F) of control (white bars), HFD (solid bars) and 
HFD + recovery (striped bars) Pre-Adolescent and Adult HF female age groups 
(n=5/group). HFD and HF + recovery groups are shown as fold change from their own 
aged matched controls. Only one control group (15wk) is shown and set to 1 for clarity. 
Post hoc planned comparisons shown at alpha levels  *p<.05, **p<.01, ***p<.001, 
****p<.0001 significantly different from own control group.  
Figure 6. Dopamine levels are increased after chronic HFD in Pre-Adolescent HF 
males. Dopamine levels in the NAc do not normalize after 4wk recovery.  Dopamine 
(DA) and dopamine metabolite 3,4-Dihydroxyphenylacetic acid (DOPAC) and dopamine 
turnover were measured in the NAc (A-D) and PFC (E-H) of control (white bars), HF 
(solid bars) and HF + recovery (striped bars) Pre-Adolescent and Adult HF age groups 
(n=8-10/group). DOPAC:DA ratio is a measure of dopamine turnover. Males are shown 
in black and females in grey. *p<.05, **p<.01 significantly different from control group.  
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Tables	  and	  Figures	  
	  
Table 1. Gene Expression Summary and Statistics in Males 
GENE	   Pre-­‐Ad	  HF	  Males	  
fold	  change	  
P	  VALUE	   Pre-­‐Ad+recov	  
Males	  	  fold	  
change	  
P	  VALUE	  
VTA	   	   	   	   	  
COMT	   1.48	   .0010	   2.013	   .0077	  
DAT	   0.48	   .0004	   0.342	   <.0001	  
TH	   0.46	   .0001	   0.471	   <.0001	  
	   	   	   	   	  
NAC	   	   	   	   	  
COMT	   1.987	   .0002	   1.46	   .6527	  
DARPP32	   1.87	   .0007	   1.25	   .0836	  
DRD1	   0.580	   .0021	   0.719	   .0085	  
DRD2	   0.672	   .0078	   0.405	   <.0001	  
	   	   	   	   	  
PFC	   	   	   	   	  
COMT	   0.485	   .0010	   1.267	   .0167	  
DARPP32	   0.605	   .0491	   1.661	   .0406	  
DRD1	   0.485	   .0010	   1.139	   .3756	  
DRD2	   0.313	   .0069	   1.149	   .7138	  
	   	   	   	   	  
GENE	   Adult	  HF	  Males	  
fold	  change	  
P	  VALUE	   Adult	  HF+	  recov	  
Males	  fold	  
change	  
P	  VALUE	  
VTA	   	   	   	   	  
COMT	   0.94	   .5670	   0.84	   .0128	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DAT	   0.674	   .049	   0.98	   .7538	  
TH	   0.657	   .0083	   1.06	   .614	  
	   	   	   	   	  
NAC	   	   	   	   	  
COMT	   0.736	   .0013	   0.846	   .164	  
DARPP32	   0.575	   .0011	   1.262	   .1945	  
DRD1	   0.638	   .0025	   1.284	   .0474	  
DRD2	   0.644	   .0078	   1.029	   .8949	  
	   	   	   	   	  
PFC	   	   	   	   	  
COMT	   0.662	   .0076	   0.520	   <.0001	  
DARPP32	   0.543	   .0047	   1.145	   .4038	  
DRD1	   0.136	   <.0001	   0.838	   .0879	  
DRD2	   1.538	   .1629	   1.696	   .2261	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Table 2. Gene Expression Summary and Statistics in Females 
GENE	   Pre-­‐Ad	  HF	  Females	  
fold	  change	  	  
P	  VALUE	   Pre-­‐Ad	  HF+	  
recovery	  Females	  
fold	  change	  	  
P	  VALUE	  
VTA	   	   	   	   	  
COMT	   1.195	   .0202	   2.633	   .0352	  
DAT	   1.76	   .0304	   1.46	   .0104	  
TH	   0.558	   .0157	   0.446	   .0004	  
	   	   	   	   	  
NAC	   	   	   	   	  
COMT	   0.5708	   .0011	   0.682	   .0007	  
DARPP32	   0.799	   .2061	   0.343	   <.0001	  
DRD1	   0.256	   .0030	   2.95	   <.0001	  
DRD2	   0.483	   .0042	   0.346	   .0004	  
	   	   	   	   	  
PFC	   	   	   	   	  
COMT	   0.496	   .0001	   0.657	   .0214	  
DARPP32	   0.608	   .0014	   0.704	   .016	  
DRD1	   0.338	   <.0001	   2.01	   .0108	  
DRD2	   0.609	   .0195	   2.43	   .0722	  
	   	   	   	   	  
	  
GENE	  
Adult	  HF	  	  
Females	  
P	  VALUE	   Adult	  HF+	  recov	  
Females	  
P	  VALUE	  
VTA	   	   	   	   	  
COMT	   1.06	   .5672	   1.384	   .0498	  
DAT	   1.28	   .0546	   0.692	   .0219	  
	   95	  
TH	   0.937	   .3179	   0.907	   .2155	  
	   	   	   	   	  
NAC	   	   	   	   	  
COMT	   3.97	   .0172	   0.288	   .0003	  
DARPP32	   0.456	   .0017	   0.639	   .1017	  
DRD1	   0.374	   .0023	   0.833	   .0355	  
DRD2	   0.178	   <.0001	   0.353	   .0019	  
	   	   	   	   	  
PFC	   	   	   	   	  
COMT	   0.807	   .0438	   0.726	   .0348	  
DARPP32	   1.057	   .8899	   1.468	   .0186	  
DRD1	   1.129	   .5851	   3.08	   <.0001	  
DRD2	   2.49	   .0897	   1.32	   .4875	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CHAPTER	  4:	  Voluntary	  wheel	  access	  and	  highly	  palatable	  diet	  
regulate	  gene	  expression	  and	  behavior	  in	  the	  central	  reward	  
system	  
 
Jesse L. Carlin, Zhe Ying, Fernando Gomez-Pinilla, Teresa M. Reyes 
Introduction	  
	  
The rise in obesity rates in the United States has paralleled the increasing 
availability of energy dense foods (Flegal et al., 2012). Palatable foods are often 
consumed because of their hedonic properties after bodily energy requirements are 
already met. Palatable foods increase dopamine in the reward regions of the brain and 
over a long period of time, consumption cause neuroadaptations that alter reward driven 
behaviors. For example, consumption of high fat diet does not just drive obesity, but 
drives binge-like eating behavior (Corwin, et al. 1998, Lucas et al., 1989), decreases 
dopamine receptor levels (Johnson & Kenny, 2010), decreases neurotransmitter levels 
(Carlin et al., 2013; Geiger et al. 2007), and decreases natural reward intake (Carlin et 
al., 2013; Vucetic et al., 2011). Part of the first line of treatment for obesity is daily 
exercise. Exercise provides individuals with both positive metabolic effects (Rothman et 
al. 2012) and cognitive benefits (extensively reviewed in Chang et al., 2012). The 
majority of the central benefits of exercise have focused on the hippocampus; here we 
examine the response of reward and feeding regions of the brain to exercise.  Similar to 
palatable food, exercise also activates reward regions of the brain and long-term wheel 
running has been shown to produce neuroadaptations that may overlap with those seen 
in obesity. Exercise is rewarding and rodents will work for access to a running wheel 
(Brene et al., 2007). Wheel running has also been shown to modulate reward behaviors 
such as decreased conditioned place preference to cocaine (Thanos et al., 2010). 
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Because exercise is rewarding, it is unknown whether exercise can prevent the 
dopamine dysfunction seen in the reward regions of the brain after chronic high fat diet.  
We looked to examine first if exercise can affect the expression of reward related 
genes in the prefrontal cortex after short term exercise exposure. Previous studies have 
shown exercise can enhance cognitive function (Winter et al., 2007), and improve 
symptoms of depression (Lawlor & Hopker, 2001). Access to a running wheel promotes 
neurogenesis in the brain (van Praag et al., 1999) and increases expression of BDNF 
mRNA (Gomez-Pinilla et al., 2011) and epigenetic related genes, such as DNMTs and 
HDACs (Abel and Rissman, 2013). Research on the beneficial effects of exercise has 
primarily focused on the hippocampus and brain derived neurotrophic factor (BDNF) as 
the central mediator of brain plasticity in this region (Gomez-Pinilla et al., 2002; Hopkins 
et al., 2010). We look to extend these studies by examining the effect of acute exercise 
on reward related genes in the prefrontal cortex. 
The interaction of exercise and high fat diet at the level of feeding and neural 
substrates of reward is currently unknown. Specifically are the generally beneficial 
effects of exercise on the brain able to prevent the negative effects of high fat diet, such 
as dysfunctional gene expression changes and neuro inflammation in the reward system 
and hypothalamus of mice. Exercise may be able to act as a reward replacement and 
reduce the risk to over consume palatable foods. Exercise also has the ability to recruit 
epigenetic mechanisms, such as DNA methylation, that could prevent the 
neuroadaptations that occur after high fat intake. Exercise has previously been shown to 
impart resilience to the molecular effects of stress on the brain (Haack et al., 2008; 
Gerecke et al., 2013); however, studies have been mixed with the behavioral outcomes 
of exercise.  Voluntary wheel running has both anxiety producing (Burghardt et al. 2004; 
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Fuss et al. 2010a,b) and anti-anxiety (Dishman et al. 1996; Salam et al. 2009) behavioral 
effects in rodent models. We performed behavioral analysis to assess anxiety levels in 
our model of high fat diet and exercise. To examine if the changes that occur after long 
term exercise are inhibited by concurrent access to high fat, we gave male mice access 
to a running wheel and a high fat /high sugar diet for 6 weeks. Four experimental groups 
(Sedentary-Control, Sedentary-HF, Exercised-Control, and Exercised-HF) were 
evaluated for changes in gene expression in brain areas that regulate reward and 
feeding behavior. Expression of dopaminergic, epigenetic, and inflammatory related 
genes in the nucleus accumbens (NAc), prefrontal cortex (PFC), and hypothalamus 
(HYP) were examined. Behavioral assays (sucrose preference, elevated plus maze and 
open field) were performed to examine if either exercise or palatable diet had the ability 
to modulate sucrose preference or anxiety-like behavior. Understanding the mechanisms 
of how high fat diet and exercise elicit neuroadaptations in the reward system will be 
important for future weight loss studies and obesity treatments. 
 
Materials	  and	  Methods	  
 
Animals. C57BL/6 mice approximately 9 weeks of age were singly housed in standard 
polyethylene cages in an environmentally controlled room (22–24°C) with a 12 h 
light/dark cycle. For the first experiment, mice either remained sedentary (n=6) or were 
given two weeks access to a voluntary running wheel in their home cages (n=12). These 
mice had ad lib access to standard control diet (#5755; 18.5% protein, 12% fat, 69.5% 
carbohydrate, Research Diets, New Brunswick, NJ). After two weeks animals were 
euthanized by carbon dioxide overdose, followed by cervical dislocation; a method 
recommended by the Panel on Euthanasia of the American Veterinary Medical 
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Association.  For the second experiment, mice had ad lib access to either standard 
control diet (#5755; 18.5% protein, 12% fat, 69.5% carbohydrate) or a western-style diet 
(# D12079B, 17% protein, 40% fat, 43% carbohydrate, Research Diets, New Brunswick, 
NJ). A subset of mice from each dietary group also received access to a voluntary 
running wheel in their home cages, generating 4 experimental groups of sedentary + 
CTRL diet, sedentary + HF diet, exercise + CTRL diet, and exercised + HF diet 
(n=10/group).  Sucrose preference was measured at baseline, 4 weeks, and 6 weeks; 
while EPM and OF tests were measured only at 6 weeks. At the end of 6 weeks access 
to exercise and/or high fat diet, animals were euthanized by carbon dioxide overdose, 
followed by cervical dislocation. Animal housing and behavioral experiments took place 
at University of California at Los Angeles. Flash frozen brain samples were shipped to 
University of Pennsylvania for further analysis. Experiments were performed in 
accordance with the United States National Institutes of Health Guide for the Care and 
Use of Laboratory Animals. The UCLA Chancellor's Animal Research Committee 
approved all procedures used in this study.  
Elevated Plus Maze. The elevated plus maze (EPM) test was carried out according to a 
previously established protocol (Walf and Frye, 2007 and Bhatia et al., 2011). The EPM 
apparatus was made of laminated wood and consisted of 2 opposing open arms (10×50 
cm) and 2 opposing closed arms (10×50 cm with 30 cm high walls). The maze was 
placed 60 cm above the floor. White curtains surrounded the maze and behavior was 
recorded by an overhead video camera. Each mouse (n=12) was placed in the middle of 
the maze facing the open arm that faced away from the experimenter. The video camera 
recorded the time each mouse spent in each of the arms over a period of 5 min. A 
closed arm entry was counted when the mouse placed all four paws in a closed arm. An 
open arm entry was recorded when the mouse placed all four paws in an open arm or 
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when the mouse's hind-limbs were placed in the central area of the maze and both fore-
limbs in an open arm with its head protruding into the open arm. 
Open Field Test. The open field test was performed in a 1.2 m diameter circular tank 
with 60 cm walls. An inner circle, 80 cm in diameter, was marked on the tank floor to 
serve as a central arena. Testing began when each mouse was placed in the middle of 
the central arena and allowed to explore the field for 10 min. Mouse behavior (n=12) was 
recorded by an overhead camera. Measurement included time spent and number of 
entries in central arena (as described in Bhatia et al., 2011) 
Sucrose Preference. Mice were individually housed (n=8-10/group) in standard cages 
for 3 days where one bottle with 200 ml of 4% sucrose solution (w/v), another with 200 
ml of tap water and house chow ad libitum were available. Sucrose (ml), water (ml), and 
food consumption (g), were measured and the placement of the bottles were reversed 
daily.  Preference was calculated using the measurements from the last 2 days only as 
follows: preference % = [(sucrose consumption/sucrose + water consumption) × 100]. 
Sucrose preference test was performed at baseline, 4 week diet and/or running wheel 
access, and 6 week diet and/or running wheel access. 
Genomic DNA and Total RNA isolation from the brain. Brains were rapidly removed 
after behavioral tests, flash frozen and stored at -80C. Dissections were made on ice 
and regions of interest were placed in RNAlater (Ambion, Austin, TX) Brain dissections 
to isolate the prefrontal cortex and hypothalamus were performed as previously 
described (Vucetic et al. 2010, Reyes et al. 2003) Genomic DNA and total RNA were 
isolated simultaneously using AllPrep DNA/RNA Mini Kit (Qiagen). 
Gene expression analysis by quantitative Real-Time PCR. For each individual 
sample, 500ng of total RNA was used in reverse transcription using High Capacity 
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Reverse Transcription Kit (ABI, Foster City, CA). Expression of target genes was 
determined by quantitative RT-PCR using gene specific Taqman Probes with Taqman 
gene expression Master Mix (ABI) on the ABI7900HT Real-Time PCR Cycler. Gene 
probes are listed in supplemental material. Relative amount of each transcript was 
determined using delta CT values as previously described in (Pfaffl 2001). Changes in 
gene expression in the prefrontal cortex (n=6-8) and hypothalamus (n=2-6) were 
calculated against an unchanged GAPDH standard. 
Methylated DNA Immunoprecipitation (MeDIP) Assay. MeDIP assay was performed 
using MagMeDIP kit (Diagenode, Denville, NJ). Methylated DNA was 
immunoprecipitated using 15ul of magnetic beads coated with anti-5methylcytidine 
antibody (Diagenode) or mouse pre-immune serum. Enrichment in MeDIP fraction was 
determined by quantitative RT-PCR using ChIP-qPCR Assay Master Mix (SuperArray) 
on the ABI7900HT Real-Time Cycler. For all genes examined, primers were obtained 
from SuperArray (ChIP-qPCR Assays (-01) kb tile, SuperArray) for the amplification of 
genomic regions spanning the CpG sites located approximately 300-500 bp upstream of 
the transcription start sites. MeDIP results were expressed as fold enrichment of 
immunoprecipitated DNA for each site. To calculate differential occupancy fold change 
(% enrichment), the MeDIP DNA fraction CT values were normalized to Input DNA 
fraction CT values.     
Global Genomic DNA Methylation. Changes in genomic DNA methylation were 
analyzed using LUminometric Methylation Assay (LUMA). Methylation sensitive and 
insensitive restriction enzymes (HpaII and MspI, respectively) each digested 500ng DNA 
with EcorI as an internal control (all enzymes from New England Biolabs, Beverly, MA) in 
Tango Buffer (33mm Tris-acetate, pH 7.9, 10mM Mg-acetate, 66mM K-acetate, 0.1 
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mg/ml BSA) purchased from Fermentas (Fermendtas Scandanavia, Stolkholm) for 4 
hours at 37 degrees Celcius. 20ul of each digestion was mixed with 20ul “Annealing 
Buffer” and transferred to Pyrosequencing plates. DNA quantification was preformed 
using a polymerase extension assay by the Pyrosequencing tm platform. PSQ tm 96 SNP 
reagents for pyrosequencing were purchased from Biotage (Biotage AB, Uppsala, 
Sweden) and RediPlate tm 96 PicoGreen kit from Molecular probes (Eugene, Oregon). 
Peak height results were obtained to calculate methylation percentage as follows: [1-
((HpaII/EcoRI)/(MspI/EcoRI))] x 100.         
Statistical Analysis. In experiment one, Student t tests were performed to analyze gene 
expression, promoter methylation, and global methylation in short term exercise 
exposure (2wk) compared to sedentary controls. Statistical significance was set an an 
alpha level of p<0.05. In experiment two, two-way ANOVA was used to evaluate the 
effects of both diet and exercise and statistically significant main effects were presented 
at an alpha level of p<0.05. Planned comparisons were performed to compare the effect 
of high fat diet, the effect of exercise, and whether exercise could mitigate the high fat 
driven response. Statistical significance was set an alpha level of p<0.05.  
 
 
 
 
 
Results	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Short term access to wheel was able to alter gene expression and DNA 
methylation in prefrontal cortex. 
In the first experiment, mice had continuous access to voluntary running wheel 
for two weeks in their home cages and were maintained throughout on control diet. 
Gene expression analysis of dopamine receptor D1 (DR1), dopamine receptor D2 (DR2) 
and mu opioid receptor (MOR) was performed in prefrontal cortex samples. Two week 
access to a wheel caused decreased expression of DR1 and MOR in the cortex (Figure 
1A p<0.05, p<0.05). DR2 expression was unaffected by short term exercise exposure. 
Quantification of DNA methylation at promoter regions of genes affected by short term 
exercise was performed. Fold change from input is presented and ACTIN was used as a 
control gene for comparison. Promoter DNA methylation was increased by exercise 
exposure for both DR1 and MOR genes (Figure 1B, p<0.05, p<0.05). Global methylation 
of genomic DNA was unaltered by a two week exercise exposure.  
Access to running wheel and high fat diet for 6 weeks caused changes in body 
weight and reward behavior. 
    In the second experiment, sedentary controls, sedentary + HF, exercised, and 
exercised + HF animals were generated and body weights were taken at the end of the 
experiment. High fat diet (HF) alone caused animals to gain a significant amount of body 
weight compared to sedentary controls. For body weight at end of experiment there was 
a significant interaction between diet and exercise (Figure 2A, F(1,36)=6.37, p=0.016). 
There was a main effect of the high fat diet on increasing body weight (Figure 2A, 
F(1,36)=47.96, p<0.0001), however weight gain in the exercised group was significantly 
less than in the sedentary group (Figure 2A, p<0.01). Body weight gain was calculated 
from start of experiment (baseline) up until 6 weeks and an interaction between diet and 
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exercise was observed (Figure 2B, F(1,36)=4.9, p=0.03). Similar to final body weight, a 
main effect of diet was observed (Figure 2B, F(1,36)=47.2, p<0.0001), such that all high 
fat fed animals gained  more weight, however the exercised + HF animals gained 
significantly less then the sedentary HF animals (Figure 2B, p<0.01). 
  Anxiety-like behaviors were measured in these animals. There was no difference 
in time spent in the open arm of the elevated plus maze between experimental groups 
(Figure 3A), nor in the time spent in the open arena during the open field test (Figure 
3B). Sucrose preference was measured at baseline, 4 weeks, and 6 weeks of the 
experimental period. At baseline, there was no difference between experimental groups. 
At 4 weeks there was a significant main effect of both HF diet (Figure 3C, F(1,36)=22.9, 
p<0.0001) and exercise (Figure 3C F(1,36)=7.32, p=.01). At 6 weeks, sucrose 
preference remained diminished in sedentary + HF, exercised, and exercised + HF 
groups. There was an interaction between diet and exercise at this time point (Figure 
3C, F(1,36)=9.86, p=.003). At 6 weeks there was a significant main effect of diet (Figure 
3C, F(1,36)=22.5, p<0.0001). 
Exercise was unable to reverse gene expression changes in reward related 
regions. 
Gene expression was analyzed in both the nucleus accumbens (NAc) and 
prefrontal cortex (PFC). In the NAc, there was a significant main effect for diet which 
increased the expression of both DR1 and DR2 (Figure 4A, F(1,16)=35.11, p<0.0001, 
F(1,16)=4.62, p=0.04). Exercise alone did not alter expression of DR1 and DR2. 
Expression of DNA methyltransferase 1 (DNMT1) was also examined in the NAc and 
significant interaction of diet and exercise was revealed (Figure 4A, F(1,16)=35.11, 
p<0.0001). There was a main effect of exercise which increase DNMT1 expression 
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(Figure 4A, F(1,16) 13.06, p=0.002). Planned comparisons show DNMT1 to be elevated 
after high fat diet compared to sedentary controls (Figure 4A, p<0.05). DNMT1 levels are 
also significantly elevated in exercised animals compared to exercise + HF (Figure 4A, 
p<0.05). In the PFC, DR1 expression levels had a non significant trend in the interaction 
between diet and exercise (p=.1). DR2 expression had a similar non-significant trend for 
interaction of diet and exercise (p=0.1). However, there was a significant main effect of 
diet for DR2 expression in the PFC (Figure 4B, F(1,28)=4.62, p=0.04). DNMT1 
expression was unaltered by diet and exercise in the PFC at this time point. 
Exercise had differing effects on neuro-inflammatory markers increased by high 
fat diet in the PFC and hypothalamus 
Expression levels of neuro-inflammatory related genes were examined in both 
the PFC and the hypothalamus. Table 1 provides detailed statistical analysis of genes 
examined in the PFC, and important results will be highlighted here.  Intake of HF diet 
caused a significant increase in inflammatory related genes chemokine (C-C motif) 
ligand 2 (CCL2), C-C chemokine receptor type 2 (CCR2), C-X-C motif chemokine 10 
(CXCL10) as compared to sedentary controls (Figure 5A, F(1,17)=17.7, p<0.001, 
F(1,16)=4.89, p<0.05, F(1,16)=4.63, p<0.05, respectively). Exercise alone had no effect 
and exercise in combination with high fat diet normalized these genes to controls levels. 
Post- hoc analysis revealed a significant difference between sedentary + HF and 
exercise + HF groups for CCL2, CCR2, and CXCL10 (Figure 5A, p<0.001, p=0.01, 
p=0.01). Intake of HF diet in sedentary animals also caused a significant increase of 
inflammatory related genes interleukin-6 (IL-6), and COX-2 as well as a trending main 
effect of diet in prostaglandin synthase E1 (PGSE-1) in the PFC (Figure 5B, 
F(1,13)=11.74, p<0.01, F(1,19)-4.88, p=0.04, p=0.07). There was a significant decrease 
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in these inflammatory markers when exercise and high fat were combined in PGSE-1 
expression levels (Figure 5A, p=0.01). Gene expression examine in the hypothalamus is 
considered preliminary because of the small sample size in the high fat group (n=2). 
Table 2 lists the detailed statistical findings of genes examined in the hypothalamus. 
Important results will be highlighted here. In the hypothalamus, there was a significant 
main effect of high fat diet on neuro-inflammatory genes CCL2, suppressor of cytokine 
signaling 3 (SOCS-3), and toll-like receptor-4 (TLR-4) expression (Figure 6A,B, 
F(1,12)=7.67, p<0.05, F(1,12=25.9, p<0.001, F(1,10)=16.93, p<0.01, respectively). 
There was also a significant main effect of exercise that increased expression levels of 
SOCS-3 and TLR-4 (Figure 6B, F(1,12)=15.1, p<0.01, F(1,10)=26.12, p<0.001) as well 
as a non significant trend effect on CCR2 and CXCL10 expression (Figure 5C, p=0.07, 
p=0.07). IL-1R expression was also increased but did not reach significance in the 
hypothalamus in the exercise + HF group (Figure 5C, p=.09).  
 
Discussion	  
 
Exercise has been shown to have many beneficial effects on the brain and is a 
common treatment for obesity. The purpose of the first experiment was to demonstrate 
that short term exercise has the ability to alter reward related gene transcription. The 
purpose of the second experiment was to examine the interaction between high fat diet 
and exercise in feeding and reward regions of the brain. It was previously unknown if 
exercise was able to prevent neuroadaptations and behavioral changes that occur in 
obesity. Overconsumption of palatable foods not only drives obesity, but also has 
damaging effects on the brain. Chronic high fat diet causes circuitry changes in brain 
regions involved in food intake and decreases reward intake behaviors (Vucetic et al., 
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2011a; Carlin et al., 2013). Exposure to a western-style diet is known to impair cognition 
(Beilharz et al., 2013) and cause neuro-inflammation that can impact food intake and 
learning and memory (De Souza et al., 2005, Jurdak et al., 2008).  Our study 
demonstrates that exercise is able to regulate gene expression in these regions; 
however, it may not be an appropriate treatment for preventing reward dysfunction or 
neuroinflammation caused by long term high fat diet intake.  
In the first experiment, mice were exposed to only two weeks of wheel exposure 
in adulthood. We found that with only two weeks of exercise, mice had decreased 
dopamine D1 receptor (DR1) and mu opioid receptor (MOR) expression levels in the 
prefrontal cortex. DA is hypothesized to be critically involved in movement and reward 
and increases in DA receptors in the striatum have been associated with increases in 
endurance capacity (Foley et al., 2006). Endogenous opioid levels have long been 
known to increase in the brainstem, caudate, and mesolimbic regions after exercise 
training (Boone et al., 1996; Werme et al., 2000, Sforzo et al., 1986, Janal et al., 1984). 
Mu opioid receptors mediate the increase in nociceptive thresholds and positive mood 
that occurs after exercise (Janal et al., 1984). However, our experiment shows the down 
regulation of both DR1 and MOR in the prefrontal cortex. This suggests differential 
regulation of DR1 and MOR in the prefrontal cortex compared to other brain regions.  
Difference in DR1 and MOR response to exercise may also be because of shorter 
exposure (2 weeks) to the running wheel and our use of mice instead of rats. Little was 
known about how exercise how exercise regulates gene expression at the molecular 
level and between in regions other than the hippocampus.  
The likely mechanism behind down regulation of expression at this time point in 
the PFC is an increase DNA methylation at the promoter region of these genes. Global 
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DNA methylation was unaffected; therefore this suggests a specific signaling event and 
not a global down regulation of methylation levels. DNA methylation plays a crucial role 
in the remodeling of chromatin in the brain, and contributes to the regulation of brain 
plasticity and gene transcription. DNA methylation regulates expression in a highly 
context-dependent manner and a stimulus may have different effects at different genes 
(Suzuki et al., 2008). One possible mechanism by which exercise may be able to alter 
DNA methylation is through synchronous neuronal activation. Gou et al., (2011) 
demonstrated that electroconvulsive stimulation produced de novo methylation and DNA 
de-methylation throughout the genome; this could be similar to what is occurring after 
exercise. The up regulation seen after longer time points on exercise may reflect further 
remodeling events occurring after chronic exposure. Because exercise had the ability to 
affect expression of reward related genes, we next set up a longer experiment to look at 
exercise’s interaction with chronic high fat diet. 
For experiment 2, we were interested in the ability of exercise to prevent both 
behavioral and gene expression changes that accompany long term high fat diet. We 
gave mice access to the running wheel and to ad lib 40% fat diet concurrently. Our 
exercise + HF group gained less body weight than sedentary + HF animals, but were still 
significantly heavier than controls. Our lab and others have previously shown that intake 
of high fat diet causes decreases in dopamine and opioid related genes and this is 
associated with dysfunction in food intake and reward behaviors (Carlin et al., 2013; 
Vucetic et al., 2011, Johnson & Kenny, 2010). High fat/high sugar diets have been 
shown to alter behavior in rodents (Soulis et al., 2007, Prasad et al., 1996). For example, 
high fat/high sucrose diet decreased performance in learning and memory tasks (White 
et al., 2009; Stranaham et al., 2008) and decreased exploration of open arm in an 
elevated plus maze test (Anderson et al., 2013). In our model, mice did not show any 
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changes in anxiety behaviors after consumption of high fat diet and/or access to running 
wheel. This was interesting because in other models, such as mildly stressed rats, 
consumption of a high fat/high sucrose diet was anxiogenic (Legendre et al., 2006). 
Additionally, our study did not find any beneficial effects on anxiety-like behavior in 
exercised mice, while other studies have found exercise to be anxiolytic. For example, in 
humans, exercise reduces anxiety symptoms and is used as a treatment for both anxiety 
and depression (Herring et al., 2010; Dunn et al., 2005a), while exercise in rats can 
decrease anxiety in an open field test and elevated plus maze (Duman et al., 2008). 
However, the length of the exposure to the diet varies between labs and a 6 week 
exposure may not have been sufficient to elicit the anxiogenic response. Future 
experiments could address whether these animals response differently in a challenging 
or stressful situation to gain a more complete understanding of their stress reactivity. 
Sucrose preference is a broad measure of natural reward intake and regulated 
by both dopamine and the endogenous opioid system. We found natural reward intake 
to be reduced in both exercise and high fat diet exposed animals. Sucrose preference 
can be diminished under a variety of different conditions, such as high fat diet intake 
(Carlin et al., 2013), chronic mild stress (Muscat et al., 1992), social deprivation (Berry et 
al., 2012) and lipopolysaccharide injection (Cross-Mellor et al., 2003). Sucrose 
preference is a model of anhedonia and diminished reward responsiveness in rodents. 
Potential mechanisms behind reduced sucrose preference after high fat diet could be 
reduced reward activation, reduced nutrient need, while reduced sucrose preference 
after exercise could be due to reward replacement. Both exercise and high fat diet are 
rewarding and we see access to one rewarding substance reducing of another 
rewarding substance, sucrose. Both high fat diet and exercise cause gene expression 
changes in reward related regions, therefore examining which genes parallel sucrose 
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preference will help us further understand the mechanism behind diminished reward 
intake in our model. Sucrose preference was diminished in animals given high fat diet, 
exercise, and exercise + high fat diet; therefore we can conclude exercise is not the 
optimal way to prevent the reward dysfunction that occurs in obesity.  However, there 
does not seem to be an additive effect for HF and exercise for sucrose preference. 
Further studies are warranted to understand the mechanism driving decreased sucrose 
preference after two distinct and qualitatively different stimuli.  
The mesolimbic dopaminergic pathway is activated by many rewarding 
behaviors, including the consumption of palatable foods and exercise. We examined 
gene expression of dopamine receptors in our experimental groups in reward related 
regions of the brain, nucleus accumbens (NAc) and prefrontal cortex (PFC). In the 
nucleus accumbens, both DR1 and DR2 expression were upregulated after 6 weeks 
high fat diet. Exercise alone did not alter the expression of dopamine receptors this 
region, even though we observed down regulation of DR1 after 2 weeks in the first 
experiment in the PFC. It may be the case a take a longer exposure is needed to alter 
receptors in nucleus accumbens. Furthermore, exercise was unable to normalize the 
expression of DR1 and DR2 in this region; and DR1 and DR2 remained elevated in 
exercise + HF animals. In the PFC of the second experiment animals, we saw a 
significant increase of DR2 expression after high fat diet and a trending increase in DR1. 
Exercise again was unable to normalize DR2 expression in the exercise + HF group. 
The PFC differs from the NAc in that there may be a possibility of an interaction for 
exercise and diet. Moreover, the pattern of expression does not parallel what we see in 
sucrose preference. Further examination of other neurotransmitter systems, such as the 
endogenous opioid system, involved in sucrose intake is necessary to see how exercise 
and high fat regulate natural reward intake behavior. 
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 Epigenetic enzyme DNA methyltransferase 1 expression was also examined in 
reward related regions. We observed in experiment 1, that exercise may regulate gene 
expression by recruiting DNA methylation to specific promoter sites. Changes in 
promoter methylation have been observed in the brain, adipose tissue, and muscle after 
exercise training and may underlie the exercise mediated gene transcription involved in 
synaptic plasticity (Pareja-Galeano et al., 2014; Ronn et al., 2014, Gomez-Pinilla et al., 
2011, Abel & Rissman, 2013). DNMT1 is highly expressed in the brain, catalyzes 
maintenance and de novo DNA methylation, and has been implicated in reward 
signaling (Gou et al., 2011, Day et al., 2013). In the NAc, there was a main effect of 
exercise on the upregulation on DNMT1. There was also an interaction between diet and 
exercise for DNMT1 in this region. High fat diet and exercise signaling both seem to 
converge to regulate DNMT1 transcription on their own. Interestingly, the combination of 
high fat diet and exercise normalizes DNMT expression. If DNMT1 is involved in the 
regulation of other genes involved in the damaging effects of high fat diet, exercise may 
have some benefit in normalizing high fat diet neuroadaptations. DNMT1 is not altered in 
the PFC in our second experiment model. Changes in DNMT1 activity levels may 
potentially be behind the changes in DNA methylation that occur after exercise in the 
short term. Further examination of this pathway will be needed to understand the 
activation pathway in both diet and exercise. At the transcriptional level at least, we see 
exercise is not able to prevent dopamine dysfunction and epigenetic regulation genes 
altered in obesity.  
Obesity seems to have a negative impact on the brain and behavior. Obesity is 
associated with learning and memory deficits (Beilharz et al., 2013), dysfunction in 
reward behaviors (Johnson & Kenny, 2010), and diminished homeostatic control over 
food intake (Hellstrom et al., 2004). Obesity is also considered to be a chronically 
	   118	  
inflamed state. One possible mechanism behind obesity’s damaging effects on the brain 
could be neuro- inflammation in prefrontal cortex and hypothalamus. Some key markers 
of neuro inflammation is the increase in cytokine and inflammatory mediators that attract 
immune cells and activate microglia. C–C motif) ligand 2 (CCL2), chemokine receptor 
CCR2, and CXCL10 are part of the inflammatory chemokine response that elicit 
lymphocyte migration and trafficking into the brain (Prinz & Priller, 2010). Interleukin-6 (I-
6) and IL-1β are increased in response to Toll-like receptor 4 (TLR-4) activation and are 
essential pieces of the inflammasome process (Manakan et al., 2012). SOCS-3 is a 
negative regulator of inflammatory cytokines as well as a negative regulator of the leptin 
receptor and could be the mediator leptin resistance found after high fat diet intake 
(Dunn et al., 2005b). Pro-inflammatory enzymes prostaglandin E synthase-1 (PGSE-1) 
and cyclooxygenase-2 (COX-2) synthesize neuro-inflammation mediators and 
perpetuate the inflammation cycle (Radler et al., 2013). These genes all together 
mediate the neuro-inflammatory response and the migration of immune cells into the 
brain, which may have damaging side effects. We demonstrated that inflammatory 
cytokines and inflammatory cytokine receptors are upregulated in the prefrontal cortex 
and hypothalamus after high fat intake and the effect of exercise may not be beneficial in 
all cases. In the PFC, inflammatory cytokines CCL2 and CXCL10 and cytokine receptor 
CCR2 mRNA was increased in animals fed high fat diet. Exercise alone had no effect on 
these genes; however, exercise in combination with high fat was able to normalize the 
inflammatory markers back to control levels in the PFC. We see a similar expression 
pattern occur with IL-6, PGSE1, which are increased after high fat diet exposure and 
normalized by exercise. Exercise has recently been shown to reduce neuroinflammation 
in the hippocampus (Kohman et al., 2013; Gomes de Silva et al., 2013). We have 
extended these finding to include the prefrontal cortex. Further experiments are needed 
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to see if this reverses and cognitive impairments associated with neuroinflammation in 
the PFC.  
Exercise does not have a uniform anti-inflammatory effect in all brain regions, 
however. In the hypothalamus, we see that it is the combination of exercise and high fat 
to be the most detrimental. Although these results are preliminary because of small 
sample sizes in the high fat group, we see some informative patterns emerge. Exercise 
+ HF animals had increased expression of cytokines CCL2, CCR2, CXCL10 as well as 
SOCS-3, TLR-4 and trending increase in IL-6. It seems that exercise actually 
exacerbates inflammation from high fat diet in the hypothalamus. Interestingly, SOCS-3 
is upregulated by high fat diet and exercise as well as the combination of the two. Leptin 
resistance has been shown to be mediated by an increased expression of SOCS-3 and 
this could be associated with central inflammation in the hypothalamus and may mediate 
the observed dysregulated food intake and energy imbalance (Zhang et al., 2008; Cai & 
Lui, 2012; Milanski et al., 2004). In our study, 6 week of high fat alone was not sufficient 
to cause an upregulation of inflammatory markers other than SOCS-3. However, when 
coupled with exercise, high fat diet is able to elicit this response. Why the hypothalamus 
is so vulnerable to inflammation is unclear.  It may be the region’s highly specialized role 
in sensing energy utilization and metabolic activity that makes it particularly prone to 
possible oxidative stress and therefore, inflammation. The high level of vasculature and 
open blood brain barrier in certain hypothalamic areas may also play a role. This 
exacerbation of inflammation by exercise suggests that exercise may not be the optimal 
means to prevent the damaging central effects of high fat diet. This has implications for 
individuals who look to remain on a high fat diet while treating obesity with exercise. 
Ways to prevent neuroinflammation as well as dopamine dysfunction in this state will 
need to be further explored. 
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In summary, we demonstrated that a short exposure to exercise has the ability to 
alter dopaminergic and opioid gene expression and promoter methylation in a region not 
previously explored. This increase in promoter DNA methylation was specific to genes 
that were changed after 2 week running wheel exposure. Further, we have 
demonstrated that high fat diet causes decreases in natural reward intake and 
dopaminergic and inflammatory gene expression changes in the nucleus accumbens, 
prefrontal cortex, and hypothalamus. Behavior and gene expression were unable to be 
reversed by exercise and, in fact, exercise seem to have its own diminishing effect on 
sucrose intake. These gene expression changes lead us to believe that central reward 
signaling and epigenetic mechanisms may be altered after high fat diet intake and that 
concurrent exercise is unable to prevent these changes. We have also seen that the 
hypothalamus is particularly sensitive to the combination of exercise and high fat diet 
when it comes to inflammation. In conclusion, we believe that although exercise is 
extremely beneficial to cognitive enhancement and weight loss, other add on therapies 
may be needed to combat the neuroadaptations that occur in obesity and lead to reward 
dysregulation. 
 
 
 
Figure	  Legends	  	  
	  
Figure 1. Two weeks of voluntary wheel running decreased dopamine receptor D1 
and mu opioid receptor gene expression and altered DNA methylation at promoter 
regions. A) Two week exposure to running wheel (black bars) decreased mRNA levels 
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of dopamine receptor D1 (DR1) and mu opioid receptor (MOR) compared to sedentary 
controls (white bars; n=6/group). Dopamine receptor D2 (DR2) was unaltered. B) Gene 
expression changes were associated with increases in DNA methylation at gene 
promoter regions of DR1 and MOR. C) Global DNA methylation in sedentary and 
exercised animals. Statistically different than controls at alpha level *p<0.05. 
Figure 2.  Animals with access to HF + exercise did not gain as much weight as 
sedentary animals on HF, but were still heavier than controls. A) Body weights at 
experimental end point were taken of sedentary controls (white bars), sedentary +HF 
(solid bar), exercise (vertical striped bar) and exercise +HF (checkered bar) groups 
(n=10/group). B) Body weight gain throughout 6 week was also analyzed. Statistically 
significant main effect of high fat diet at alpha level ****p<0.0001. Post hoc analysis 
between sedentary HF and exercise HF groups at significant level ##p<0.01. 
Figure 3. Animals given access to running wheel and/or high fat diet did not show 
alterations in anxiety behavior. However, both exercised and/or high fat diet 
access reduced natural reward intake. Animals of sedentary controls (white bars), 
sedentary +HF (solid bar), exercise (vertical striped bar) and exercise +HF (checkered 
bar) groups (n=10/group) were tested in both the elevated plus maze (A), open field, (B) 
and sucrose preference (C) to assess anxiety behavior and natural reward intake. A) 
Time in open arm in elevated plus maze in seconds (s). B) Time in center arena of open 
field test in seconds (s). C) Percent preference of 4% sucrose solution to water. Main 
effect of high fat diet shown as significant at alpha level of,****p<0.0001. Main effect of 
exercise shown at alpha level of ^^p=0.01.  
Figure 4. Gene expression of dopamine receptors and DNA methyltransferase are 
increased by high fat diet and not reversed by exercise in reward regions of the 
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brain. Gene expression was measured in the nucleus accumbens (NAc, A) and the 
prefrontal cortex (PFC, B) in sedentary controls (white bars), sedentary +HF (solid bars), 
exercise (vertical striped bars) and exercise +HF (checkered bars) groups (n=6-8/group). 
Fold change is calculated compared to sedentary controls. *p<.05 represents a 
significant main effect of diet, ##p<.01 main effect of exercise.  
Figure 5. Gene expression of neuro-inflammatory related genes were increased by 
high fat diet and normalized by exercise in the prefrontal cortex.  Gene expression 
was measured in the prefrontal cortex (PFC, A) in sedentary controls (white bars), 
sedentary +HF (solid bars), exercise (vertical striped bars) and exercise +HF (checkered 
bars) groups (n=6-8/group). Fold change is calculated compared to sedentary controls. 
A statistically significant main effect of high fat diet is shown at an alpha level *p<0.05, 
**p<0.01, ***p<0.001. Planned comparisons show significant difference between groups 
at an alpha level of #p<0.5, ##p<0.01, ###p<0.001.  
Figure 6. Neuro-inflammatory related genes were increased by high fat diet and 
further increased by the combination of high fat diet and exercise in the 
hypothalamus. Gene expression was measured in the prefrontal cortex (PFC, A) in 
sedentary controls (white bars), sedentary +HF (solid bars), exercise (vertical striped 
bars) and exercise +HF (checkered bars) groups (n=6-8/group). Fold change is 
calculated compared to sedentary controls. A statistically significant main effect of high 
fat diet is shown at an alpha level *p<0.05. A statistically significant main effect of 
exercise is shown at an alpha level ^^p<0.01, ^^^p<.001. Planned comparisons show 
significant difference between groups at an alpha level of ##p<0.01 
Table 1 Neuro-inflammatory gene expression in the prefrontal cortex. Summary of 
two-way ANOVA analysis of gene expression from the PFC preformed in sedentary, 
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high fat, exercise, and exercise + high fat groups. Interactions and main effects are 
presented alongside their p values. 
Table 2 Neuro-inflammatory gene expression in the hypothalamus. Summary of 
two-way ANOVA analysis of gene expression from the hypothalamus preformed in 
sedentary, high fat, exercise, and exercise + high fat groups. Interactions and main 
effects are presented alongside their p values.  
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Table 1. Gene expression in PFC 
Gene Interaction Diet effect Exercise effect 
CCL2 F(1,17)=20.4, 
p=0.0003 
F(1,17)=17.7, 
p=0.0006 
ns 
CCR2 F(1,16)=6.58, 
p=0.021 
F(1,16)=4.89, 
p<0.05 
F(1,16)=4.63, 
p<0.05 
CXCL10 F(1,17)=13.6, 
p=0.002 
F(1,17)=12.15, 
p=0.0028 
ns 
IL-6 F(1,13)=7.00, 
p=0.02 
F(1,13)=11.74, 
p<0.0045 
ns 
PGES F(1,18)=15.73, 
p<0.0009 
Trend, p=0.07 ns 
COX- 2 ns F(1,19)=4.88, 
p=0.04 
ns 
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Table 2. Gene expression in hypothalamus 
 
Gene Interaction Diet effect Exercise effect 
CCL2 ns F(1,12)=7.67 ns 
CCR2 ns ns Trend p=0.07 
CXCL10 ns (p=.11) ns Trend p=0.07 
SOCS-3 ns F(1,12)=25.9, 
p=0.0003 
F(1,12)=15.1, 
p=0.0022 
TLR-4 F(1,10)=11.56, 
p=0.0068 
F(1,10)=16.93, 
p=0.0021 
F(1,10)=26.12, 
p=0.005 
IL-6 ns ns ns 
IL-1R ns ns ns 
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CHAPTER	  5:	  GENERAL	  DISCUSSION	  
 
Only 56 years ago, the prevalence of obesity was 13%. Today it is estimated that 
69% of adults and 30% of adolescents are overweight (BMI 25-29.9) or obese (BMI > 
30) in the United States (Ogden et al., 2011). The enormous toll that obesity takes in 
money and health from our society justifies an exploration of the drivers of the epidemic, 
the mechanisms of the disease, as well as the factors that aid in its prevention and cure. 
There are many drivers of the obesity epidemic, and it is now clear that this 5 fold 
increase over 50 years cannot be explained by genetics alone. Although certain genes 
can increase one’s risk of obesity, an individual cannot become obese without the 
availability of calories to consume. The emergence of fast food establishments, a “snack 
food” industry and policies that favor corn and soybean production are just a few trends 
that have paralleled the obesity trend. Corn and soybean production is so inexpensive 
that an enormous supply of “junk” has been created using solely these two crops. Corn 
alone makes up over 25% of the food found on the supermarket shelves (Pollan, 2002). 
The inexpensive input has made it easy and profitable for companies to make food with 
high concentrations of sugar and fat that increase overconsumption. Companies that 
produce the combinations of highly concentrated sugar and fat have only been around 
60 years or so.  For instance, the first McDonalds opened in 1957, and the first marketed 
potato chip brand, Lays, began in 1938. The snack food market is a $46.1 billion industry 
and they produce highly concentrated sugar and fat products that are extremely difficult 
to resist.  People are over consuming these modern manufactured foods and the 
consequences have been disastrous. Cheap, palatable foods are a permanent part of 
America’s food landscape and its imperative for us find ways to lessen their impact on 
our health. 
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Why is it so difficult to say no to these manufactured, calorie-laden foods?  We 
can imagine throughout the millions of years of human evolution, there was no need for 
the ability to suppress appetite. What was important was the ability to hunt and gather 
enough food to survive during lean times. We can imagine the brain to consider 
overeating of high-calorie food as beneficial, especially if you are uncertain of your next 
meal. Having large fat stores was a luxury, and the brain and body evolved ways to 
maintain them. Today, this behavior is no longer adaptive and is even counterproductive 
in a world where food is bountiful and energy-dense. The ability of these energy dense 
foods to override our homeostatic mechanisms leads to a brain-environment mismatch 
and increasing fat stores and declining health in many individuals. Obesity is associated 
with many chronic illnesses, such as cardiovascular disease, diabetes, osteoarthritis, 
and certain types of cancer. Fortunately, obesity is largely preventable and highly 
curable if we can only find ways to combat their effect on our brains. Even in the face of 
the facts and negative health outcomes, many people continue to over consume highly 
palatable foods, and thereby gain fat.  Obesity, in this light, has often been compared to 
drug addiction. This comparison is highly controversial because of the negative 
associations accompanying the label “addiction” and many feel that one cannot be 
“addicted” to something necessary for survival. However, if the comparison is made on 
the neurobiological level and leads to better therapies and better drug targets, it may be 
a useful framework.  
We have been introduced to the similarities between the neural circuits regulating 
feeding and drug addiction in chapter 1. Obesity neuroscience and drug addiction have 
previously been researched separately and addiction was identified as a disease much 
before obesity and manufactured foods were a problem. The inability to suppress intake 
despite negative consequences (e.g. foot shocks, cold environment) were shown with 
	   134	  
cocaine intake studies first.  Today, neuroscience is seeing the effects of highly 
palatable food mirror what was seen in the early addiction studies. Drugs of abuse hijack 
this extended motivation/feeding circuit by supra-natural activation and, over time, 
change it so other desires are dampened, and normal functioning is no longer possible. 
Obesity is also characterized by the unnatural hijacking of the dopamine 
motivation/feeding circuit. The foods we are eating today are unnaturally high in reward 
value and can stimulate and alter the brain in ways similar to drugs of abuse. 
Manufactured foods found in the modern diet contain concentrations of sugar and fat not 
found in nature and previously unavailable to human beings. Studying these calorie-
dense foods like an addictive drug at the neurobiological level may be beneficial and 
lead to better obesity treatments.  
 
Hypo-reward Hypothesis of Obesity 
The hypo reward hypothesis of obesity is similar to the development of tolerance 
in addicted individuals. The hypo reward hypothesis postulates that there is diminished 
reward value for palatable foods in obese and obesity-prone individuals. The diminished 
reward value would necessitate more consumption in order to reach desired reward 
level. This is similar to tolerance that develops over time after chronic intake of drugs of 
abuse. An addicted individual needs to escalate his intake in order to achieve the 
desired effect. In chapter 2, 3, and 4 it was demonstrated that chronic high fat diet does 
indeed alter the mesolimbic dopamine region and reward behaviors. Four models of diet-
induced obesity were examined in this dissertation. Chapters 2 and 3 examined different 
age groups on chronic high fat diet and used standard chow replacement as an obesity 
intervention in both male and female mice. We discovered that both age and sex were 
critical factors in the development and reversal of neuroadaptations seen in obesity. In 
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chapter 4, we examined exercise as an intervention for obesity and discovered how 
exercise can have its own effects on the brain that may not be entirely beneficial when 
paired with high fat diet. The decrease in dopaminergic gene expression, diminished 
dopamine neurotransmitter levels, and decreased sucrose preference were consistent 
with the hypo reward hypothesis of obesity and comparable to what is seen after long 
term drug intake. However, these changes did not necessarily show that chronic intake 
of high fat lead to further overconsumption. In fact, overconsumption of palatable food 
did not occur until acute or long term standard chow intervention and binge like 
consumption was only observed in females. 
 The hypo-reward hypothesis of obesity predicts that diminished inhibitory control 
paired with the decrease reward value of palatable foods will lead to further 
overconsumption of palatable foods. We saw decreases in dopaminergic genes and 
dopamine neurotransmitter levels in the prefrontal cortex as well as the nucleus 
accumbens. The prefrontal cortex is involved in inhibitory control of reward intake and 
dysfunction in this region is associated with impulsive behavior. Females were seen to 
have an imbalance of dopamine receptor DR1 and DR2 in the prefrontal cortex after 
standard chow replacement, which may be the mechanism seen behind the binge-like 
consumption of palatable food in this group. Our findings further strengthen the hypo-
reward hypothesis of obesity. However, our results also highlight the importance of sex 
difference and nutritional status when examining palatable food consumption in the 
future.  
 
 
Chronic high fat diet alters the dopamine reward system in an age and sex 
dependent manner. 
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Age Effects 
We have investigated the age of onset and sex as critical variables in the neuro-
adaptations seen after chronic high-fat diet intake.  Taking the results of both chapters 2 
and 3 we see that the timing of chronic high fat diet is a critical factor that affects the 
development of dopamine system neuroadaptations and adulthood reward behaviors. 
One behavior that was altered in an age dependent manner by chronic high fat diet was 
sucrose preference. Sucrose preference is a measure of natural reward and diminished 
sucrose intake is a mark of anhedonia in rodents and suggests decreased reward 
sensitivity. These results corroborate with other studies that show high fat diet is 
associated with depressive-like behaviors in rodents (Sharma et al., 2013). Males who 
began the high fat diet at birth and at pre-adolescence showed decreased sucrose 
preference; however, males who began the diet in adulthood had control level 
preference for sucrose. This suggests a critical time period from weaning (3 weeks of 
age) to pre-adulthood (before 6 weeks of age) to be extremely important for 
programming natural reward value in adulthood since the change was seen in both 
models of early hat fat exposure. High fat diet exposure during lactation has previously 
been shown to promote obesity in offspring (Tsuduki et al., 2013) and has implications 
for monitoring food consumption in lactating mothers in addition to monitoring food 
intake of offspring during early postnatal period.  Interestingly, this age effect was not 
seen in females and all female groups had decreased sucrose preference. This 
suggests that all stages of female brain development may be vulnerable to high fat diet 
programming of reward dysfunction. This has implications for the treatment of obesity in 
the female and childhood obesity populations. If it is true that decreased reward value 
causes individuals who were obese as children and females to over consume palatable 
foods, interventions that can stop over consumption should be focused on these 
	   137	  
populations. For example, strategies such as portion control at mealtime may be more 
beneficial than total caloric restriction or exercise in these groups.  
We next explored how intake of another rewarding substance, high fat diet, and 
how it can regulate dopaminergic gene expression to elicit a decrease in reward 
sensitivity.  Mesolimbic dopamine and opioid signaling after sucrose consumption 
determines the reward value of the sucrose solution. Dopamine signaling is mostly 
involved with the “wanting” aspect of sucrose intake, while opioid signaling mediates the 
“liking” aspect of sucrose intake (Mahler et al., 2011). In chapter 2 and 3 we see that 
dopaminergic genes were down regulated by chronic high fat diet in a sex and age 
dependent manner. However, because of the decrease in sucrose preference, we would 
also predict a down regulation of opioid signaling in the same regions. In fact, our lab 
has previously shown mu opioid receptor expression to be diminished after 20 weeks 
high fat diet in the VTA and NAc (Vucetic et al., 2011).  The earlier high fat models also 
had more vulnerability in regards to changes in dopamine neurotransmitter levels. The 
difference in COMT regulation after high fat diet intake could be the basis behind the 
opposite regulation of dopamine (DA) neurotransmitter levels. It is also possible that the 
differences in COMT could be in response to the changes seen in total neurotransmitter 
levels. An earlier exposure to high fat diet also lead to decreased DA levels in VTA 
projecting regions NAc and PFC. High fat from pre-adolescence caused an increase in 
DA levels in these same regions. It seems that high fat diet from postnatal day 1 
throughout lactation affects the expression of COMT, and therefore DA metabolism, in 
an opposing trajectory than pre-adolescence HF. Being able to observe dopamine 
circuitry at an earlier time point might give us insight to projections are developing at this 
time that can change the trajectory of how the brain responds to high fat diet. 
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Sex Differences 
The ventral tegmental area was also a region where we not only saw an age 
effect, but also a significant sex difference. Dopamine transporter (DAT) was regulated 
by high fat diet in opposite directions in males and females. Chronic high fat diet caused 
decreased expression of DAT in males and increased expression of DAT in females in 
all of our DIO models. In chapter 2 we explored this sex difference further at the 
epigenetic level. Levels of DAT reflect the general state of dopaminergic function in the 
brain, and changes in DAT activity will alter dopamine function and dopamine dependent 
behaviors (Jaber et al., 1997; Amsterdam et al., 2007). A down regulation in DAT, as 
seen in DAT knockout mice, leads to an increase in dopamine levels and elevated 
motivation for sweet foods (Pencina et al., 2003). Although motivation for palatable foods 
was not assessed, elevated consumption of palatable food was seen in the DIO animals 
only after acute HFD removal. Palatable food consumption was mostly depressed by the 
presence of the high fat diet. However, females who received high fat earlier in life did 
not significantly decrease their palatable food intake in the presence of ad lib high fat 
diet. Additionally, pre-adolescent HF females reached binging levels of palatable food 
intake when HFD was removed. The sex difference seen in DAT expression in response 
to high fat diet may underlie the higher level of palatable food intake seen in pre-
adolescent HF females. Indeed, it has been shown that female rats have a higher level 
of total DAT protein in the nucleus accumbens and striatum than males (Becker, 1999). 
It is also true that females are more sensitive to the rewarding effects of cocaine, a drug 
that binds to DAT (Zakharova et al., 2009). DAT is an important pharmacological target 
for obesity treatments as well as treatments for depression and attention-deficit 
hyperactivity disorder (ADHD) (Sakrikar et al., 2012; Ledford et al., 2010). 
Understanding the mechanisms behind how DAT expression is regulated in obesity will 
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be important when treating both male and female populations. It was not previously 
known that DAT was regulated by DNA methylation at the promoter region. Targeting 
epigenetic machinery may be a new drug target with the ability to reverse reward deficits 
seen in obesity. Insulin receptor/AKT/PI3kinase pathway also regulates DAT expression 
and dopamine homeostasis (Speed et al. 2011). This is also a potential target pathway 
where diet, hormones and metabolic sensing pathways intersect in the VTA and affect 
dopaminergic function. Future experiments will be needed to see if the insulin/PI3Kinase 
pathway is affected by high fat diet and converges on epigenetic proteins such as DNA 
methyltransferase-1(DNMT1) and alters transcription. 
 
Dopamine Receptor Balance 
Interesting gene expression patterns were observed in the nucleus accumbens 
and prefrontal cortex after high fat feeding. These areas are important for reward 
behaviors and impulsivity and are implicated in the control of feeding behavior as well as 
the administration of drugs of abuse. It has previously been shown by other labs that 
dopamine receptor levels are down regulated in obese models (Johnson & Kenny 2010, 
Ong et al., 2013, Alsio et al., 2010). We observed a down regulation in dopamine 
receptor D1 and D2 in the nucleus accumbens and prefrontal cortex in males and female 
mice on high fat diet in chapters 2 and 3. However we see a different pattern emerge 
after a shorter period of high fat intake in chapter 4. Mice in chapter 4 were placed on a 
40% fat, 41% carbohydrate diet at 9 weeks of age for 6 weeks total. In that model we 
observed an increase in DR1 and DR2 in the nucleus accumbens and prefrontal cortex 
in this model. Differences in expression may possibly be due to starting the diet even 
later in life and for be maintained on diet for a shorter period of time. Additionally, a lower 
percentage of fat (40% vs 60% of calories) was used over the 6 weeks and this 
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exposure may not have been sufficient to down regulate dopamine receptors in these 
postsynaptic regions as we observed in chapters 2 and 3. It has previously been shown 
that 4 weeks of high fat feeding is insufficient to alter gene expression in the 
hypothalamus (De Leeuw van Weenen et al., 2009). Future experiments looking at 
earlier time points and different diet compositions will help us narrow down what 
molecules are responding to the high fat diet itself and which are homeostatic 
responses. 
Dopamine impacts energy balance and reward behavior through activation of 
both DRD1 and DRD2 receptors. In the prefrontal cortex, this balance of DR1 and DR2 
was disrupted in an age and sex dependent manner. It seems that the post-weaning to 
adolescence time period is critical in the development of normal dopaminergic circuitry in 
the prefrontal cortex. The prefrontal cortex forms later in development and early 
postnatal nutritional insults are poised to affect projections and proper synapse 
formation. Decreases in DR2 levels may have implications for increased risk for 
impulsivity and bingeing in obese individuals who were also obese as children. Drugs 
that block DRD2 enhance appetite and induce weight gain in animals and humans (Ader 
et al., 2005, Baptista et al., 2002). Lack of normal DR2 levels is associated with “reward 
deficiency syndrome”, which elicits exaggerated response to reward in the face of 
diminished signal transduction (Comings and Blum, 2000). Reward deficiency syndrome 
increases the risk of engaging in compulsive activities such as gambling, eating, and 
sex, and risk taking behaviors. These behaviors should be monitored in the obese 
populations and may be become an issue when trying to calorie restrict. Total dopamine 
levels (Giros et al., 1996), treatment by pharmacological agents (Buckland et al., 1992), 
as well as external rewards, such as sexual activity (Melis et al., 1995), and exercise 
(Foley et al., 2006) also all affect dopamine receptor expression level. We have since 
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added to these findings and show that chronic high fat diet alters dopamine receptor 
expression in a sex and time dependent manner.  
 
Neurotransmitter Levels 
Dopamine neurotransmitter levels were measured in nucleus accumbens nd 
prefrontal cortex after high fat diet intake. We observed the early life high fat diet to be 
important in altering neurotransmitter levels in adulthood; however diet exposure during 
the lactation period seems to be different than exposure during post weaning. High fat 
diet from birth leads to diminished DA levels in both males and females in adulthood, 
while high fat from weaning leads to increased DA levels in adulthood. Both age groups 
have diminished TH expression, however, opposite regulation of COMT expression in 
the VTA of animals that began the diet at birth and animals who began the diet at 
weaning. Looking at an earlier time point on the diet may give us clues to what is 
specifically altered in the lactation period that drives DA in one direction and what is 
affected in the post weaning period that drives DA in the other direction. We know that 
the sensitive window for DA regulation is closed by 6 weeks of age because Adult HF 
animal’s DA levels remain unaffected by high fat diet. 
 
 Palatable food consumption was affected by presence of ad lib high fat diet. 
In order to assess if high fat diet increased the consumption of palatable foods 
we gave mice access to high fat/high sugar food (peanut butter chips) for one hour every 
day and measured their consumption. We saw that consumption of the palatable food 
depended on the presence of ad lib high fat diet in both male and female animals. 
Animals decrease their total daily intake and their one hour palatable food intake when 
given high fat diet ad lib. Acute removal of the ad lib high fat diet causes normalization in 
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males and a binge-like consumption of palatable food consumption in females. Animals 
still had ad lib access to food and were not food restricted. Moreover, the acute removal 
of high fat diet during the experimental period is not a sufficient amount of time to 
reverse neuroadaptations seen in obesity. Therefore, we can see that the 
neuroadaptations caused by high fat diet increase the risk of over consumption during a 
diet withdrawal. Binge eating disorder is found in a subset of obese patients and is 
associated with dopamine dysfunction in the frontal-striatal (Davis & Carter, 2009). It is 
also thought that binge eating disorder arises in adolescence from development 
abnormalities (Michaelides et al., 2012). It is possible that high fat diet during this time 
can help program the propensity for bingeing later in life. Persistent changes occurring in 
the prefrontal cortex, either in dopamine neurotransmitter levels or decreased dopamine 
receptor levels could be the mechanism behind females reaching binge levels of 
consumption (>25% daily calories). These findings have implications for obese 
individuals trying to treat obesity with a low fat diet strategy and suggest that females 
may find this strategy more difficult. Which specific neuroadaptations are responsible for 
the increase in palatable food consumption are not yet known. These results highlight 
the need for targeted studies investigating the mechanisms of palatable food intake in 
both males and females. 
 
Reversal of neuroadaptations by standard chow replacement depends on age of 
diet onset and sex 
 
We demonstrated that it is possible to reverse the neuroadaptations and 
behavioral changes seen after high fat diet with a 4-week standard chow replacement. 
However, in some cases, we observed a pattern of persistence that depended on both 
age of diet onset and sex.  A 4 week standard chow replacement was chosen as an our 
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first obesity intervention. Four weeks was a sufficient length of time to reverse behavioral 
adaptations but not a sufficient length of time to normalize body or fat pad weight. This 
allowed us to look at the effects of high fat diet itself while animals remained significantly 
heavier and did not go through the added stress of significant body weight loss. Sucrose 
preference was an example of behavioral normalization in diet induced obesity models 
before body weight returned to control levels. This suggests diminished sucrose 
preference was attributed to presence or intake of high fat diet itself and not increased 
body weight.  The availability of high fat diet was also associated with diminished one 
hour palatable food intake. Once ad lib diet was removed, animals normalized or 
increased their one hour consumption of high fat/high sugar pellets. This down 
regulation was consistent with the hypo reward hypothesis of obesity that predicts a 
decreased reward value for food. However we do not see the risk of over consumption 
until removal of the high fat diet. Although we demonstrated the ability to reverse 
behavioral deficits, there were many instances where the neuroadaptations persisted 
after high fat removal. Moreover, we found that sex and age were critical factors that 
affected the persistence of these circuitry changes.  
 
Dopaminergic Neurobiological Changes after Diet Removal 
Many dopaminergic gene expression changes remained decreased after diet 
removal and were associated with the overconsumption of palatable foods. Gene 
expression after a 4 week standard chow replacement had an interesting pattern of 
persistence and reversal that varied by sex, brain region, and age of onset. Overall, the 
early high fat diet models seen in chapters 2 and 3 had a more persistent gene 
expression phenotype than the adult HF model. Females who began HFD from birth 
were less able to normalize gene expression changes in the VTA after standard chow 
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replacement. This inability to normalize after a 4 recovery period was also seen in 
dopamine receptors and DA neurotransmitter levels in the PFC of the males who began 
the high fat intake from time of birth. This implies the lactation period to be a particularly 
vulnerable period for male prefrontal cortex development and could have implications for 
cue induced feeding (Petrovich, 2013), self control (Alonso-Alonso et al., 2007), and 
food related decision making when “dieting” (Hare et al., 2009) in adulthood. One hour 
consumption of palatable food was not assessed in the high fat from birth group. Future 
studies will have to determine if high fat during lactation is a risk factor for over 
consumption during a dieting period.  
In chapter 3, we further assessed the impact of age on the persistence of high fat 
diet brain and behavioral adaptations. We found that beginning high fat consumption 
earlier lead to more persistent changes after a standard chow replacement period. Pre-
adolescent HF males had reduced dopaminergic gene expression in the VTA and NAc 
after standard chow replacement, while Adult HF males were able to normalize 
expression. Pre-adolescent HF males also had increased amount of DA and DA 
turnover in the NAc after standard chow replacement, whereas Adult HF males DA 
levels were unaffected. There was also a persistence of diminished gene expression in 
females who began the diet in pre-adolescence while adult HF females were able to 
normalize.  
 
Dopamine Receptor Expression after Diet Removal 
Removal of the high fat diet in females lead to a dysfunctional balance of DR1 
and DR2 in the NAc in both pre-adolescent and adult exposed groups. In both the NAc 
and PFC, DR2 expression levels remained decreased while DR1 was able to normalize. 
This disruption of positive and negative control in dopaminergic tone was associated 
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with increase consumption of palatable foods. Females reached binge levels of 
consumption (<25% caloric intake) after a standard chow recovery period and this is 
possibly due to the increased risk of impulsivity that is associated with diminished DR2 
tone (Johnson & Kenny, 2010; Noble, 2000). Withdrawing palatable food has previously 
been shown to heighten craving and motivation for sucrose and high-fat food as well as 
increase physiological and behavioral indices of anxiety (Sharma et al., 2013; 
Teegarden et al., 2007). High fat diet caused lasting neurochemical and behavioral 
changes related to dopaminergic function that have also been observed during chronic 
drug administration and their withdrawal (Russo et al., 2009; Robinson & Nestler, 2011). 
The diminished DR2 tone after HF withdrawal could have implications for altered 
consumption of drugs of abuse. For example, rodents on a high fat diet have exhibited 
reduced conditioned place preference for amphetamines (Davis et al., 2008), impairment 
of cocaine self administration (Wellman et al., 2007) and an obesity-prone rat strain has 
shown a reduced conditioned place preference for cocaine (Thanos et al., 2010).  
Disruption of the dopamine circuitry is implicated in the loss of control seen in both 
addiction and obesity (Volkow et al., 2011) and being able to reverse these 
neuroadaptations may be the key to obesity therapy.  
 
Switching to a lower fat or lower calorie diet is the first line of defense against 
obesity; however, long term compliance on a new diet is the reason behind high failure 
rates of “diets”. It is possible that the neuroadaptations that persist after long term high 
fat consumption contribute to dietary relapse. Understanding how age and sex impact 
brain and behavior in the high fat withdrawal stage will have implication for obesity 
management and interventions. We know now that the obese brain is markedly different 
than the lean brain and these changes can predispose one to overconsumption once 
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high fat diet is removed. Since both pharmacological and behavioral therapies are often 
combined with diet replacement, understanding the brain during this switch and factors 
that can raise adherence rates will help the success of therapies in the future. 
 
Exercise does not reverse reward dysfunction and neuroinflammation seen in 
obesity 
 
Our experiments in chapter 2 and 3 compared the physiologic, behavioral, 
biochemical, and molecular alterations occurring after high fat diet intake and acute and 
long term withdrawal in both males and females at different ages of exposure. We 
demonstrated it is possible to reverse some of the neuroadaptations and reward 
dysfunction that occurs in obesity by replacing HFD with standard chow. However, there 
were some instances were adaptations persisted and this suggests that some 
populations may be more resistant to central normalization with dieting. Chapter 4 
explores exercise as an additional way to prevent the neuroadaptations caused by high 
fat diet. Exercise has the ability to activate reward regions of the brain and alter reward 
behavior (Bothe et al., 2013; Greenwood et al., 2011). Many of the studies 
demonstrating the cognitive benefits seen after exercise were focused on the learning 
and memory in the hippocampus. Exercise is now a potential treatment option for 
addiction disorders (Smith & Lynch, 2011). However, it was previously unknown if 
exercise could prevent the dysfunction seen in reward related regions in obesity. We 
found that although exercise has the ability to reduce body weight in obese individuals, it 
was not an optimal treatment for reward dysfunction in obesity. Exercise was unable to 
prevent the increases in dopamine receptor expression and decreases in natural reward 
consumption caused by high fat diet. This has implications for obesity treatment 
regimes. Exercise alone would not be sufficient to treat reward dysfunction in obesity 
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and additional therapies should be added. Our study examined exercise in conjunction 
with a high fat diet; it is possible that a low fat diet is needed with exercise to prevent 
reward dysfunction after high fat diet intake. 
We also examined the ability of exercise to inhibit neuroinflammation seen in the 
brain after high fat diet intake. Obesity is increasingly being linked with a sub-clinical 
inflammatory state, as seen by higher than normal levels of pro-inflammatory mediators 
such as the cytokines interleukin (IL)-1β and tumor necrosis factor (TNF)-α in the 
circulation of chronically obese individuals (Somm et al., 2006, Mantzoros et al., 1997). It 
is now known that this is due in part to expanding adipose tissue, major source of 
cytokines and cytokine-like hormones, such as leptin (Trayhurn & Wood, 2005). 
Expanding adipose tissue and the high fat diet itself can both increase the production of 
inflammatory markers. Although the cellular and molecular pathway underlying how the 
high fat diet increases cytokine production are unclear, studies have demonstrated that 
saturated fatty acids can directly stimulate TLR-4 (Milanski et al., 2009). If direct 
stimulation of the inflammatory response is possible by fat molecules from the diet, an 
intervention of exercise and a low fat diet, not exercise plus a continuation of the high fat 
diet, should be the recommended way to combat neuro inflammation in obesity. 
We observed that intake of high fat diet caused an increase in inflammatory 
markers in the hypothalamus and prefrontal cortex. Inflammation in these regions could 
disrupt feeding and reward behaviors and maybe even lead to problems with impulse 
control. Exercise has many beneficial effects on the brain and is a first line of treatment 
for obesity. Exercise has the ability to normalize expression of inflammatory markers in 
the prefrontal cortex, but may have an additive effect in the hypothalamus. Exercise has 
beneficial effects on adiposity in the periphery, but would not be able to decrease the 
damaging effects of central inflammation. Exercise’s inability to normalize reward 
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dysfunction and neuroinflammation has implications for future obesity treatments. It may 
be recommended that individuals switch to a lower fat diet while exercising or use 
supplementation with anti-inflammatory medications during intervention. We observed 
an interaction with exercise and high fat in some brain regions. However, studies show 
that the quality of fat in the diet is just as important as the quantity. The ratio of 
arachidonic acid (AA) to docosahexaenoic acid (DHA) is important for pro-and anti-
inflammatory processes, and supplementation with DHA may be beneficial for the 
treatment of neuroinflammation (Bazan, 2005; Serhan, 2005). The experimental diet was 
high in saturated fat to match the western diet eaten by people today. It is now known 
that diets rich in saturated fat increase oxidative stress in the brain (Stranaham et al., 
2011) reduce neurogenesis (Lindqvist et al., 2006), and enhance neuroinflammation 
(Thaler et al., 2012). It could be recommended in the future that if individuals are to 
remain on high fat diet while exercising, DHA or fish oil supplement is necessary to 
prevent the exacerbated inflammatory response seen in certain brain regions. 
 
 
High fat diet and exercise cause lasting changes in gene expression possibly 
through the recruitment of epigenetic machinery. 
 
 Results from these experiments demonstrate that early life nutrition can have 
long-lasting genetic and behavioral consequences that are linked to alterations of the 
epigenetic state. Our results suggest that there may be multiple sensitive windows 
throughout development that can change the trajectory of reward circuitry development. 
One way a sensitive window could occur is through chromatin remodeling over 
development leaving some genes open for both transcription and modification of 
transcription levels. Some genes may no longer be vulnerable as the brain develops and 
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some might continue be vulnerable way into adulthood. Another important factor 
determining sensitive windows would be the timing of development of each specific brain 
regions. The PFC continues to develop throughout adolescence and maybe open to 
remodeling later in life, whereas a more caudal region like the VTA is fully developed. 
For instance, we observed high fat from birth lead to increased DNA methylation at the 
DAT promoter region in the VTA. On the other hand, a different stimulus of short term 
exercise beginning at 9 weeks of age increased DNA methylation at DR1 and MOR 
promoter in the cortex. We also observed more persistent dopaminergic gene 
expression changes in the prefrontal cortex of early high fat from birth than in the PFC of 
animals receiving high fat from adulthood.  Each brain region has different levels of 
plasticity and sensitive time periods that can alter the developmental trajectory of 
neurotransmitter system will vary over space and time.  
Epigenetics is viewed as the way through which the environment interacts with 
an individual's genome to determine aspects of gene expression. A subset of 
epigenetic changes is very stable, which makes them ideal mediators both of reward 
system vulnerability and of the long lasting drug or food-induced brain maladaptations 
that underlie an addiction disease. DNA methylation was classically thought of as a 
very stable means of gene repression (Klose & Bird, 2006). However we show that 
DNA methylation at the DAT promoter region was reversible with 4 week standard 
chow replacement in males starting high fat from birth. The de-methylation step may 
be an additional hurdle to overcome before gene expression can return to normal 
levels. This time needed to demethylate the promoter region could account for the 
persistence of gene expression changes seen in pre-adolescent high fat animals after 
standard chow replacement.  How the high fat diet and exercise interact with DNA 
methyltransferase on a molecular level is currently unknown.  However, identifying 
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sensitive windows for epigenetic modification can point to time periods where drugs 
acting on these pathways may be more beneficial and prevent chronic illnesses, like 
obesity, in the future.  
We demonstrated that exercise was unable to reverse the dysfunction in natural 
reward intake seen after high fat diet consumption. In fact, exercise alone reduced 
sucrose preference similar to high fat diet. Since exercise and high fat are both 
rewarding and increase dopamine levels in the mesolimbic region of the brain, it is 
possible they elicit neuroadaptations through a similar pathway. One common 
mechanism that exercise and high fat diet may converge on is regulation of DNA 
methylation at promoter regions to elicit gene expression changes. Exercise and high fat 
intake do not alter global DNA methylation, however global methylation assays detect 
intergenic and genome wide levels of methylation. Exercise and high fat seem to work to 
alter DNA methylation at the promoter region to regulate gene expression in the specific 
genes we examined. It is possible that other genes promoters were altered by DNA 
methylation in a similar manner even though global methylation levels remained 
unchanged. 
 DNA methyltransferase 1 (DNMT1) is involved mainly in maintaining existing 
DNA methylation patterns and its activity is regulated by phosphorylation. The N-terminal 
region of Dnmt1 is known to interact with various proteins, such as methyl-CpG-binding 
protein 2 (MeCP2),and various protein kinases (Kamesita et al., 2008). Further 
molecular studies are needed to analyze the specific pathways involved in both high fat 
and exercise that converge on DNMT1 to regulate gene expression. One possible 
upstream pathway previously shown to be involved in both reward mechanisms and 
epigenetic modulation would be the PI3Kinase/AKT phosphorylation cascade that can 
activate DNMT1 (Speed et al., 2011; Mei et al., 2010; Day et al., 2013). Understanding 
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this pathway could give us new potential targets for the treatment of obesity and its 
associated reward dysfunction. Our results on both diet withdrawal and exercise suggest 
new directions in the development of more successful therapies for obesity prevention. 
We demonstrated the importance of finding additional obesity interventions and further 
appreciate the potent rewarding effects of both palatable food and exercise on the brain. 
 
Limitations 
 
Other Neurotransmitter Systems 
As we attempted to answer how age and sex affected the response to high fat 
diet and the response to obesity intervention such as high fat withdrawal and exercise, 
many more questions were created in the process. The hypo reward hypothesis of 
obesity predicted the diminished sucrose preference we observed after high fat diet, 
however we did not find a good candidate gene that predicted diminished sucrose 
followed by reversal after a standard chow replacement. This could be because the 
rewarding aspects of sucrose come from both dopamine and the endogenous opioid 
system. Our lab has previously shown diminished MOR levels after high fat diet that was 
associated with increases in DNA methylation at the promoter region (Vucetic et al., 
2012). However, it is currently unknown how MOR may respond to a standard chow 
replacement. Levels of MOR in the withdrawal period would give us a better 
understanding of both sucrose preference and one hour palatable food intake. Moreover, 
sucrose preference and palatable food consumption do not give a full picture of the 
“wanting” aspect of reward. Experiments such as progressive ratio training can be 
compared to dopaminergic gene expression and help us better understand the 
motivational state of being on and off the high fat diet.   
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Functionality of Gene Expression Changes 
Examining the full functionality of gene expression changes was also a limitation 
of this set of experiments. Dopamine receptors were altered in response to high fat diet; 
however, we did not see any alterations in dopamine receptor signaling. There was no 
difference in response to a DR1 agonist locomotion or c-FOS induction (data not 
shown). However, a dose response to DR1 agonist was not performed and it is possible 
we may see differences in sensitivity to DR1 agonist at additional doses in future 
experiments. Additionally, it is known that dopamine receptor mRNA levels can change 
in response to increasing or decreasing dopamine neurotransmitter levels in the 
examined regions. Downstream signaling at the c-FOS induction step could have been 
up regulated to account for the decrease in receptor levels and the response remained 
at normal levels.  There were no functional experiments performed for DR2. DR2 
signaling is extremely important for over consumption behaviors and analyzing DR2 
signaling in addition to mRNA levels would have given us a richer picture of the reward 
system on high fat diet.   
 
Sex Hormones 
An additional limitation to this study is the unknown level of sex hormones in 
animals at time of diet onset. We can assume that animals beginning high fat diet at birth 
had lower levels of both estrogen and testosterone than animals in adulthood. The 
differences we see between age of onset and sex could be due to a complex interaction 
with levels of sex hormones changing throughout life. All animals were adults during 
data collection and measurements occurred at the same time each day to minimize 
variance that occurs across the circadian cycle. One future way to incorporate hormone 
levels into the analysis would be to measure both estrogen and testosterone at start of 
diet onset and see if hormone level correlates with body weight changes and gene 
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expression changes in adulthood. One way to control for variations in hormones over 
time would be to monitor female cycling and only take measurements of females in the 
same point of the estrus cycle. Since we know estrus cycle is important for 
administration of drugs of abuse, like cocaine (Roberts et al., 1989) it may also be 
important for the intake of sucrose or palatable foods. We saw that both early life and 
adult exposed females had reduced sucrose preferences and increased levels of DAT 
expression after high fat diet intake. Seeing if these sex differences remain at all time 
points of the estrus cycle or in ovarectomized animals will give us insight into the 
importance of sex hormones in the central response to high fat diet.   
 
Obesity Resistant Animals 
 Another limitation to this study was not observing metabolic and behavioral 
effects before onset of diet. When mice are placed on a high fat diet, often times there 
are some obesity resistant animals as well as highly obesity prone animals in the group. 
Examining the behavioral correlates in the two extremes (obesity resistant and obesity 
prone before and after chronic intake would have been another interesting and 
informative way to analyze the data. We did not find a high level of obesity resistant mice 
in our experimental model in order to power the proper analysis. This could have been 
due to the high level (60%) of dietary fat eaten, which is known to quickly drive obesity in 
our mouse strain. Obesity resistant animals may be more prevalent at a lower level of 
dietary fat obesity model. Even without this analysis, our results provide possible risk 
factors that may predict adherence to dietary intervention.   
Analyzing the time point before diet intake would have provided us with additional 
risk factors that predict extreme obesity and hyperphagia or factors that predict obesity 
resistance at different times of development. Looking at metabolic and adiposity data at 
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earlier time points on the diet could have provided us with further understanding on 
adiposity development in younger aged mice. Both brain development and fat cell 
development are occurring at the same time. It is possible that early life adipose tissue is 
just as vulnerable to the nutritional environment as the brain. If beginning high fat diet 
earlier in life leads to more or less fat cells that could mean possible differences in leptin 
signaling to the reward regions and therefore an altered dopaminergic tone. 
 
Lactation Period 
 Chapter 2 examines the response to high fat diet and withdrawal in animals 
exposed since birth. One confounding factor of this study is availability of the high fat 
diet during the lactation period. This would mean the mother was also exposed and the 
offspring were receiving the high fat diet through the mother’s milk. It is difficult to 
compare the diet induced obese animals in chapter 2 with the other experimental models 
in chapters 3 and 4. The data are still extremely valuable because of how important the 
lactation period is for the developing brain. However, it is difficult to tease apart the 
maternal diet and the effects of the high fat diet in offspring when looking at data later in 
adulthood. We controlled for this confounding factor in later experiments and compared 
high fat beginning from weaning and high fat beginning at six weeks of age.  
 
Age of Exercise Exposure 
In chapter 4 we examined both a short term and long term exposure to exercise 
and its effect on behavior, dopamine receptor levels, and neuro inflammatory markers. 
We also examined the interaction of long term exercise with long term high fat diet. One 
limitation to this study is not being able to compare the high fat diet effects in chapter 4 
with the high fat diet effects observed in chapters 2 and 3. Animals in the exercise and 
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high fat diet study received different diet composition, had a shorter length of time on the 
diet, and began intake at a much later age (9 weeks). The differences in results from our 
exercise model compared to our other DIO models highlights how important it is to 
control for all these variables in future studies.  
 
High Fat Diet Composition 
The composition of the diet is another limitation of these experiments.  Animals 
received ad lib exposure to 60% or 40% high fat diet. Although these diets quickly and 
reliably drive obesity, these formulations are not an exact model of the modern diet. The 
typical American diet is 50% carbohydrate, 15% protein, and 35% fat (Last et al., 2006) 
and people are provided with a wide variety of choices. There is also the enormous 
presence of food cues to consider, such as advertisements and cultural norms weaved 
throughout the day that can prime the individual and increase the consumption of food. It 
has been demonstrated that humans habituate when given the same food items and 
decrease intake when presented with them daily. But when presented a variety of food 
choices, people tend to increase their intake (Epstein et al., 2011). We observed a 
similar phenomenon in our animal models. Animals on the ad lib 60% high fat diet have 
decreased daily intake of their ad lib chow (data not shown). However, when the diet is 
removed, and they are presented with a new palatable food choice, they rapidly 
normalize or increase their intake. This decrease of high fat diet intake after 12 weeks 
means that animals may be habituated or “bored” with the diet. The habituation to the 
diet could be a factor of the hypo-reward state of obesity or a parallel characteristic. 
Other labs have used a “cafeteria” diet that may mirror the variability seen in modern 
human diet better than the homogenous 60% diet used in our study. If further studies 
show that a variety of tastes increase energy intake and drive obesity, this could have 
implications for school menu planners, public health officials, a nutritionist that find 
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combating obesity important. Suggesting that people stick to a routine and the same 
foods may be a good strategy, in conjunction with caloric restriction and exercise, for 
obesity treatment. 
 
Interaction between Voluntary Exercise and High Fat diet 
 No previous study has examined the interaction of high fat diet and exercise in 
reward regions of the brain or the interaction with regard to neuro inflammation. Since 
both palatable food consumption and physical activity have actions at the mesolimbic 
dopaminergic system, our attention focused on the influence of chronic exercise in the 
prevention of the neuroadaptations seen in obesity. However, we found that exercise 
had its own effects on reward behaviors and the dopaminergic gene expression. 
Furthermore, we did not find any strong effect of exercise or high fat diet on anxiety 
behavior; although this has been shown in other models.  This could be due to 
differences in rodent species, housing conditions (singly versus communal), duration of 
exercise, and exercise intensity. One big limitation of this study was lack of information 
on the length and distance the animals ran. Animals were given voluntary access to the 
running wheel and there is a chance that some animals did not obtain sufficient amount 
of exercise per day in order to see behavioral changes after 6 weeks of exposure. 
Although a large amount of exercise is not necessary to see behavioral effects. In fact, 
previous studies have shown that a minimum of 8 wheel revolutions per day was enough 
to increase leptin sensitivity and decrease body weight on a control diet (Shapiro et al., 
2011). One way to control for variation between running animals would be to use forced 
running instead of voluntary running so all the animals have equivalent speed, 
frequency, duration, and intensity of exercise exposure.  Forced exercise is often 
thought to be an added stressor to the animal. However, other researchers have 
suggested that forced exercise more closely models the average human exercise 
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regimen, while a voluntary exercise may only model highly motivated endurance athletes 
(Leasure et al., 2008). Data on intensity of exercise and distance travelled could help 
stratify the analysis into high and low volume runners and we would possibly see 
predicted anti-anxiety effects. 
 
Sex Differences in Exercise Response 
Another limitation to the exercise study is that it was only performed in males. We 
have seen from chapters 2 and 3 that there are many sex differences in response to 
high fat diet and would predict sex specific responses for exercise exposure. Other labs 
have shown sex specific responses to exercises, such as the reduction of cocaine 
administration after exercise in females (Cosgrove et al., 2002). Voluntary wheel running 
has also been shown to increase extinction and attenuate reinstatement of cocaine self-
administration in adult female rats (Zlebnik et al., 2010). These results suggest that 
females may benefit more from exercise in abolishing reward dysfunction after high fat 
diet intake. Further studies in female mice are needed to confirm this prediction.  
 
 Additionally, it is possible that exercise may have a more beneficial effect in 
prevention of reward dysfunction before high fat diet onset rather than concurrently with 
high fat diet intake. One important experiment would be to see if exercise exposure in 
adolescence prevents future reward dysfunction when placed high fat diet in adulthood.  
 
Implications	  and	  Conclusions	  
 
 
 As the number obese individuals continue to rise every year, many people are 
seeking answers for why so many people struggle with overconsumption and why there 
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are such high failure rates for weight loss. Although obesity is the consequence of 
imbalanced caloric intake and energy expenditure, diet and exercise alone have not 
been enough to combat most cases of obesity. Decreased caloric consumption and 
increased physical activity can be effective in normalizing weight in the short term; 
however these lifestyle modifications have proven very difficult to sustain (Volkow et al., 
2007). When attempting to diet, obese individuals initially lose weight; however, this 
weightloss slows down until about an average of six months where then weight begins to 
return back to baseline (Jeffery et al., 2000). Adherence to the weight loss strategy is the 
most difficult part to curing obesity and individuals often  “relapse” back to old, unhealthy 
eating habits (Knowler et al., 2009). Current pharmacologic treatments for obesity have 
failed to adequately address the problem and seem to only have short term benefits 
(Yanovski, 2005). Our experiments suggest that the obese brain is markedly different 
with than the lean brain and changes along with BMI changes. Drugs that work in the 
short term may no longer be effective after significant weight loss. We also 
demonstrated that sex differences and age of obesity onset are other potential factors 
behind the failure rates of pharmaceutical interventions. Characterizing how the 
dopamine system responds to the development of obesity and to obesity interventions is 
important for understanding what factors lead to increased success rates in weight loss. 
The development of effective weight loss interventions requires a thorough 
understanding of the factors that drive and/or prevent the overconsumption of palatable 
food. Obesity is increasingly recognized as a behavioral disorder and certain 
populations, such as females and adults who were obese as children, may benefit from 
adjunct behavioral strategies to combat over consumption.   
We demonstrated that early life periods such as lactation and pre-adolescence 
periods in the mouse are important factors in the response to high fat diet and 
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intervention. High fat diet caused more neurochemical and gene expression changes in 
the dopamine system if started earlier in life. These changes tended to be more 
persistent and may put adults who were obese as children at increased risk for failure 
when attempting to diet. The lactation period in the mouse is not equivalent to the 
lactation period in humans because of the timing of brain development. The lactation 
period in mice is more equivalent to the third trimester in humans. This has potential 
implications for pregnant mothers to maintain healthy eating habits throughout 
pregnancy and for parents and schools to help instill healthy eating habits in their 
children.  
As adults, the most important issue is maintaining the weight reduction. Our 
results have implications for adults who were obese as children and are beyond the 
preventative stage. It might be beneficial for this population to know that reversal of 
central dysfunction might take longer than the rest of the population, and additional 
strategies may be required when trying to lose weight. For instance, psychotherapy 
could be useful to help combat dysfunctional reward behaviors in combination with diet 
and exercise. The view that obesity is caused by a lack of willpower or poor self-control 
is extremely prevalent, and promotes the stigmatization of overweight and obese 
individuals. These results demonstrate that the high fat diet itself is acting on the brain to 
change it and promote overconsumption. High fat diet can activate epigenetic machinery 
to make these changes last very long and be more difficult to reverse. In addition to the 
scientific value of these studies, further promoting that obesity is a disease caused by 
environmental factors similar to addiction, may help the psychology of obesity patients 
and direct attention away from the poor “character” or “morality” stereotypes that are 
associated with the obese state. 
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Our results demonstrate that high fat diet has the ability to cause 
neuroadaptations in the reward pathway such as changes in gene expression and 
dopamine neurotransmitter levels. Altering levels of dopamine and dopamine signaling 
may have implications in drugs acting in on these proteins. It is possible that if tested 
under the right conditions, we would see an altered response to drugs such as cocaine 
and amphetamines. We would predict a decrease in the rewarding effect of cocaine in 
males and increase in the rewarding effect of cocaine in females. This can be tested 
through cocaine place preference or progressive ratio tests for cocaine administration. 
Furthermore, increases or decreases in dopamine transporter levels seen after high fat 
diet would also have implications for drugs already on the market that target this protein, 
such as methylphenidate and bupropion, used in the treatment of Attention Deficit 
Hyperactivity Disorder (ADHD) and depression. This may have implications for treating 
obese patients and they may need different dosing schedules that depend on sex and 
age of obesity onset. The link between obesity and depression has been repeatedly 
established (Luppino et al., 2010). We see that high fat diet affects the pathway 
implicated in both addiction and major depression. Researchers looking to target 
dopaminergic proteins in these regions for obesity treatment will have to be cautious of 
the potential addictive or depressive effects that can occur. In fact, in the case of 
Rimonabant, this anti-obesity drug failed to make it through clinical trials because of the 
increase in suicide rates that were associated with its usage.  
Obesity is a complicated state that is associated with increases in adiposity, 
changes in hormone levels, inflammation, and neuroadaptations that affect the 
homeostatic and hedonic food intake systems. We see from our study that just one 
intervention may not be sufficient to prevent all these symptoms. Although both exercise 
and dieting have beneficial weight loss effects, they may not be optimal treatment on 
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their own in curing the reward dysfunction and neuro-inflammation occurring after high 
fat diet. Combinations of treatments together or at different time points may be the most 
effective way to treat obesity. Additionally, as BMI decreases due to intervention, other 
adjunct therapies may be necessary. Experiments studying how the brain changes in 
response to high fat diet and weight loss will help us work out the optimal age and sex 
specific targets for treatment. 
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